WO2020108421A1 - Hexaarylbiimidazole hybrid photoinitiator and application - Google Patents

Hexaarylbiimidazole hybrid photoinitiator and application Download PDF

Info

Publication number
WO2020108421A1
WO2020108421A1 PCT/CN2019/120524 CN2019120524W WO2020108421A1 WO 2020108421 A1 WO2020108421 A1 WO 2020108421A1 CN 2019120524 W CN2019120524 W CN 2019120524W WO 2020108421 A1 WO2020108421 A1 WO 2020108421A1
Authority
WO
WIPO (PCT)
Prior art keywords
meth
photosensitive resin
acrylate
resin composition
bis
Prior art date
Application number
PCT/CN2019/120524
Other languages
French (fr)
Chinese (zh)
Inventor
钱彬
Original Assignee
常州格林感光新材料有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 常州格林感光新材料有限公司 filed Critical 常州格林感光新材料有限公司
Priority to JP2021531320A priority Critical patent/JP7264535B2/en
Priority to KR1020217020531A priority patent/KR102542920B1/en
Publication of WO2020108421A1 publication Critical patent/WO2020108421A1/en

Links

Images

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
    • G03F7/031Organic compounds not covered by group G03F7/029
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/30Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • C08F220/343Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate in the form of urethane links
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06Polymerisation of acrylate or methacrylate esters on to polymers thereof
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/032Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders
    • G03F7/033Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders the binders being polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. vinyl polymers

Definitions

  • the invention belongs to the technical field of photocuring, and specifically relates to a hexaarylbisimidazole mixed photoinitiator, a photosensitive resin composition containing the photoinitiator, and the application of the photosensitive resin composition.
  • the manufacture of microelectronic circuits such as printed circuit boards, integrated circuits, thin film transistors, semiconductor packages, etc. generally includes the formation of resist patterns using photolithography.
  • the photosensitive resin composition layer or laminate coated on the substrate is exposed in combination with a mask having a predetermined pattern, and then developed using a developer with different solubility in the exposed part and the non-exposed part to form a resist
  • the pattern is etched, and then the substrate is plated and/or etched using the resist pattern as a mask to form a desired conductor pattern on the substrate.
  • HABI Hexaarylbisimidazole compounds
  • the current research also emphasizes that the photosensitive composition can be developed or processed in an aqueous phase. If the solubility of the components of the photosensitive resin composition in the developing solution is low, insoluble components that are poorly dispersible in the developing solution when the development process is repeated are remarkably increased, and aggregates (sludge) appear. When the development process is continued, the condensate will re-attach to the substrate, which may cause a short circuit and block the piping of the development tank.
  • the purpose of the present invention is to provide A HABI type mixed photoinitiator.
  • the hexaarylbisimidazole mixed photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connection positions of 1'-2, 2-3', 1-2' and 2'-3 Of the biimidazole compound, and the total mass percentage of the four connected biimidazole compounds in the mixed photoinitiator is more than 92%,
  • Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
  • the aryl group refers to any functional group or substituent derived from a simple aromatic ring, for example: phenyl, o-tolyl, 1-naphthyl (or ⁇ -naphthyl), 2-naphthyl and the like.
  • the object of the present invention is also to provide a photosensitive resin composition containing the above-mentioned mixed photoinitiator, and the application of the composition in manufacturing printed circuit boards, protective patterns, conductor patterns, lead wires, semiconductor packages, and the like.
  • the photosensitive resin composition containing the above-mentioned hexaarylbisimidazole-based mixed photoinitiator has good compatibility, excellent sensitivity, and a small amount of developing waste, and can be widely used as a dry film and a wet film.
  • sludge and "developing waste” in this application refer to substances accumulated in the developing solution, which are insoluble in the developing solution and will be redeposited on the developed substrate, thereby reducing the efficiency of the developing solution.
  • the hexaarylbisimidazole mixed photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connection positions of 1'-2, 2-3', 1-2' and 2'-3 Of the biimidazole compound, and the total mass percentage of the four connected biimidazole compounds in the mixed photoinitiator is more than 92%,
  • Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
  • biimidazole compounds satisfying the four connection positions 1'-2, 2-3', 1-2' and 2'-3 of the structure represented by the general formula (I) have the following structures:
  • the substituted aryl group may be mono-substituted or poly-substituted.
  • the substituent on the aryl group may be halogen, nitro, cyano, amine, hydroxy, C 1 -C 20 alkyl or alkenyl, C 1 -C 8 alkoxy, each of which is independent
  • the methylene group in the variable ie, each substituent may be optionally substituted with oxygen, sulfur, and imine groups.
  • the substituent on the aryl group may be fluorine, chlorine, bromine, nitro, cyano, amine, hydroxy, C 1 -C 10 alkyl or alkenyl, C 1 -C 5 alkoxy Group, wherein the methylene group in each independent variable may be optionally substituted by oxygen, sulfur, imine groups.
  • At least one of Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 and Ar 6 is an aryl group containing a halogen substituent.
  • the halogen substituent can improve the color change effect during the curing process to enhance the recognition ability of the electronic eye during development (Note: the photosensitive resin layer will change color after exposure, and form a color difference with the unexposed area, which is recognized by the electronic eye. The invention can make the color difference more obvious), thereby improving the quality of the applied products.
  • the halogen substituent is chlorine.
  • the HABI in this application means hexaaryldiimidazole, which is formed by coupling two triarylimidazoles (which may be the same or different, depending on the substituent on the aryl group). Due to the induction effect of the substituents on the aromatic ring, the ⁇ electron cloud density of the aromatic ring is reduced, and the induction effect causes the aromatic ring to twist. The conjugate center on the imidazole ring shifts, making the substituted aryl group and imidazole not in the same plane ( The triarylimidazole is in a curved state). When the two imidazoles are finally coupled, the connection of N and C shows different spatial configurations, which has a great impact on the performance of HABI.
  • HABI photoinitiators also exist 1-4′, 1-5′, 3- 4', 3-5', 1-1', 1-3', 3-1', 3-3', 4-1', 4-3', 5-1', 5-3', etc. .
  • the applicant's research found that HABI can only show the best performance when the four connection sites 1'-2, 2-3', 1-2', 2'-3 exist and the total content accounts for more than 92% of the total HABI. Excellent solubility and sensitivity.
  • the solubility of a single substance at any kind of connection site is far less than the mixture of the present invention, and if the total content of these four kinds of connection sites is less than 92%, the sensitivity tends to become significantly lower.
  • a biimidazole compound satisfying four connection positions of 1′-2, 2-3′, 1-2′ and 2′-3 of the structure represented by the general formula (I) is preferably The total mass percentage in the mixed photoinitiator is 95% or more, and it is particularly preferred that the four types of 1'-2, 2-3', 1-2' and 2'-3 satisfy the structure represented by the general formula (I)
  • the connected position is composed of a biimidazole compound.
  • CN1292892A mentions a HABI photoinitiator used in photoresist photopolymerization systems, namely 2,2',5-tris(o-chlorophenyl)-4-( 3,4-dimethoxyphenyl)-4',5'-diphenyl-1,2-diimidazole, commonly referred to as "TCDM-HABI", the document mentions that the use of at least one pro
  • the HABI of water substituents (such as methoxy) can greatly reduce the amount of sludge in the used developer.
  • HABI photoinitiators are a type of photoinitiator known in the photoresist field, and can be prepared by oxidative coupling of triphenylimidazoles or substituted triphenylimidazoles. Specific preparation processes can refer to, for example, US3784557, US4622286, and US4311783 Etc. in the prior art (the entire contents of which are hereby incorporated by reference). On the basis of the existing process, adding a solvent recrystallization process can easily obtain HABI mixed photoinitiators that meet the above composition requirements of the present invention.
  • the solvent may be one or a combination of two or more of toluene, methanol, ethyl acetate, dichloromethane, and water.
  • the photosensitive resin composition of the present invention generally includes, in addition to the HABI-based mixed photoinitiator, an alkali-soluble polymer; a compound having an ethylenically unsaturated double bond; other photoinitiators and/or sensitizers; And optional additives.
  • the alkali-soluble polymer can impart a film-forming function to the photosensitive resin composition.
  • As the alkali-soluble polymer as long as it has such characteristics, it can be applied without particular limitation.
  • the applicable alkali-soluble polymer may be (meth)acrylic polymer, styrene polymer, epoxy polymer, aliphatic polyurethane (meth)acrylate polymer, aromatic polyurethane (method Group) acrylate polymer, amide resin, amide epoxy resin, alkyd resin, phenol resin, etc.
  • the alkali-soluble polymer can be obtained by radical polymerization of a polymerizable monomer.
  • the polymerizable monomer include styrene, vinyl toluene, ⁇ -methylstyrene, p-methylstyrene, p-ethylstyrene, p-chlorostyrene, etc.
  • Maleic acid monoester fumaric acid, cinnamic acid, ⁇ -cyanocinnamic acid, itaconic acid, crotonic acid, propanoic acid, N-vinyl caprolactam; N-vinyl pyrrolidone, etc.
  • These polymerizable monomers may be used alone or in combination of two or more.
  • the alkali-soluble polymer having a carboxyl group may be an acrylic resin containing (meth)acrylic acid as a monomer unit, which is introduced into the carboxyl group by using (meth)acrylic acid as a monomer unit; it may further contain (meth)acrylic acid in addition ( A copolymer of alkyl methacrylate as a monomer unit; it may also contain a polymerizable monomer other than (meth)acrylic acid and alkyl (meth)acrylate in addition to (meth)acrylic acid (such as A copolymer having an ethylenically unsaturated group as a monomer component.
  • the carboxyl group-containing alkali-soluble polymer can be obtained by radical polymerization of a polymerizable monomer having a carboxyl group and other polymerizable monomers, especially from (meth)acrylate, ethylenically unsaturated carboxylic acid and other (Meth) acrylate polymer made by copolymerization of comonomers.
  • the (meth)acrylate may be methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, pentyl (meth)acrylate , Hexyl (meth)acrylate, heptyl (meth)acrylate, octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, (meth)acrylic acid Decyl ester, undecyl (meth)acrylate, dodecyl (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, diethyl (meth)acrylate Aminoethyl, (meth)acrylate dimethylaminoethyl, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, furfuryl (meth)acrylate
  • the ethylenically unsaturated carboxylic acid may be acrylic acid, methacrylic acid, crotonic acid, maleic acid, fumaric acid, itaconic acid, with acrylic acid and methacrylic acid being particularly preferred. These ethylenically unsaturated carboxylic acids may be used alone or in combination of two or more.
  • the other copolymerizable monomers may be (meth)acrylamide, n-butyl (meth)acrylate, styrene, vinyl naphthalene, (meth)acrylonitrile, vinyl acetate, vinyl cyclohexane Wait. These other copolymerizable monomers may be used alone or in combination of two or more.
  • the alkali-soluble polymer may be used alone or in combination of two or more.
  • Examples of the alkali-soluble polymers used in combination of two or more include two or more types of alkali-soluble polymers composed of different copolymerization components, two or more types of alkali-soluble polymers with different weight average molecular weights, and two types with different degrees of dispersion. The above alkali-soluble polymers, etc.
  • the weight-average molecular weight of the alkali-soluble polymer is not particularly limited, but in terms of mechanical strength and alkali developability, the weight-average molecular weight is preferably 15,000 to 200,000, and more preferably 30,000 to 150,000, particularly preferably 30000-120000.
  • the weight average molecular weight is greater than 15,000, the developer resistance after exposure tends to be further improved, and when the weight average molecular weight is less than 200,000, the development time tends to become shorter, and can maintain other components such as photoinitiator Of compatibility.
  • the weight-average molecular weight of the alkali-soluble polymer is measured by gel permeation chromatography (GPC), and is obtained by conversion using a standard polystyrene standard curve.
  • the acid value of the alkali-soluble polymer is preferably 50-300 mgKOH/g, more preferably 50-250 mgKOH/g, still more preferably 70-250 mgKOH/g, and particularly preferably 100- 250mgKOH/g.
  • the acid value of the alkali-soluble resin is less than 50 mgKOH/g, it is difficult to ensure a sufficient development speed.
  • it exceeds 300 mgKOH/g the adhesion is reduced, pattern short-circuiting is likely to occur, and the storage stability and viscosity of the composition are prone to occur. The problem of rising.
  • the molecular weight distribution [weight average molecular weight (Mw)/number average molecular weight (Mn)] of the alkali-soluble resin is preferably 1.5 to 6.0, and particularly preferably 1.8 to 3.7. When the molecular weight distribution is within the above range, the developability is excellent.
  • the content of the alkali-soluble polymer in the composition is preferably 20 to 70 parts by mass, more preferably 30 to 60 parts by mass based on 100 parts by mass of the total photosensitive resin composition.
  • the content of the alkali-soluble polymer is 20 parts by mass or more, the durability of the photosensitive resin composition to plating treatment, etching treatment, etc. can be improved, and when the content is 70 parts by mass or less, it is beneficial to improve the photosensitive resin composition Sensitivity.
  • the compound having an ethylenically unsaturated double bond can promote the film formation of the photosensitive resin composition.
  • the compound having an ethylenically unsaturated double bond is not particularly limited, and a photopolymerizable compound having at least one ethylenically unsaturated bond in the molecule can be used.
  • Illustrative examples include: compounds obtained by reacting ⁇ , ⁇ -unsaturated carboxylic acids with polyols, bisphenol A (meth)acrylate compounds, ⁇ , ⁇ -unsaturated carboxylic acids and glycidyl groups The compound obtained by the reaction of the compound, a urethane monomer such as a (meth)acrylate compound having a urethane bond in the molecule, nonylphenoxypolyvinyloxyacrylate, ⁇ -chloro- ⁇ -hydroxypropyl - ⁇ '-(meth)acryloyloxyethyl-phthalate, ⁇ -hydroxyethyl- ⁇ '-(meth)acryloyloxyethyl-phthalate, ⁇ -hydroxypropyl- ⁇ '-(meth)
  • Examples of the compound obtained by reacting the above-mentioned ⁇ , ⁇ -unsaturated carboxylic acid with a polyhydric alcohol include polyethylene glycol di(meth)acrylate having an ethyleneoxy number of 2-14, and the number of propyleneoxy groups being Polypropylene glycol di(meth)acrylate of 2-14, polyethyleneoxy ⁇ polypropyleneoxydiol di(methyl) with an ethyleneoxy number of 2-14 and a propyleneoxy number of 2-14 Acrylate, trimethylolpropane di(meth)acrylate, trimethylolpropane tri(meth)acrylate, EO modified trimethylolpropane tri(meth)acrylate, PO modified trihydroxy Methylpropane tri(meth)acrylate, EO, PO modified trimethylolpropane tri(meth)acrylate, tetramethylolmethane tri(meth)acrylate, tetramethylolmethane tetra(meth)acrylate Base)
  • EO means ethylene oxide
  • PO means propylene oxide
  • the compound modified with PO means a compound having a block structure of an oxypropylene group.
  • Examples of the bisphenol A-based (meth)acrylate compound include 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane, 2,2- Bis(4-((meth)acryloyloxypolypropoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypolybutoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypolyethoxypolypropoxy)phenyl)propane, etc.
  • 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane examples include 2,2-bis(4-((meth)acryloyloxy Diethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxytriethoxy)phenyl)propane, 2,2-bis(4-((methyl ) Acryloyloxytetraethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypentethoxy)phenyl)propane, 2,2-bis(4- ((Meth)acryloyloxyhexaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxyheptethoxy)phenyl)propane, 2,2- Bis(4-((meth)acryloyloxyoctaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryl
  • the number of oxyethylene groups per molecule of the 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane is preferably 4-20, and more preferably 8-15. These compounds may be used alone or in combination of two or more.
  • the (meth)acrylate compound having a urethane bond in the molecule a (meth)acrylic monomer having an OH group at the ⁇ position and a diisocyanate compound (isophorone diisocyanate, 2 , 6-toluene diisocyanate, 2,4-toluene diisocyanate, 1,6-hexamethylene diisocyanate, etc.) addition reaction product, tri((meth)acryloyloxytetraethylene glycol isocyanate ) Hexamethylene isocyanurate, EO modified urethane di(meth)acrylate, PO modified urethane di(meth)acrylate, EO, PO modified urethane di(meth)acrylic acid Ester etc. These compounds may be used alone or in combination of two or more.
  • nonylphenoxypolyvinyloxy acrylate examples include nonylphenoxytetravinyloxy acrylate, nonylphenoxypentavinyloxy acrylate, and nonylphenoxyhexaethylene.
  • phthalic acid compounds examples include ⁇ -chloro- ⁇ -hydroxypropyl- ⁇ '-(meth)acryloyloxyethyl phthalate and ⁇ -hydroxyalkyl- ⁇ '-(Meth)acryloyloxyalkyl phthalate, etc. These compounds may be used alone or in combination of two or more.
  • alkyl (meth)acrylate examples include methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, N-butyl (meth)acrylate, sec-butyl (meth)acrylate, tert-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, phenyl (meth)acrylate, (meth) ) Isobornyl acrylate, hydroxymethyl (meth)acrylate, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, (meth)acrylic acid 2-hydroxypropyl ester, benzyl (meth)acrylate, amyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, isooctyl (
  • methyl (meth)acrylate preferred are methyl (meth)acrylate, ethyl (meth)acrylate, trimethylolpropane tri(meth)acrylate, ethoxylated trimethylolpropane tri(meth)acrylate, Pentaerythritol tri(meth)acrylate, ethoxylated pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexaacrylate. These compounds may be used alone or in combination of two or more.
  • the compound having an ethylenically unsaturated double bond is preferably a bisphenol A-based (meth)acrylate compound and a compound having a urethane bond in the molecule ( Meth)acrylate compound. From the viewpoint of improving sensitivity and resolution, a bisphenol A (meth)acrylate compound is preferred.
  • 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane such as Shin Nakamura Chemical Industry Co., Ltd., BPE-200
  • polyethoxybisphenol A methacrylate such as Shin Nakamura Chemical Industry Co., Ltd., BPE-5000; Hitachi Chemical Co., Ltd., FA-321M
  • 2-bis(4-((meth)acryloyloxypolybutoxy)phenyl)propane such as Shin Nakamura Chemical Industry Co., Ltd., BPE-1300
  • the content of the compound having an ethylenically unsaturated double bond is preferably 20-50 parts by mass, and more preferably 25-45 parts by mass.
  • the sensitivity and resolution of the photosensitive resin composition will be further improved; when the content is less than 50 parts by mass, the photosensitive resin composition is easier It is thinned and the durability against etching is further improved.
  • the HABI hybrid photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connections of 1'-2, 2-3', 1-2' and 2'-3 Bis-imidazole compound, and the total mass percentage of the four-linked bis-imidazole compound in the mixed photoinitiator is 92% or more, preferably 95% or more, and particularly preferably 100%,
  • Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
  • the HABI-based hybrid photoinitiator of the present invention may be selected from or include:
  • compounds such as compound A1 and compound A2 may exist alone, or two or more kinds may be used in combination.
  • the hexaarylbisimidazole-based mixed photoinitiator of the present invention is preferably 1 to 10 parts by mass. Within this content range, the composition can exhibit good system compatibility and excellent curing performance.
  • the photosensitive resin composition of the present invention may further contain other photoinitiators and/or sensitizers to increase the compatibility, sensitivity, and resolution of the photosensitive resin system through a common/synergistic effect.
  • the other photoinitiators and/or sensitizers may include (but are not limited to): diimidazoles, pyrazolines, aromatic ketones, anthraquinones, benzoin and benzoin alkyl ethers, Oxime esters, triazines, triphenylamines, coumarins, thioxanthones, acridines and other photoinitiators known to those skilled in the art. These photoinitiators can be used alone or in combination of two or more.
  • the bisimidazole compounds include: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl-diimidazole, 2,2',5-tri(o Chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1,1'-diimidazole, 2,2',5-tri(2-fluoro Phenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-diimidazole, 2,2'-bis(2,4-dichlorophenyl)-4 ,4',5,5'-tetraphenyl-diimidazole, 2,2'-bis(2-fluorophenyl)-4-(o-chlorophenyl)-5-(3,4-dimethoxy Phenyl)-4',5'-diphenyl-diimidazole, 2,2'-bis(
  • the pyrazoline compounds include: 1-phenyl-3-(4-tert-butylstyryl)-5-(4-tert-butylphenyl)pyrazoline, 1-phenyl-3 -Biphenyl-5-(4-tert-butylphenyl) pyrazoline, ethoxylated (9) trimethylol pyrazoline ester, ethoxylated (10) bisphenol A pyrazoline ester And the like. These pyrazoline compounds may be used alone or in combination of two or more.
  • the aromatic ketone compounds include: acetophenone, 2,2-dimethoxy-2-phenylacetophenone, 2,2-diethoxy-2-phenylacetophenone, 1 ,1-dichloroacetophenone, benzophenone, 4-benzoyldiphenyl sulfide, 4-benzoyl-4'-methyldiphenyl sulfide, 4-benzoyl-4'-ethyl Diphenyl sulfide, 4-benzoyl-4'-propyl diphenyl sulfide, 4,4'-bis(diethylamino) benzophenone, 4-p-toluene mercaptobenzophenone, 2 ,4,6-trimethylbenzophenone, 4-methylbenzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(methyl, ethyl (Amino) benzophenone, acetophenone dimethyl ketal, benzyl dimethyl
  • the anthraquinone compounds include: 2-phenylanthraquinone, 2,3-diphenylanthraquinone, 1-chloroanthraquinone, 2-methylanthraquinone, 2,3-dimethylanthraquinone, 2-ethylanthracene-9,10-diethyl, 1,2,3-trimethylanthracene-9,10-dioctyl fat, 2-ethylanthracene-9,10-bis(4-chlorobutyric acid Methyl ester), 2-(3-((3-ethyloxetan-3-yl)methoxy)-3-oxopropyl)anthracene-9,10-diethyl ester, 9,10 -Dibutoxyanthracene, 9,10-diethoxy-2-ethylanthracene, 9,10-bis(3-chloropropoxy)anthracene, 9,10-bis(2-hydroxye
  • benzoin and benzoin alkyl ether compounds include: benzoin methyl ether, benzoin ethyl ether, benzoin phenyl ether and the like. These benzoin and benzoin alkyl ether compounds may be used alone or in combination of two or more.
  • the oxime ester compounds include: 1-(4-phenylthiophenyl)-n-octane-1,2-dione-2-benzoic acid oxime ester, 1-(6-(2-methyl Benzoyl)-9-ethylcarbazol-3-yl)-ethane-1-one-oxime acetate, 1-(6-(2-methylbenzoyl)-9-ethylcarbazole- 3-yl)-butane-1-one-oxime acetate, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-propane-1-one-acetic acid Oxime ester, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-1-cyclohexyl-methane-1-one-oxime acetate, 1-(6- (2-methylbenzoyl)-9-ethylcarbazol-3-yl)-3-cyclopenty
  • triazine compounds include: 2-(4-ethylbiphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(3,4- Methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 3- ⁇ 4-[2,4-bis(trichloromethyl)-s-triazine -6-yl]phenylthio ⁇ propionic acid, 1,1,1,3,3,3-hexafluoroisopropyl-3- ⁇ 4-[2,4-bis(trichloromethyl)-s- Triazin-6-yl]phenylthio ⁇ propionate, ethyl-2- ⁇ 4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]phenylthio ⁇ ethyl Ester, 2-ethoxyethyl-2- ⁇ 4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]
  • the triphenylamine compounds include: N,N-bis-[4-(2-styryl-1-yl)-phenyl]-N,N-bis(2-ethyl-6methylbenzene Group)-1,1-bisphenyl-4,4-diamine, N,N-bis-[4-(2-styryl-1-yl)-4′-methylphenyl]-N, N-bis(2-ethyl-6methylphenyl)-1,1-bisphenyl-4,4-diamine and the like. These triphenylamine compounds may be used alone or in combination of two or more.
  • the coumarin compounds include: 3,3'-carbonylbis(7-diethylamine coumarin), 3-benzoyl-7-diethylamine coumarin, 3,3'-carbonyl Bis(7-methoxycoumarin), 7-(diethylamino)-4-methylcoumarin, 3-(2-benzothiazole)-7-(diethylamino)coumarin , 7-(diethylamino)-4-methyl-2H-1-benzopyran-2-one (7-(diethylamino)-4-methylcoumarin), 3-benzoyl- 7-Methoxycoumarin and its analogues.
  • These coumarin compounds may be used alone or in combination of two or more.
  • the thioxanthone compounds include: thioxanthone, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropylthioxanthone, 2 -Chlorothioxanthone, 1-chloro-4-propoxythioxanthone, isopropylthioxanthone, diisopropylthioxanthone and the like. These thioxanthone compounds may be used alone or in combination of two or more.
  • acridine compounds include: 9-phenyl acridine, 9-p-methylphenyl acridine, 9-m-methylphenyl acridine, 9-o-chlorophenyl acridine, 9-o-fluorine [4-(9-acridinyl)phenoxy]acetate of phenylacridine, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol ether cyclohexane ether (ie PAD107, Produced by Changzhou Qiangli Electronic New Materials Co., Ltd.), 1,7-bis(9-acridinyl)heptane, 9-ethylacridine, 9-(4-bromophenyl)acridine, 9-(3 -Chlorophenyl) acridine, 1,7-bis(9-acridine) heptane, 1,5-bis(9-acridinepentane), 1,3
  • the content of the other photoinitiator and/or sensitizer is not more than 8 parts by mass.
  • the photosensitive resin composition of the present invention may optionally contain an appropriate amount of other auxiliary agents as needed.
  • the auxiliary agent may be dyes such as malachite green, tribromophenyl sulfone, colorless crystal violet and other light color developers, pigments, fillers, plasticizers, stabilizers, coating aids, peeling accelerators, etc. .
  • dyes, pigments, and photochromic agents exemplarily, tris(4-dimethylaminophenyl)methane, tris(4-dimethylamino-2methylphenyl)methane, fluorane Phthalocyanines such as dyes, toluenesulfonic acid monohydrate, basic magenta, phthalocyanine green and phthalocyanine blue, auramine, by-product magenta, crystal violet, methyl orange, Nile blue 2B, Victoria blue, peacock Green, Diamond Green, Basic Blue 20, Brilliant Green, Eosin, Ethyl Violet, Erythrosine Sodium B, Methyl Green, Phenolphthalein, Alizarin Red S, Thymol Phenolphthalein, Methyl Violet 2B, Quinadine Red, Rose Bengal Agar, Mitaniel Yellow, Thymol Sulfophthalein, Xylenol Blue, Methyl Orange, Orange IV, Diphenyl Fluorane Phthalocyanines
  • tris(4-dimethylaminophenyl)methane ie, leuco crystal violet, LCV.
  • These dyes, pigments and photochromic agents may be used alone or in combination of two or more.
  • fillers such as silica, alumina, talc, calcium carbonate, and barium sulfate (excluding the above-mentioned inorganic pigments) may be used.
  • the filler may be used alone or in combination of two or more.
  • plasticizer for example, it may be: phthalate such as dibutyl phthalate, diheptyl phthalate, dioctyl phthalate, diallyl phthalate, etc.
  • Glycol esters such as acid esters, triethylene glycol diacetate, tetraethylene glycol diacetate, sulfonamides such as p-toluenesulfonamide, benzenesulfonamide, n-butylbenzenesulfonamide, triphenyl phosphate, Trimethyl phosphate, triethyl phosphate, triphenyl phosphate, tricresyl phosphate, tricresyl phosphate, tolyl diphenyl phosphate, tricresyl phosphate, 2-naphthyl Diphenyl phosphate, tolyl bis 2,6-xylyl phosphate, aromatic condensed phosphate, tri(chloropropy
  • the above stabilizer exemplarily, it may be: hydroquinone, 1,4,4-trimethyl-diazobicyclo(3.2.2)-non-2-ene-2,3-dioxide, 1 -Phenyl-3-pyrazolidone, p-methoxyphenol, alkyl and aryl substituted hydroquinones and quinones, tert-butylcatechol, 1,2,3-pyrogallol, copper resinate, naphthalene Amine, ⁇ -naphthol, cuprous chloride, 2,6-di-tert-butyl-p-cresol, phenothiazine, pyridine, nitrobenzene, dinitrobenzene, p-toluoquinone and chloroquinone.
  • the stabilizer may be used alone or in combination of two or more.
  • the coating aid from the viewpoint of safety and versatility, it may be: acetone, methanol, methyl alcohol, ethyl alcohol, isopropyl alcohol, methyl ethyl ketone, propylene glycol monomethyl ether acetate , Ethyl lactate, cyclohexanone, ⁇ -butyrolactone, dichloromethane, etc.
  • the coating aid may be used alone or in combination of two or more.
  • peeling accelerator examples include benzenesulfonic acid, toluenesulfonic acid, xylenesulfonic acid, phenolsulfonic acid, methyl, propyl, heptyl, octyl, decyl, and dodecane Alkylbenzene sulfonic acid, etc.
  • the peeling accelerator may be used alone or in combination of two or more.
  • the content of the auxiliary agent is not more than 10 parts by mass.
  • the photosensitive resin composition of the present invention can be prepared as a dry film, that is, a photosensitive resin laminate, and is used in the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, and semiconductor packages through different processes in different The desired pattern is formed on the substrate.
  • the photosensitive resin composition of the present invention can also be applied to the corresponding substrate in each corresponding manufacturing step by a wet film coating machine, that is, used as a wet film for printed circuit boards, protective patterns, conductor patterns, frame wires, In the manufacture of semiconductor packages, different patterns are formed on different substrates through different processes.
  • the photosensitive resin laminate which is a dry film of the present invention includes a photosensitive resin layer formed of a photosensitive resin composition and a support that supports the photosensitive resin layer.
  • the production of a dry film includes: coating a photosensitive resin composition on a support and drying to form a photosensitive resin layer; optionally, attaching a cover film (protective layer) as needed.
  • the drying conditions are at 60-100°C for 0.5-15 min.
  • the thickness of the photosensitive resin layer is preferably 5-95 ⁇ m, more preferably 10-50 ⁇ m, and more preferably 15-30 ⁇ m. If the thickness of the photosensitive resin layer is less than 5 ⁇ m, the insulation is not good, and if the thickness of the photosensitive resin layer exceeds 95 ⁇ m, the resolution may be poor.
  • plastic films such as polyethylene terephthalate, polyethylene naphthalate, polypropylene, polyethylene, cellulose acetate, polyalkylmethacrylate Ester, methacrylate copolymer, polyvinyl chloride, polyvinyl alcohol, polycarbonate, polystyrene, cellophane, vinyl chloride copolymer, polyamide, polyimide, ethylene chloride-vinyl acetate copolymer, polytetramethylene Vinyl fluoride, polytrifluoroethylene and the like.
  • composite materials composed of two or more materials can also be used.
  • polyethylene terephthalate having excellent light penetration is used.
  • the thickness of the support is preferably 5-150 ⁇ m, and more preferably 10-50 ⁇ m.
  • the coating of the photosensitive resin composition is not particularly limited, and for example, a spray coating method, a drum coating method, a spin coating method, a slit coating method, a compression coating method, a curtain coating method, and a dye coating can be used Conventional methods such as cloth method, line coating method, blade coating method, roll coating method, blade coating method, spray coating method, dip coating method, etc.
  • the present invention provides the application of the above dry film in the manufacture of printed circuit boards, including:
  • Lamination step Laminating a photosensitive resin laminate on a copper-clad laminate or flexible substrate;
  • Exposure step Expose the photosensitive resin layer in the photosensitive resin laminate, and irradiate active light in the form of an image to photocur the exposed portion;
  • Conductor pattern forming process etching or plating the part of the surface of the copper-clad laminate or flexible substrate that is not covered by the protection pattern;
  • Peeling step peeling the protective pattern from the copper-clad laminate or flexible substrate.
  • the present invention provides the application of the above dry film in manufacturing a protective pattern, including the above-mentioned lamination step, exposure step and development step, the difference is that in the lamination step, the photosensitive resin laminate can be laminated on various materials On the substrate.
  • the present invention provides the application of the above dry film in manufacturing a conductor pattern, including the above-mentioned lamination step, exposure step, development step, and conductor pattern formation step, except that in the lamination step, the photosensitive resin laminate is laminated on the metal Board or metal-coated insulating board.
  • the present invention provides the application of the above dry film in manufacturing a frame wire, including the above-mentioned lamination step, exposure step, development step, and conductor pattern forming step, except that the photosensitive resin laminate is laminated in the lamination step On the metal plate, the part not covered by the protection pattern is etched in the conductor pattern forming process.
  • the present invention provides the application of the above dry film in the manufacture of semiconductor packages, including the above-mentioned lamination step, exposure step, development step, and conductor pattern forming step, the difference is that in the lamination step, the photosensitive resin laminate is laminated on On a wafer with a large-scale integrated circuit, the part not covered by the protection pattern is plated in the conductor pattern forming process.
  • the photosensitive resin composition of the present invention can be directly applied on a substrate by a wet film method, and is used for the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, semiconductor packages, and the like.
  • the photosensitive resin composition can be applied on the substrate by conventional methods such as roll coating, blade coating, spray coating, and dip coating, and dried to form the photosensitive resin layer.
  • the exposure may include a mask exposure method (a method in which a negative or positive mask pattern of a wiring pattern irradiates active light in the form of an image), a projection exposure method, or a direct imaging exposure method using laser, digital optics
  • a mask exposure method a method in which a negative or positive mask pattern of a wiring pattern irradiates active light in the form of an image
  • a projection exposure method or a direct imaging exposure method using laser, digital optics
  • the method of direct drawing exposure such as the processing exposure method, irradiates the active light in the form of an image.
  • a well-known light source such as a carbon arc lamp, a mercury vapor arc lamp, an ultra-high pressure indicator lamp, a high-pressure indicator lamp, a gas laser such as a xenon lamp, an argon laser, a solid laser such as a YAG laser, a semiconductor laser, and gallium nitride can be used It is a blue-violet laser and other light sources that effectively emit ultraviolet light.
  • a light source that efficiently emits visible light such as a floodlight for photography or a fluorescent lamp can also be used.
  • the photosensitive resin composition of the present invention is not particularly limited to the type of light source of active light, and the exposure amount is preferably 10-1000 mJ/cm 2 .
  • the unexposed portion of the photosensitive resin layer is removed with a developer.
  • the support When the support is present on the photosensitive resin layer, the support can be removed by an automatic peeler, etc., and then the unexposed portion can be removed using a developer such as an alkaline aqueous solution, an aqueous developer, or an organic solvent.
  • a developer such as an alkaline aqueous solution, an aqueous developer, or an organic solvent.
  • the alkaline aqueous solution may be 0.1-5 mass% sodium carbonate solution, 0.1-5 mass% potassium carbonate solution, 0.1-5 mass% sodium hydroxide solution, etc.
  • the pH value is preferably 9-11.
  • Surfactants, defoamers, organic solvents, etc. can also be added to the alkaline aqueous solution.
  • the development method may be conventional methods such as dipping, spraying, and brushing.
  • the conductor layer of the uncovered circuit-forming substrate is etched away to form a conductor pattern.
  • the etching method can be selected according to the conductor layer to be removed.
  • examples of the etching solution include copper oxide solution, iron oxide solution, alkali etching solution, hydrogen peroxide-based etching solution, and the like.
  • the plating process using the resist pattern formed on the substrate as a mask, copper, solder, or the like is plated on the insulating plate of the uncovered circuit-forming substrate. After the plating process, the resist pattern is removed to form a conductor pattern.
  • a method of the plating treatment either electroplating treatment or electroless plating treatment may be used, and electroless plating treatment is preferable.
  • Examples of the electroless plating treatment include copper plating such as copper sulfate plating and copper pyrophosphate plating, high-throw solder plating and other solder plating, and watt bath (nickel sulfate-chloride) Nickel) plating and nickel sulfamate plating and other nickel plating, hard gold plating and soft gold plating and other gold plating.
  • copper plating such as copper sulfate plating and copper pyrophosphate plating, high-throw solder plating and other solder plating, and watt bath (nickel sulfate-chloride) Nickel) plating and nickel sulfamate plating and other nickel plating, hard gold plating and soft gold plating and other gold plating.
  • the resist pattern can be removed by an aqueous solution that is more alkaline than the alkaline aqueous solution used in the development step.
  • an aqueous solution that is more alkaline than the alkaline aqueous solution used in the development step.
  • a strong alkaline aqueous solution for example, a 1-10% by mass sodium hydroxide aqueous solution can be used.
  • Figure 1 is a high performance liquid chromatogram of compound a1.
  • Figure 2 is the structure spectrum of T1 obtained by single crystal diffraction
  • Figure 3 is a comparison of the sensitivity test results of compounds a1, a2, a3, a8, a9, a10
  • the product was analyzed using high performance liquid chromatography.
  • Figure 1 is a high performance liquid chromatogram of product a1.
  • the analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.5%.
  • the product a1 is a mixture obtained from two different monoimidazoles (ie, M1, M2) by pair-wise coupling and mutual coupling, including T1, T2, and T3.
  • M1, M2 monoimidazoles
  • T1, T2, and T3 the components a1-1, a1-2 and a1-3 were verified and analyzed.
  • T1 has only one peak in the liquid phase, but two peak shapes are obtained by single crystal diffraction, see Figure 2. According to the structural characteristics, it can be determined that the main product of the coupling of two monoimidazoles is a mixture of N containing hydrogen on one imidazole and C on the 2-position of the other imidazole, thus indicating that the structure of T1 is The 1-2' and 2'-3 connection positions mentioned above.
  • the imidazole used to synthesize T1 is M1, which belongs to symmetric imidazole, so the 1-2' and 2'-3 obtained by coupling are of similar polarity, and the liquid phase is difficult to separate. And because of the structural symmetry of M1, the structure of the product obtained by its own coupling is 1-2' and 1'-2, and 2'-3 and 3-2' are the same, so the main structure of T1 is 1-
  • the products of the two connecting positions of 2'and 3-2' have the structural formulas as shown below, respectively T1-1: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl -1,2'-diimidazole and T1-2: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole;
  • the monoimidazole M2 synthesized by T2 belongs to asymmetric monoimidazole. There are two configurations of M2, M2-1 and M2-2, as shown below:
  • T2 is synthesized by asymmetric monoimidazole coupling.
  • there are eight main structures connected by 1-2 and 2-3 connecting sites but for the self-coupled monoimidazole, the structure of 1-2' is the same as 1'-2.
  • the structure of 2'-3 and 3-2' is also the same, so for T2, there are actually four main structures connected by 1-2 and 2-3 connection sites, and their compositions are:
  • T2-1 2,2',5,5'-tetra(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-2',3-diimidazole
  • T2 -2 2,2',4,5'-tetra(o-chlorophenyl)-4',5-bis(3,4-dimethoxyphenyl)-1,2'-diimidazole
  • T2- 3 2,2',5,5'-tetra(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-1,2'-diimidazole
  • T2-4 2,2',4,5'-tetra(o-chlorophenyl)-4',5-bis(3,4-dimethoxyphenyl)-2',3-diimidazole, the structure is shown below :
  • T3 is formed by coupling M1 and M2 two by two.
  • the main structure of the pure T3 separated in the liquid phase is the product with four kinds of connection positions.
  • the structure of the products with four kinds of connection positions is confirmed by LCMS.
  • Mass spectrometry analysis obtained molecular fragment peaks of 755 and 756 with the software attached to the instrument.
  • the molecular weight of the product was 754, which was consistent with T+1 and T+2, proving that these four products have similar structures and the same molecular weight.
  • T3 is formed by connecting symmetrical imidazole M1 and asymmetrical imidazole M2 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, which are composed of:
  • T3-1 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1,2'-di Imidazole
  • T3-2 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2',3 -Diimidazole
  • T3-3 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2, 3'-diimidazole
  • T3-4 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl- 1',2-Diimidazole, the structural formula is as follows:
  • the product a1 is composed of T1 (T1-1, T1-2), T2 (T2-1, T2-2, T2-3, T2-4) and T3 (T3-1, T3-2, T3-3, T3-4) combined, in which the content of the biimidazole compound composed of four connecting positions 1'-2, 2-3', 1-2' and 2'-3 in a1 is 92.5% .
  • A2-a10 were prepared separately, and the conditions of each product are shown in Table 1 below.
  • solubility of pure HABI (a6 and a7) with a single structure is very poor, and even if it is mixed with other HABI (a4 and a5), the solubility cannot be improved.
  • the initiator must have the structure of the same substituent and there are four kinds of linking sites simultaneously to achieve the optimal solubility shown in the present invention.
  • the photosensitive resin compositions of Comparative Examples 1-6 were prepared for sensitivity test, and the unit of dosage of each substance in the table was g.
  • TMPTA was purchased from Tianjin Beilian Fine Chemical Development Co., Ltd.
  • NPG was purchased from Shenzhen Pengshunxing Technology Co., Ltd.
  • PGMEA was purchased from Jinan Huifengda Chemical Co., Ltd.
  • the peak value represents the maximum heat dissipation, mw/mg, the greater the heat dissipation, the higher the sensitivity.
  • the slope represents the curing rate, the smaller the slope, the higher the sensitivity.
  • the results are shown in Figure 3.
  • the sensitivity test results are: a10 (76.1%) ⁇ a9 (83.0%) ⁇ a8 (88.5%) ⁇ a1 (92.5%) ⁇ a2 (95.6%) ⁇ a3 (98.3).
  • This further confirms that the total mass of the biimidazole compound composed of four connection sites of 1'-2, 2-3', 1-2' and 2'-3 in the mixed photoinitiator has a certain effect on the sensitivity, when When the content is higher than 92%, the sensitivity is improved.
  • the analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.5%.
  • the product a11 is a mixture obtained from two different monoimidazoles (ie, M2 and M3) by pairwise coupling and mutual coupling, including T2, T4 and T5.
  • T2, T4 and T5 were analyzed and verified.
  • T2, T4 and T5 were obtained respectively, and the structure was confirmed separately.
  • T2 has the same structure as compound a1.
  • T4 is formed by the coupling of asymmetric monoimidazole M3 itself, there are four main structures connected by 1-2 and 2-3 connection sites, and their composition is:
  • T4-1 2,2'-bis(4-chlorophenyl)-5,5'-bis(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)- 2,3'-Diimidazole
  • T4-2 2,2'-bis(4-chlorophenyl)-4,5'-bis(o-chlorophenyl)-4',5-bis(3,4- Dimethoxyphenyl)-1,2'-diimidazole
  • T4-3 2,2'-bis(4-chlorophenyl)-5,5'-bis(o-chlorophenyl)-4,4 '-Bis(3,4-dimethoxyphenyl)-1,2'-diimidazole
  • T4-4 2,2'-bis(4-chlorophenyl)-4',5-bis(o Chlorophenyl)-4,5'-bis(3,4-dimethoxyphenyl)-2,3'-diimi
  • T5 is formed by the coupling of asymmetric M2 and asymmetric M3, and there are four main structures connected by 1-2 and 2-3 connection sites.
  • Their composition is:
  • T5-1 2-(4-chlorophenyl)-2', 5,5'-tri(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-2 ,3'-diimidazole
  • T5-2 2'-(4-chlorophenyl)-2,5,5'-tri(o-chlorophenyl)-4,4'-bis(3,4-dimethyl Oxyphenyl)-1,2'-diimidazole
  • T5-3 2-(4-chlorophenyl)-2',5,5'-tris(o-chlorophenyl)-4,4'-bis (3,4-dimethoxyphenyl)-2',3-diimidazole
  • T5-4 2'-(4-chlorophenyl)-2,5,5'-tri(o-chlorophenyl) -4,4'-bis(3,4-dimethoxyphenyl)-1',2-diimidazole
  • the product a11 is composed of T2 (T2-1, T2-2, T2-3, T2-4), T4 (T4-1, T4-2, T4-3, T4-4) and T5 ( T5-1, T5-2, T5-3, T5-4), which consists of biimidazole compounds composed of four connecting positions 1'-2, 2-3', 1-2' and 2'-3
  • T2 T2-1, T2-2, T2-3, T2-4
  • T4 T4-1, T4-2, T4-3, T4-4
  • T5 T5-1, T5-2, T5-3, T5-4
  • A12-a20 were prepared separately, and the conditions of each product are shown in Table 3 below.
  • solubility data in the table above further shows that the solubility of pure HABI (a16 and a17) with a single structure is very poor, and even if it is mixed with other HABI (a14 and a15), the solubility cannot be improved. It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
  • the analysis result showed that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 was 92.1%.
  • the product a21 is a mixture obtained from two different symmetrical monoimidazoles (ie, M1, M4) by pairwise self-coupling and mutual coupling, including T1, T6, and T7. In order to accurately verify the structure of the product, the components T1, T6 and T7 were verified and analyzed.
  • T1, T6 and T7 were obtained respectively, and the structure was confirmed separately.
  • T1 has the same structure as compound a1.
  • T6 has two structures, but there is only one peak in the liquid phase, and its structural composition is similar to that of T1.
  • T6 is obtained by self-coupling of symmetric imidazole, so the polarities of 1-2' and 2'-3 obtained by coupling are similar ,
  • the liquid phase is difficult to separate, the structural formula is as follows, respectively T6-1: 2,2'-bis(2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-1 , 2'-diimidazole and T6-2: 2,2'-bis(2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole;
  • the separated T6 was analyzed, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained 729 and 730 molecular fragment peaks with the software attached to the instrument. The molecular weight of the product was 728, which was in agreement with T+1 and T+2, proving that these two products have similar peak structures and the same molecular weight.
  • T7 is formed by coupling symmetrical M1 and symmetrical M4 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, whose composition are:
  • T7-1 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2,3'-diimidazole
  • T7 -2 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-1',2-diimidazole
  • T7- 3 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-diimidazole
  • T7-4 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole, the structural formula is shown below :
  • the product a21 is composed of T1 (T1-1, T1-2), T6 (T6-1, T6-2) and T7 (T7-1, T7-2, T7-3, T7-4) It is a combination, in which the content of the biimidazole compound composed of four connecting positions of 1'-2, 2-3', 1-2' and 2'-3 in a21 is 92.1%.
  • A22-a30 were prepared separately, and the conditions of each product are shown in Table 4 below.
  • the solubility data in the table above further shows that the solubility of pure HABI (a26 and a27) with a single structure is very poor, and even if it is mixed with other HABI (a24 and a25), the solubility cannot be improved.
  • the HABI-type mixed photoinitiators described in the present invention It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
  • the analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.7%.
  • the product a31 is a mixture obtained from two different symmetrical monoimidazoles (ie, M1, M5) through pairwise self-coupling and mutual coupling, including T1, T8, and T9. In order to accurately verify the structure of the product, the components T1, T8 and T9 were verified and analyzed.
  • T1, T8 and T9 were obtained respectively, and the structure was confirmed separately.
  • T1 has the same structure as compound a1.
  • T8 has two structures, but there is only one peak in the liquid phase, and its structural composition is similar to that of T1.
  • T8 is obtained by self-coupling of symmetric imidazole (M5), so the 1-2' and 2'-3 obtained by coupling The polarities are similar, and the liquid phase is difficult to separate.
  • the structural formulas are as follows: T8-1: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetra(2-naphthyl )-1,2'-diimidazole and T8-2: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetrakis(2-naphthyl)-2',3- Diimidazole
  • the separated T8 was analyzed, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained the molecular fragment peaks of 860 and 861 with the software attached to the instrument. The molecular weight of the product was 859, which was in agreement with T+1 and T+2, proving that the two products had similar peak structures and the same molecular weight.
  • T9 is formed by coupling symmetrical M1 and symmetrical M5 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, and their composition is:
  • T9-1 2,2'-bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-1,2'-diimidazole
  • T9-2 2,2'-bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-2',3-diimidazole
  • T9-3 2,2' -Bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-1',2-diimidazole
  • T9-4 2,2'-bis(o Chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-2,3'-diimidazole, the structural formula is as follows:
  • the separated T9 was analyzed, and the structure was confirmed by LCMS.
  • the mass spectrometry analysis obtained the molecular fragment peaks of 760 and 761 with the software attached to the instrument.
  • the molecular weight of the product was 759, which was consistent with T+1 and T+2, which proved that the four products had similar peak structures and the same molecular weight.
  • the product a31 is composed of T1 (T1-1, T1-2), T8 (T8-1, T8-2) and T9 (T9-1, T9-2, T9-3, T9-4) It is a combination, in which the content of the biimidazole compound composed of four connecting positions of 1'-2, 2-3', 1-2' and 2'-3 in a21 is 92.7%.
  • A32-a40 were prepared separately, and the conditions of each product are shown in Table 5 below.
  • the solubility data in the above table further shows that the solubility of pure HABI (a36 and a37) with a single structure is very poor, and even if it is mixed with other HABI (a34 and a35), the solubility cannot be improved.
  • the HABI-type mixed photoinitiators described in the present invention It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
  • the photosensitive resin composition was sufficiently stirred, and it was evenly coated on the surface of a 25 ⁇ m thick polyethylene terephthalate film as a support using a bar coater, and dried in a dryer at 95° C. for 5 minutes. A photosensitive resin layer with a thickness of 40 ⁇ m was formed, and then a 15 ⁇ m-thick polyethylene film as a protective layer was laminated on the surface of the photosensitive resin layer where no polyethylene terephthalate film was laminated to obtain a dry film.
  • a 1.2-mm-thick copper-clad laminate laminated with a 35- ⁇ m-thick rolled copper foil was used, and the surface was subjected to wet polishing roll grinding (Scotch-Brite (registered trademark) HD#600 manufactured by 3M Corporation, and passed twice ).
  • the polyethylene film protective layer was peeled off from the dry film, and then using a hot roll laminator (AL-70 manufactured by Asahi Kasei Co., Ltd.), it was laminated on a copper clad preheated to 60°C at a roll temperature of 105°C. Laminate.
  • the gas pressure is 0.35 MPa, and the lamination speed is 1.5 m/min.
  • the mask was placed on a polyethylene terephthalate film as a support, and exposed by an ultra-high pressure mercury lamp (HMW-201KB manufactured by ORCMANUFACTURINGCO., LTD.).
  • HMW-201KB manufactured by ORCMANUFACTURINGCO., LTD.
  • the polyethylene terephthalate film was peeled off, and a 1% by mass Na 2 CO 3 aqueous solution at 30° C. was sprayed on the photosensitive resin layer using an alkali developing machine (developer for dry film manufactured by FujiKiko Co., Ltd.) Above, the unexposed portion of the photosensitive resin layer is dissolved and removed in a time twice as long as the minimum development time.
  • the minimum development time is the shortest time required to completely dissolve the photosensitive resin layer of the unexposed portion.
  • the photosensitive resin composition was sufficiently stirred, and the composition was uniformly coated on the surface of a 25 ⁇ m-thick polyethylene terephthalate film as a support using a bar coater. Dry in a dryer at 95°C for 5 min to form a photosensitive resin layer. Then the surface of the photosensitive resin layer was visually inspected and graded as follows:
  • the photosensitive resin layer was exposed for 15 minutes using a 21-stage stepped exposure meter manufactured by Stouffer with a 21-stage brightness change from transparent to black to evaluate its sensitivity. After the exposure, development is carried out at twice the minimum development time, and according to the exposure amount of the stepped exposure table with the resist film completely remaining being 8, the following classification is performed:
  • the exposure is 20mJ/cm 2 or less
  • the exposure is 20mJ/cm 2 -50mJ/cm 2 , excluding the end value;
  • the exposure is 50mJ/cm 2 or more.
  • the resolution of the dry film was measured.
  • the resolution is the minimum value of the pattern after the unexposed portion is cleaned out of the resist pattern formed by development after exposure.
  • the resolution value is 30 ⁇ m-50 ⁇ m, excluding the end value
  • The resolution value is above 50 ⁇ m.
  • the hydrophilicity was evaluated by the amount of precipitation after the photosensitive resin layer was dissolved.
  • the photosensitive resin composition was sufficiently stirred, and applied uniformly on the surface of a 25 ⁇ m-thick polyethylene terephthalate film as a support using a bar coater. Dry in a dryer at 95°C for 4 minutes to form a photosensitive resin layer with a layer thickness of approximately 30.5 ⁇ m and a layer weight of approximately 3.2 g.
  • 0 precipitation amount is less than 0.005g
  • 5 Medium amount of light yellow substance (usually fine), the amount of precipitation is between 0.05-0.08g;
  • the developability is evaluated according to the following criteria:
  • the HABI mixed photoinitiator of the present invention has excellent compatibility when applied to a photosensitive resin composition.
  • the composition has high sensitivity, good resolution and developability, and has excellent hydrophilicity, making the developer It can be reused, and there will be no clogging of the filter by developing garbage.
  • the comprehensive application performance advantage of the present invention is remarkable.

Abstract

A hexaarylbiimidazole hybrid photoinitiator, having a structure as represented by formula (I), and containing a biimidazole compound having four attachment sites, i.e., 1'-2, 2-3', 1-2' and 2'-3. The total mass percentage content of the biimidazole compound having the four attachment positions in the hybrid photoinitiator is above 92%. Ar 1, Ar 2, Ar 3, Ar 4, Ar 5, and Ar 6 in the formula (I) each independently represents a substituted or unsubstituted aryl group. A photosensitive resin composition containing the hexaarylbiimidazole hybrid photoinitiator has good compatibility, excellent photosensitivity, and a small amount of developing waste, and can be widely used in the forms of a dry film and a wet film.

Description

六芳基双咪唑类混合光引发剂及应用Hexaarylbisimidazole mixed photoinitiator and its application 技术领域Technical field
本发明属于光固化技术领域,具体涉及一种六芳基双咪唑类混合光引发剂,含有该光引发剂的感光性树脂组合物,以及感光性树脂组合物的应用。The invention belongs to the technical field of photocuring, and specifically relates to a hexaarylbisimidazole mixed photoinitiator, a photosensitive resin composition containing the photoinitiator, and the application of the photosensitive resin composition.
背景技术Background technique
印刷电路板、集成电路、薄膜晶体管、半导体封装等微电子电路的制造通常包括使用光刻法形成抗蚀图案。光刻法中,对涂覆于基板上的感光性树脂组合物层或层叠体,结合具有规定图案的掩膜进行曝光,然后采用对曝光部和非曝光部溶解度不同的显影液显影,形成抗蚀图案,再将抗蚀图案作为掩模对基板进行镀覆和/或蚀刻加工等,从而在基板上形成所需的导体图案。The manufacture of microelectronic circuits such as printed circuit boards, integrated circuits, thin film transistors, semiconductor packages, etc. generally includes the formation of resist patterns using photolithography. In the photolithography method, the photosensitive resin composition layer or laminate coated on the substrate is exposed in combination with a mask having a predetermined pattern, and then developed using a developer with different solubility in the exposed part and the non-exposed part to form a resist The pattern is etched, and then the substrate is plated and/or etched using the resist pattern as a mask to form a desired conductor pattern on the substrate.
随着精密电子设备上印刷线路板的微小化,具有高感光度、高解像性和分辨率的感光性树脂组合物成为研究热点,而作为感光性树脂组合物的关键组分之一,光引发剂被要求具有高的引发效率、好的体系相容性和好的溶解性等。六芳基双咪唑类化合物(HABI)是一类非常重要的自由基光引发剂,在紫外光作用下可光解产生大分子自由基,但是HABI及其衍生物常态为固体,在体系中的溶解度容易不佳。光引发剂的充分溶解及分散直接关系到其在树脂体系中的引发效率。With the miniaturization of printed circuit boards on precision electronic equipment, photosensitive resin compositions with high sensitivity, high resolution and resolution have become research hotspots, and as one of the key components of photosensitive resin compositions, light The initiator is required to have high initiation efficiency, good system compatibility and good solubility. Hexaarylbisimidazole compounds (HABI) are a very important type of free radical photoinitiator. Under the action of ultraviolet light, they can be photolyzed to produce macromolecular free radicals, but HABI and its derivatives are normally solid, The solubility is easily poor. The full dissolution and dispersion of the photoinitiator is directly related to its initiation efficiency in the resin system.
除了溶解度和感光度的要求,目前的研究也更多强调感光性组合物可水相显影或水相可加工。若感光性树脂组合物的组分在显影液中溶解度较 低,则重复进行显影工序时对显影液分散性差的不溶性成分会显著增加,从而出现凝集物(淤渣)。当继续进行显影工序时,凝集物会重新附着在基板上,可能会导致短路,还会使显影槽的配管堵塞。In addition to the requirements of solubility and sensitivity, the current research also emphasizes that the photosensitive composition can be developed or processed in an aqueous phase. If the solubility of the components of the photosensitive resin composition in the developing solution is low, insoluble components that are poorly dispersible in the developing solution when the development process is repeated are remarkably increased, and aggregates (sludge) appear. When the development process is continued, the condensate will re-attach to the substrate, which may cause a short circuit and block the piping of the development tank.
发明内容Summary of the invention
针对现有使用HABI及其衍生物作为光引发剂的感光性树脂组合物在形成抗蚀图案时高感光度、高溶解度和显影垃圾少等优点不能兼具的弊端,本发明的目的首先在于提供一种HABI类混合光引发剂。Aiming at the disadvantages of the existing photosensitive resin composition using HABI and its derivatives as a photoinitiator, when forming a resist pattern, the advantages of high sensitivity, high solubility, and low development waste cannot be combined, the purpose of the present invention is to provide A HABI type mixed photoinitiator.
本发明的六芳基双咪唑类混合光引发剂,具有如通式(I)所示结构,其中含有1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物,且该四种连接位的双咪唑化合物在混合光引发剂中的总质量百分含量为92%以上,The hexaarylbisimidazole mixed photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connection positions of 1'-2, 2-3', 1-2' and 2'-3 Of the biimidazole compound, and the total mass percentage of the four connected biimidazole compounds in the mixed photoinitiator is more than 92%,
Figure PCTCN2019120524-appb-000001
Figure PCTCN2019120524-appb-000001
通式(I)中,Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6可以相同也可以不同,各自独立地表示取代或未取代的芳基。所述芳基是指任何从简单芳香环衍生出的官能团或取代基,例如:苯基、邻甲苯基、1-萘基(或α-萘基)、2-萘基等。 In the general formula (I), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group. The aryl group refers to any functional group or substituent derived from a simple aromatic ring, for example: phenyl, o-tolyl, 1-naphthyl (or α-naphthyl), 2-naphthyl and the like.
本发明的目的还在于提供包含上述混合光引发剂的感光性树脂组合物,以及该组合物在制造印刷电路板、保护图案、导体图案、引框线、半导体封装等方面的应用。The object of the present invention is also to provide a photosensitive resin composition containing the above-mentioned mixed photoinitiator, and the application of the composition in manufacturing printed circuit boards, protective patterns, conductor patterns, lead wires, semiconductor packages, and the like.
包含上述六芳基双咪唑类混合光引发剂的感光性树脂组合物相容性好、感光度优异、显影垃圾量较少,能够以干膜和湿膜的方式得到广泛应用。The photosensitive resin composition containing the above-mentioned hexaarylbisimidazole-based mixed photoinitiator has good compatibility, excellent sensitivity, and a small amount of developing waste, and can be widely used as a dry film and a wet film.
发明详述Detailed description of the invention
基于本发明的目的,以下对各方面进行更详细的说明。Based on the purpose of the present invention, each aspect will be described in more detail below.
本申请中的术语“淤渣”和“显影垃圾”是指在显影液中积累起来的物质,它不溶于显影液并会再沉积于已显影的基底上,从而降低显影液的效率。The terms "sludge" and "developing waste" in this application refer to substances accumulated in the developing solution, which are insoluble in the developing solution and will be redeposited on the developed substrate, thereby reducing the efficiency of the developing solution.
<六芳基双咪唑类混合光引发剂><Hexaarylbisimidazole mixed photoinitiator>
本发明的六芳基双咪唑类混合光引发剂,具有如通式(I)所示结构,其中含有1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物,且该四种连接位的双咪唑化合物在混合光引发剂中的总质量百分含量为92%以上,The hexaarylbisimidazole mixed photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connection positions of 1'-2, 2-3', 1-2' and 2'-3 Of the biimidazole compound, and the total mass percentage of the four connected biimidazole compounds in the mixed photoinitiator is more than 92%,
Figure PCTCN2019120524-appb-000002
Figure PCTCN2019120524-appb-000002
通式(I)中,Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6可以相同也可以不同,各自独立地表示取代或未取代的芳基。 In the general formula (I), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
具体来说,满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物,具有下列结构:Specifically, the biimidazole compounds satisfying the four connection positions 1'-2, 2-3', 1-2' and 2'-3 of the structure represented by the general formula (I) have the following structures:
Figure PCTCN2019120524-appb-000003
Figure PCTCN2019120524-appb-000003
所述取代的芳基可以是单取代的,也可以是多取代的。The substituted aryl group may be mono-substituted or poly-substituted.
优选地,芳基上的取代基可以为卤素、硝基、氰基、胺基、羟基、C 1-C 20的烷基或链烯基、C 1-C 8的烷氧基,其中各独立变量(即,各取代基)中的亚甲基可以任选地被氧、硫、亚胺基所取代。 Preferably, the substituent on the aryl group may be halogen, nitro, cyano, amine, hydroxy, C 1 -C 20 alkyl or alkenyl, C 1 -C 8 alkoxy, each of which is independent The methylene group in the variable (ie, each substituent) may be optionally substituted with oxygen, sulfur, and imine groups.
更优选地,芳基上的取代基可以为氟、氯、溴、硝基、氰基、胺基、羟基、C 1-C 10的烷基或链烯基、C 1-C 5的烷氧基,其中各独立变量中的亚甲基可以任选地被氧、硫、亚胺基所取代。 More preferably, the substituent on the aryl group may be fluorine, chlorine, bromine, nitro, cyano, amine, hydroxy, C 1 -C 10 alkyl or alkenyl, C 1 -C 5 alkoxy Group, wherein the methylene group in each independent variable may be optionally substituted by oxygen, sulfur, imine groups.
进一步优选地,Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6中至少一个是含有卤素取代基的芳基。通过卤素取代基可以提高固化过程中的变色效果,以增强在显影时电子眼的识别能力(注:感光性树脂层经曝光后会发生颜色变化,与未曝光区域形成色差,从而被电子眼识别,本发明可以使色差更明显),进而提高应用产品的质量。特别优选地,卤素取代基为氯。 Further preferably, at least one of Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 and Ar 6 is an aryl group containing a halogen substituent. The halogen substituent can improve the color change effect during the curing process to enhance the recognition ability of the electronic eye during development (Note: the photosensitive resin layer will change color after exposure, and form a color difference with the unexposed area, which is recognized by the electronic eye. The invention can make the color difference more obvious), thereby improving the quality of the applied products. Particularly preferably, the halogen substituent is chlorine.
本申请中所说的HABI意指六芳基二咪唑,由两个三芳基咪唑(可以相同也可以不同,取决于芳基上的取代基)偶合而成。由于芳香环上取代基的诱导效应,降低了芳香环的π电子云密度,诱导效应促使芳香环扭曲,咪唑环上的共轭中心出现了偏移,使得取代芳基与咪唑不处于同一平面(三芳基咪唑成曲面态),最终两个咪唑偶合时,N、C的连接呈现出不同的空间构型,从而对HABI的性能产生了极大影响。The HABI in this application means hexaaryldiimidazole, which is formed by coupling two triarylimidazoles (which may be the same or different, depending on the substituent on the aryl group). Due to the induction effect of the substituents on the aromatic ring, the π electron cloud density of the aromatic ring is reduced, and the induction effect causes the aromatic ring to twist. The conjugate center on the imidazole ring shifts, making the substituted aryl group and imidazole not in the same plane ( The triarylimidazole is in a curved state). When the two imidazoles are finally coupled, the connection of N and C shows different spatial configurations, which has a great impact on the performance of HABI.
除上文所述的1’-2、2-3’、1-2’、2’-3四种连接位外,HABI类光引发剂还存在1-4’、1-5’、3-4’、3-5’、1-1’、1-3’、3-1’、3-3’、4-1’、4-3’、5-1’、5-3’等连接位。然而申请人研究发现,只有当1’-2、2-3’、1-2’、2’-3四种连接位存在且总含量占HABI总量的92%以上时,HABI才能表现出最优的溶解性和感光度。任一种连接位的单一物质的溶解性均远远小于本发明的混合物,而如果这四种连接位的总含量低于92%,则感光度有明显变低的趋势。In addition to the 1′-2, 2-3′, 1-2′, 2′-3 connection sites mentioned above, HABI photoinitiators also exist 1-4′, 1-5′, 3- 4', 3-5', 1-1', 1-3', 3-1', 3-3', 4-1', 4-3', 5-1', 5-3', etc. . However, the applicant's research found that HABI can only show the best performance when the four connection sites 1'-2, 2-3', 1-2', 2'-3 exist and the total content accounts for more than 92% of the total HABI. Excellent solubility and sensitivity. The solubility of a single substance at any kind of connection site is far less than the mixture of the present invention, and if the total content of these four kinds of connection sites is less than 92%, the sensitivity tends to become significantly lower.
作为本发明的HABI类混合光引发剂,优选满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物在混合光引发剂中的总质量百分含量为95%以上,特别优选由满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物组成。As the HABI-based mixed photoinitiator of the present invention, a biimidazole compound satisfying four connection positions of 1′-2, 2-3′, 1-2′ and 2′-3 of the structure represented by the general formula (I) is preferably The total mass percentage in the mixed photoinitiator is 95% or more, and it is particularly preferred that the four types of 1'-2, 2-3', 1-2' and 2'-3 satisfy the structure represented by the general formula (I) The connected position is composed of a biimidazole compound.
代表性地,现有技术中,CN1292892A提到了一种用于光刻胶光聚合体系中的HABI类光引发剂,即2,2’,5-三(邻-氯苯基)-4-(3,4-二甲氧基苯基)-4’,5’-二苯基-1,2-二咪唑,通常被称为“TCDM-HABI”,该文献中提到,使用至少含有一个亲水取代基(如甲氧基)的HABI能够大大减少循环使用的显影液中的淤渣量。然而申请人研究发现,单一的2,-2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1,2’-二咪唑或2,-2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1’,2-二咪唑在丁酮或PGMEA中的溶 解度很低,例如在PGMEA中2,-2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1,2’-二咪唑的溶解度不到3%;使用这两种单一HABI配制的感光性树脂组合物,显影时显影液中的淤渣量都远远达不到预期的效果。令人意外地,将2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1,2’-二咪唑、2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-2’,3-二咪唑、2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-2,3’-二咪唑、2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1’,2-二咪唑四者相混合时,该混合物在溶剂中的溶解度得到了极大提升;并且将该混合物应用在感光性树脂组合物中,能显著减少循环使用的显影液中的淤渣量,使得显影液可重复多次、有效使用。Representatively, in the prior art, CN1292892A mentions a HABI photoinitiator used in photoresist photopolymerization systems, namely 2,2',5-tris(o-chlorophenyl)-4-( 3,4-dimethoxyphenyl)-4',5'-diphenyl-1,2-diimidazole, commonly referred to as "TCDM-HABI", the document mentions that the use of at least one pro The HABI of water substituents (such as methoxy) can greatly reduce the amount of sludge in the used developer. However, the applicant's research found that a single 2,-2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1 ,2'-diimidazole or 2,-2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1' ,2-Diimidazole has very low solubility in methyl ethyl ketone or PGMEA, for example, 2,-2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl) in PGMEA -4',5'-diphenyl-1,2'-diimidazole has a solubility of less than 3%; using these two single HABI photosensitive resin compositions, the amount of sludge in the developer during development is far Far from the expected results. Surprisingly, the 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1,2' -Diimidazole, 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2',3-di Imidazole, 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2,3'-diimidazole, 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1',2-diimidazole When mixing, the solubility of the mixture in the solvent is greatly improved; and the application of the mixture in the photosensitive resin composition can significantly reduce the amount of sludge in the developer used repeatedly, so that the developer can be repeated multiple times , Effective use.
HABI类光引发剂是光刻胶领域公知的一类光引发剂,可通过三苯基咪唑类或取代三苯基咪唑类化合物的氧化偶合来制备,具体制备工艺可参照例如US3784557、US4622286和US4311783等现有技术中的记载(在此将其全文引入以作为参考)。在现有工艺的基础上,增加溶剂重结晶工艺,即可方便地获得满足本发明上述组成要求的HABI类混合光引发剂。所述溶剂可以是甲苯、甲醇、乙酸乙酯、二氯甲烷、水中的一种或两种以上的组合物。HABI photoinitiators are a type of photoinitiator known in the photoresist field, and can be prepared by oxidative coupling of triphenylimidazoles or substituted triphenylimidazoles. Specific preparation processes can refer to, for example, US3784557, US4622286, and US4311783 Etc. in the prior art (the entire contents of which are hereby incorporated by reference). On the basis of the existing process, adding a solvent recrystallization process can easily obtain HABI mixed photoinitiators that meet the above composition requirements of the present invention. The solvent may be one or a combination of two or more of toluene, methanol, ethyl acetate, dichloromethane, and water.
<感光性树脂组合物><Photosensitive resin composition>
本发明的感光性树脂组合物,除了上述HABI类混合光引发剂之外,通常还包含:碱可溶性聚合物;具有烯属不饱和双键的化合物;其它光引发剂和/或增感剂;以及任选的助剂。The photosensitive resin composition of the present invention generally includes, in addition to the HABI-based mixed photoinitiator, an alkali-soluble polymer; a compound having an ethylenically unsaturated double bond; other photoinitiators and/or sensitizers; And optional additives.
碱可溶性聚合物Alkali soluble polymer
碱可溶性聚合物可赋予感光性树脂组合物成膜功能。作为碱可溶性聚合物,只要是具有这样特性的聚合物就可以没有特别限制地适用。The alkali-soluble polymer can impart a film-forming function to the photosensitive resin composition. As the alkali-soluble polymer, as long as it has such characteristics, it can be applied without particular limitation.
示例性地,适用的碱可溶性聚合物可以是(甲基)丙烯酸系聚合物、苯乙烯系聚合物、环氧系聚合物、脂肪族聚氨酯(甲基)丙烯酸酯聚合物、芳香族聚氨酯(甲基)丙烯酸酯聚合物、酰胺系树脂、酰胺环氧系树脂、醇酸系树脂、以及酚醛系树脂等。Exemplarily, the applicable alkali-soluble polymer may be (meth)acrylic polymer, styrene polymer, epoxy polymer, aliphatic polyurethane (meth)acrylate polymer, aromatic polyurethane (method Group) acrylate polymer, amide resin, amide epoxy resin, alkyd resin, phenol resin, etc.
进一步地,碱可溶性聚合物可经由聚合性单体进行自由基聚合而得到。作为聚合性单体,可例举出:苯乙烯、乙烯基甲苯、α-甲基苯乙烯、对甲基苯乙烯、对乙基苯乙烯、对氯苯乙烯等在α-位或在芳香族环上被取代的可聚合的苯乙烯衍生物;丙烯酰胺、双丙酮丙烯酰胺等丙烯酰胺衍生物;丙烯腈、乙烯基正丁基醚等乙烯基醇的醚类衍生物;(甲基)丙烯酸、α-溴代(甲基)丙烯酸、α-氯代(甲基)丙烯酸、β-呋喃基(甲基)丙烯酸、β-苯乙烯基(甲基)丙烯酸等(甲基)丙烯酸衍生物;(甲基)丙烯酸烷基酯、(甲基)丙烯酸苄酯、甲基丙烯酸苯氧基乙酯、(甲基)丙烯酸四氢糠基酯、(甲基)丙烯酸二甲基氨基乙酯、(甲基)丙烯酸二乙基氨基乙酯、(甲基)丙烯酸缩水甘油酯、2,2,2-三氟乙基(甲基)丙烯酸酯、2,2,3,3-四氟丙基(甲基)丙烯酸酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸四氢糠基酯、(甲基)丙烯酸二甲基氨基乙酯、(甲基)丙烯酸二乙基氨基乙酯、(甲基)丙烯酸缩水甘油酯等(甲基)丙烯酸酯类;马来酸、马来酸酐、马来酸单甲酯、马来酸单乙酯、马来酸单异丙酯等马来酸单酯;富马酸、肉桂酸、α-氰基肉桂酸、衣康酸、巴豆酸、丙醇酸、N-乙烯基己内酰胺;N-乙烯基吡咯烷酮等。这些聚合性单体可以单独使用,也可以两种以上组合使用。Further, the alkali-soluble polymer can be obtained by radical polymerization of a polymerizable monomer. Examples of the polymerizable monomer include styrene, vinyl toluene, α-methylstyrene, p-methylstyrene, p-ethylstyrene, p-chlorostyrene, etc. at the α-position or in the aromatic Polymerizable styrene derivatives substituted on the ring; acrylamide derivatives such as acrylamide and diacetone acrylamide; ether derivatives of vinyl alcohol such as acrylonitrile and vinyl n-butyl ether; (meth)acrylic acid , Α-bromo (meth) acrylic acid, α-chloro (meth) acrylic acid, β-furyl (meth) acrylic acid, β-styryl (meth) acrylic acid and other (meth) acrylic acid derivatives; Alkyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl methacrylate, tetrahydrofurfuryl (meth)acrylate, dimethylaminoethyl (meth)acrylate, ( Diethylaminoethyl methacrylate, glycidyl (meth)acrylate, 2,2,2-trifluoroethyl (meth)acrylate, 2,2,3,3-tetrafluoropropyl ( Meth)acrylate, 2-ethylhexyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, dimethylaminoethyl (meth)acrylate, diethylamino (meth)acrylate (Meth)acrylates such as ethyl ester, glycidyl (meth)acrylate; maleic acid, maleic anhydride, monomethyl maleate, monoethyl maleate, monoisopropyl maleate, etc. Maleic acid monoester; fumaric acid, cinnamic acid, α-cyanocinnamic acid, itaconic acid, crotonic acid, propanoic acid, N-vinyl caprolactam; N-vinyl pyrrolidone, etc. These polymerizable monomers may be used alone or in combination of two or more.
进一步地,从碱显影性和密合性的角度考虑,优选使用含羧基的碱可 溶性聚合物。具有羧基的碱可溶性聚合物可以为包含(甲基)丙烯酸作为单体单元的丙烯酸树脂,其通过使用(甲基)丙烯酸作为单体单元导入羧基;可以为除(甲基)丙烯酸以外进一步包含(甲基)丙烯酸烷基酯作为单体单元的共聚物;也可以为除(甲基)丙烯酸以外进一步含有除(甲基)丙烯酸和(甲基)丙烯酸烷基酯以外的聚合性单体(如具有乙烯性不饱和基团的单体)作为单体成分的共聚物。Further, from the viewpoint of alkali developability and adhesion, it is preferable to use a carboxyl group-containing alkali-soluble polymer. The alkali-soluble polymer having a carboxyl group may be an acrylic resin containing (meth)acrylic acid as a monomer unit, which is introduced into the carboxyl group by using (meth)acrylic acid as a monomer unit; it may further contain (meth)acrylic acid in addition ( A copolymer of alkyl methacrylate as a monomer unit; it may also contain a polymerizable monomer other than (meth)acrylic acid and alkyl (meth)acrylate in addition to (meth)acrylic acid (such as A copolymer having an ethylenically unsaturated group as a monomer component.
进一步地,含羧基的碱可溶性聚合物可通过具有羧基的聚合性单体与其它聚合性单体进行自由基聚合而得到,特别是由(甲基)丙烯酸酯、乙烯性不饱和羧酸和其它可共聚单体共聚而成的(甲基)丙烯酸酯系聚合物。所述的(甲基)丙烯酸酯可以是(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸丙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸戊酯、(甲基)丙烯酸己酯、(甲基)丙烯酸庚酯、(甲基)丙烯酸辛酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸壬酯、(甲基)丙烯酸癸酯、(甲基)丙烯酸十一烷基酯、(甲基)丙烯酸十二烷基酯、(甲基)丙烯酸环己酯、(甲基)丙烯酸苄基酯、(甲基)丙烯酸二乙胺基乙酯、(甲基)丙烯酸酯二甲胺基乙酯、(甲基)丙烯酸羟乙酯、(甲基)丙烯酸羟丙酯、(甲基)丙烯酸糠基酯、(甲基)丙烯酸缩水甘油酯等。这些(甲基)丙烯酸酯可以单独使用,也可以两种以上组合使用。所述的乙烯性不饱和羧酸可以是丙烯酸、甲基丙烯酸、丁烯酸、马来酸、富马酸、衣康酸,特别优选丙烯酸、甲基丙烯酸。这些乙烯性不饱和羧酸可以单独使用,也可以两种以上组合使用。所述的其它可共聚单体可以是(甲基)丙烯酰胺、(甲基)丙烯酸正丁酯、苯乙烯、乙烯基萘、(甲基)丙烯晴、乙酸乙烯基酯、乙烯基环己烷等。这些其它可共聚单体可以单独使用,也可以两种以上组合使用。Further, the carboxyl group-containing alkali-soluble polymer can be obtained by radical polymerization of a polymerizable monomer having a carboxyl group and other polymerizable monomers, especially from (meth)acrylate, ethylenically unsaturated carboxylic acid and other (Meth) acrylate polymer made by copolymerization of comonomers. The (meth)acrylate may be methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, pentyl (meth)acrylate , Hexyl (meth)acrylate, heptyl (meth)acrylate, octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, nonyl (meth)acrylate, (meth)acrylic acid Decyl ester, undecyl (meth)acrylate, dodecyl (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, diethyl (meth)acrylate Aminoethyl, (meth)acrylate dimethylaminoethyl, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, furfuryl (meth)acrylate, (meth)acrylic acid Glycidyl ester and so on. These (meth)acrylates may be used alone or in combination of two or more. The ethylenically unsaturated carboxylic acid may be acrylic acid, methacrylic acid, crotonic acid, maleic acid, fumaric acid, itaconic acid, with acrylic acid and methacrylic acid being particularly preferred. These ethylenically unsaturated carboxylic acids may be used alone or in combination of two or more. The other copolymerizable monomers may be (meth)acrylamide, n-butyl (meth)acrylate, styrene, vinyl naphthalene, (meth)acrylonitrile, vinyl acetate, vinyl cyclohexane Wait. These other copolymerizable monomers may be used alone or in combination of two or more.
碱可溶性聚合物可以单独一种使用,也可以两种以上组合使用。作为 组合两种以上使用的碱可溶性聚合物,可列举出由不同共聚成分构成的两种以上的碱可溶性聚合物、不同重均分子量的两种以上的碱可溶性聚合物、不同分散度的两种以上的碱可溶性聚合物等。The alkali-soluble polymer may be used alone or in combination of two or more. Examples of the alkali-soluble polymers used in combination of two or more include two or more types of alkali-soluble polymers composed of different copolymerization components, two or more types of alkali-soluble polymers with different weight average molecular weights, and two types with different degrees of dispersion. The above alkali-soluble polymers, etc.
在本发明的感光性树脂组合物中,对碱可溶性聚合物的重均分子量没有特别限制,但从机械强度与碱显影性方面综合考虑,重均分子量优选为15000-200000,更优选为30000-150000,特别优选为30000-120000。当重均分子量大于15000时,曝光后耐显影液性有进一步提高的倾向,当该重均分子量小于200000时,显影时间有变得更短的倾向,且可以保持与光引发剂等其它组分的相容性。碱可溶性聚合物的重均分子量通过凝胶渗透色谱法(GPC)进行测定,通过使用标准聚苯乙烯的标准曲线进行换算而得到。In the photosensitive resin composition of the present invention, the weight-average molecular weight of the alkali-soluble polymer is not particularly limited, but in terms of mechanical strength and alkali developability, the weight-average molecular weight is preferably 15,000 to 200,000, and more preferably 30,000 to 150,000, particularly preferably 30000-120000. When the weight average molecular weight is greater than 15,000, the developer resistance after exposure tends to be further improved, and when the weight average molecular weight is less than 200,000, the development time tends to become shorter, and can maintain other components such as photoinitiator Of compatibility. The weight-average molecular weight of the alkali-soluble polymer is measured by gel permeation chromatography (GPC), and is obtained by conversion using a standard polystyrene standard curve.
进一步地,从碱显影性良好的角度考虑,碱可溶性聚合物的酸值优选为50-300mgKOH/g,更优选为50-250mgKOH/g,进一步优选为70-250mgKOH/g,特别优选为100-250mgKOH/g。当碱可溶性树脂的酸值低于50mgKOH/g时,难以确保充分的显影速度,当超过300mgKOH/g时,密合性减小,容易发生图案短路,且易出现组合物贮存稳定性降低、粘度上升的问题。Further, from the viewpoint of good alkali developability, the acid value of the alkali-soluble polymer is preferably 50-300 mgKOH/g, more preferably 50-250 mgKOH/g, still more preferably 70-250 mgKOH/g, and particularly preferably 100- 250mgKOH/g. When the acid value of the alkali-soluble resin is less than 50 mgKOH/g, it is difficult to ensure a sufficient development speed. When it exceeds 300 mgKOH/g, the adhesion is reduced, pattern short-circuiting is likely to occur, and the storage stability and viscosity of the composition are prone to occur. The problem of rising.
碱可溶性树脂的分子量分布[重均分子量(Mw)/数均分子量(Mn)]优选为1.5-6.0,特别优选为1.8-3.7。当分子量分布处于所述范围时,显影性优异。The molecular weight distribution [weight average molecular weight (Mw)/number average molecular weight (Mn)] of the alkali-soluble resin is preferably 1.5 to 6.0, and particularly preferably 1.8 to 3.7. When the molecular weight distribution is within the above range, the developability is excellent.
以感光性树脂组合物总量100质量份计,碱可溶性聚合物在组合物中的含量优选是20-70质量份,更优选是30-60质量份。当碱可溶性聚合物的含量在20质量份以上,可确保感光性树脂组合物对于镀敷处理、蚀刻处理等的耐久性得到提高,当含量在70质量份以下,有利于提高感光性树脂组合物的灵敏度。The content of the alkali-soluble polymer in the composition is preferably 20 to 70 parts by mass, more preferably 30 to 60 parts by mass based on 100 parts by mass of the total photosensitive resin composition. When the content of the alkali-soluble polymer is 20 parts by mass or more, the durability of the photosensitive resin composition to plating treatment, etching treatment, etc. can be improved, and when the content is 70 parts by mass or less, it is beneficial to improve the photosensitive resin composition Sensitivity.
具有烯属不饱和双键的化合物Compounds with ethylenically unsaturated double bonds
具有烯属不饱和双键的化合物可促进感光性树脂组合物成膜。The compound having an ethylenically unsaturated double bond can promote the film formation of the photosensitive resin composition.
对具有烯属不饱和双键的化合物没有特别限定,只要在分子内具有至少一个乙烯性不饱和键的光聚合性化合物就可以使用。示例性地,可列举出:α,β-不饱和羧酸与多元醇反应而得的化合物、双酚A类(甲基)丙烯酸酯化合物、α,β-不饱和羧酸与含缩水甘油基的化合物反应而得的化合物、分子内具有氨酯键的(甲基)丙烯酸酯化合物等氨基甲酸酯单体、壬基苯氧基多乙烯氧基丙烯酸酯、γ-氯-β-羟基丙基-β’-(甲基)丙烯酰氧基乙基-邻苯二甲酸酯、β-羟基乙基-β’-(甲基)丙烯酰氧基乙基-邻苯二甲酸酯、β-羟基丙基-β’-(甲基)丙烯酰氧基乙基-邻苯二甲酸酯、苯二甲酸类化合物、(甲基)丙烯酸烷基酯等。这些化合物可以单独使用,也可两种以上组合使用。The compound having an ethylenically unsaturated double bond is not particularly limited, and a photopolymerizable compound having at least one ethylenically unsaturated bond in the molecule can be used. Illustrative examples include: compounds obtained by reacting α,β-unsaturated carboxylic acids with polyols, bisphenol A (meth)acrylate compounds, α,β-unsaturated carboxylic acids and glycidyl groups The compound obtained by the reaction of the compound, a urethane monomer such as a (meth)acrylate compound having a urethane bond in the molecule, nonylphenoxypolyvinyloxyacrylate, γ-chloro-β-hydroxypropyl -Β'-(meth)acryloyloxyethyl-phthalate, β-hydroxyethyl-β'-(meth)acryloyloxyethyl-phthalate, β-hydroxypropyl-β'-(meth)acryloyloxyethyl-phthalate, phthalic acid compounds, alkyl (meth)acrylate, etc. These compounds may be used alone or in combination of two or more.
作为上述α,β-不饱和羧酸与多元醇反应而得的化合物,可例举出:亚乙氧基数为2-14的聚乙二醇二(甲基)丙烯酸酯、亚丙氧基数为2-14的聚丙二醇二(甲基)丙烯酸酯、亚乙氧基数为2-14且亚丙氧基数为2-14的聚亚乙氧基·聚亚丙氧基二醇二(甲基)丙烯酸酯、三羟甲基丙烷二(甲基)丙烯酸酯、三羟甲基丙烷三(甲基)丙烯酸酯、EO改性三羟甲基丙烷三(甲基)丙烯酸酯、PO改性三羟甲基丙烷三(甲基)丙烯酸酯、EO,PO改性三羟甲基丙烷三(甲基)丙烯酸酯、四羟甲基甲烷三(甲基)丙烯酸酯、四羟甲基甲烷四(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、二季戊四醇六(甲基)丙烯酸酯、聚丙二醇单(甲基)丙烯酸酯、聚乙二醇单(甲基)丙烯酸酯、三丙二醇二(甲基)丙烯酸酯等。这些化合物可以单独使用,也可两种以上组合使用。在这里,“EO”表示环氧乙烷,经EO改性的化合物是指具有氧化乙烯基的嵌段结构的化合物。“PO”表示环氧丙烷,经PO改性的化合物是指具有氧化丙烯基的嵌段结 构的化合物。Examples of the compound obtained by reacting the above-mentioned α,β-unsaturated carboxylic acid with a polyhydric alcohol include polyethylene glycol di(meth)acrylate having an ethyleneoxy number of 2-14, and the number of propyleneoxy groups being Polypropylene glycol di(meth)acrylate of 2-14, polyethyleneoxy·polypropyleneoxydiol di(methyl) with an ethyleneoxy number of 2-14 and a propyleneoxy number of 2-14 Acrylate, trimethylolpropane di(meth)acrylate, trimethylolpropane tri(meth)acrylate, EO modified trimethylolpropane tri(meth)acrylate, PO modified trihydroxy Methylpropane tri(meth)acrylate, EO, PO modified trimethylolpropane tri(meth)acrylate, tetramethylolmethane tri(meth)acrylate, tetramethylolmethane tetra(meth)acrylate Base) acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, polypropylene glycol mono(meth)acrylate, polyethylene glycol mono(meth)acrylate, tripropylene glycol di (Meth) acrylate, etc. These compounds may be used alone or in combination of two or more. Here, "EO" means ethylene oxide, and the compound modified with EO means a compound having a block structure of an oxyethylene group. "PO" means propylene oxide, and the compound modified with PO means a compound having a block structure of an oxypropylene group.
作为上述双酚A类(甲基)丙烯酸酯化合物,可例举出:2,2-双(4-((甲基)丙烯酰氧基多乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基多丙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基多丁氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基多乙氧基多丙氧基)苯基)丙烷等。作为上述2,2-双(4-((甲基)丙烯酰氧基多乙氧基)苯基)丙烷,可例举出:2,2-双(4-((甲基)丙烯酰氧基二乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基三乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基四乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基五乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基六乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基七乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基八乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基九乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十一乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十二乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十三乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十四乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十五乙氧基)苯基)丙烷、2,2-双(4-((甲基)丙烯酰氧基十六乙氧基)苯基)丙烷等。上述2,2-双(4-((甲基)丙烯酰氧基多乙氧基)苯基)丙烷的1分子内的氧化乙烯基数优选为4-20,更优选为8-15。这些化合物可以单独使用,也可两种以上组合使用。Examples of the bisphenol A-based (meth)acrylate compound include 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane, 2,2- Bis(4-((meth)acryloyloxypolypropoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypolybutoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypolyethoxypolypropoxy)phenyl)propane, etc. Examples of the 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane include 2,2-bis(4-((meth)acryloyloxy Diethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxytriethoxy)phenyl)propane, 2,2-bis(4-((methyl ) Acryloyloxytetraethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxypentethoxy)phenyl)propane, 2,2-bis(4- ((Meth)acryloyloxyhexaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxyheptethoxy)phenyl)propane, 2,2- Bis(4-((meth)acryloyloxyoctaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxy nonaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxydecethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxyundecyloxy) Phenyl)propane, 2,2-bis(4-((meth)acryloyloxydodecyloxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxy Tridecethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxytetraethoxy)phenyl)propane, 2,2-bis(4-((meth Group) acryloyloxy pentaethoxy)phenyl)propane, 2,2-bis(4-((meth)acryloyloxyhexadecyloxy)phenyl)propane and the like. The number of oxyethylene groups per molecule of the 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane is preferably 4-20, and more preferably 8-15. These compounds may be used alone or in combination of two or more.
作为上述分子内具有氨酯键的(甲基)丙烯酸酯化合物,可例举出:在β位具有OH基的(甲基)丙烯酸类单体和二异氰酸酯化合物(异佛尔酮二异氰酸酯、2,6-甲苯二异氰酸酯、2,4-甲苯二异氰酸酯、1,6-六亚甲基二异氰酸酯等)的加成反应产物、三((甲基)丙烯酰氧基四亚乙基二醇异氰酸酯)六亚甲基异氰脲酸酯、EO改性氨酯二(甲基)丙烯酸酯、PO改性氨酯二(甲基)丙烯酸 酯、EO,PO改性氨酯二(甲基)丙烯酸酯等。这些化合物可以单独使用,也可两种以上组合使用。As the (meth)acrylate compound having a urethane bond in the molecule, a (meth)acrylic monomer having an OH group at the β position and a diisocyanate compound (isophorone diisocyanate, 2 , 6-toluene diisocyanate, 2,4-toluene diisocyanate, 1,6-hexamethylene diisocyanate, etc.) addition reaction product, tri((meth)acryloyloxytetraethylene glycol isocyanate ) Hexamethylene isocyanurate, EO modified urethane di(meth)acrylate, PO modified urethane di(meth)acrylate, EO, PO modified urethane di(meth)acrylic acid Ester etc. These compounds may be used alone or in combination of two or more.
作为上述壬基苯氧基多乙烯氧基丙烯酸酯,可例举出:壬基苯氧基四乙烯氧基丙烯酸酯、壬基苯氧基五乙烯氧基丙烯酸酯、壬基苯氧基六乙烯氧基丙烯酸酯、壬基苯氧基七乙烯氧基丙烯酸酯、壬基苯氧基八乙烯氧基丙烯酸酯、壬基苯氧基九乙烯氧基丙烯酸酯、壬基苯氧基十乙烯氧基丙烯酸酯、壬基苯氧基十一乙烯氧基丙烯酸酯等。这些化合物可以单独使用,也可两种以上组合使用。Examples of the nonylphenoxypolyvinyloxy acrylate include nonylphenoxytetravinyloxy acrylate, nonylphenoxypentavinyloxy acrylate, and nonylphenoxyhexaethylene. Oxyacrylate, nonylphenoxy heptaethyleneoxy acrylate, nonylphenoxy octaethyleneoxy acrylate, nonylphenoxy nonavinyloxy acrylate, nonylphenoxy decavinyloxy Acrylate, nonylphenoxy undecyloxy acrylate, etc. These compounds may be used alone or in combination of two or more.
作为上述苯二甲酸类化合物,可例举出:γ-氯-β-羟基丙基-β’-(甲基)丙烯酰氧基乙基邻苯二甲酸酯、β-羟基烷基-β’-(甲基)丙烯酰氧基烷基邻苯二甲酸酯等。这些化合物可以单独使用,也可两种以上组合使用。Examples of the above-mentioned phthalic acid compounds include γ-chloro-β-hydroxypropyl-β'-(meth)acryloyloxyethyl phthalate and β-hydroxyalkyl-β '-(Meth)acryloyloxyalkyl phthalate, etc. These compounds may be used alone or in combination of two or more.
作为上述(甲基)丙烯酸烷基酯,可例举出:(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸正丙酯、(甲基)丙烯酸异丙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸仲丁酯、(甲基)丙烯酸叔丁酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸苯酯、(甲基)丙烯酸异冰片酯、(甲基)丙烯酸羟甲酯、(甲基)丙烯酸羟乙酯、(甲基)丙烯酸羟丙酯、(甲基)丙烯酸-2-羟乙酯、(甲基)丙烯酸-2-羟丙酯、(甲基)丙烯酸苄基酯、(甲基)丙烯酸戊酯、(甲基)丙烯酸四氢糠基酯、(甲基)丙烯酸异辛酯、乙氧基化壬基酚(甲基)丙烯酸酯、丙二醇聚丙烯醚二(甲基)丙烯酸酯、1,9-壬二醇二(甲基)丙烯酸酯、1,10-癸二醇二(甲基)丙烯酸酯、乙氧基化聚四氢呋喃二醇二(甲基)丙烯酸酯、乙氧基化聚丙二醇二(甲基)丙烯酸酯等。其中,优选为(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、三羟甲基丙烷三(甲基)丙烯酸酯、乙氧基化三羟甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、乙氧化季戊四醇四(甲基)丙烯酸酯、 二季戊四醇五(甲基)丙烯酸酯、二季戊四醇六丙烯酸酯。这些化合物可以单独使用,也可两种以上组合使用。Examples of the above-mentioned alkyl (meth)acrylate include methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, N-butyl (meth)acrylate, sec-butyl (meth)acrylate, tert-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, phenyl (meth)acrylate, (meth) ) Isobornyl acrylate, hydroxymethyl (meth)acrylate, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, (meth)acrylic acid 2-hydroxypropyl ester, benzyl (meth)acrylate, amyl (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, isooctyl (meth)acrylate, nonyl ethoxylate Phenol (meth)acrylate, propylene glycol polypropylene ether di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, 1,10-decanediol di(meth)acrylate, Ethoxylated polytetrahydrofurandiol di(meth)acrylate, ethoxylated polypropylene glycol di(meth)acrylate, etc. Among them, preferred are methyl (meth)acrylate, ethyl (meth)acrylate, trimethylolpropane tri(meth)acrylate, ethoxylated trimethylolpropane tri(meth)acrylate, Pentaerythritol tri(meth)acrylate, ethoxylated pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexaacrylate. These compounds may be used alone or in combination of two or more.
从提高分辨率、耐镀覆性、密合性的角度来看,所述具有烯属不饱和双键的化合物优选双酚A类(甲基)丙烯酸酯化合物和分子内具有氨酯键的(甲基)丙烯酸酯化合物。从可以提高灵敏度和解析度的角度来看,优选双酚A类(甲基)丙烯酸酯化合物。作为双酚A类(甲基)丙烯酸酯化合物的市售品,示例性地,有2,2-双(4-((甲基)丙烯酰氧基多乙氧基)苯基)丙烷(如新中村化学工业株式会社制,BPE-200)、多乙氧基双酚A甲基丙烯酸酯(如新中村化学工业株式会社制,BPE-5000;日立化成株式会社制,FA-321M)、2,2-双(4-((甲基)丙烯酰氧基多丁氧基)苯基)丙烷(如新中村化学工业株式会社,BPE-1300)等。From the viewpoint of improving resolution, plating resistance, and adhesion, the compound having an ethylenically unsaturated double bond is preferably a bisphenol A-based (meth)acrylate compound and a compound having a urethane bond in the molecule ( Meth)acrylate compound. From the viewpoint of improving sensitivity and resolution, a bisphenol A (meth)acrylate compound is preferred. As a commercially available product of a bisphenol A (meth)acrylate compound, there is exemplified 2,2-bis(4-((meth)acryloyloxypolyethoxy)phenyl)propane (such as Shin Nakamura Chemical Industry Co., Ltd., BPE-200), polyethoxybisphenol A methacrylate (such as Shin Nakamura Chemical Industry Co., Ltd., BPE-5000; Hitachi Chemical Co., Ltd., FA-321M), 2 , 2-bis(4-((meth)acryloyloxypolybutoxy)phenyl)propane (such as Shin Nakamura Chemical Industry Co., Ltd., BPE-1300), etc.
在100质量份感光性树脂组合物中,具有烯属不饱和双键的化合物的含量优选为20-50质量份,更优选为25-45质量份。当所述具有烯属不饱和双键的化合物的含量在20质量份以上时,感光性树脂组合物的灵敏度和解析度会进一步提高;当其含量在50质量份以下,感光性树脂组合物更易薄膜化,且对于蚀刻处理的耐久性进一步提高。In 100 parts by mass of the photosensitive resin composition, the content of the compound having an ethylenically unsaturated double bond is preferably 20-50 parts by mass, and more preferably 25-45 parts by mass. When the content of the compound having an ethylenically unsaturated double bond is more than 20 parts by mass, the sensitivity and resolution of the photosensitive resin composition will be further improved; when the content is less than 50 parts by mass, the photosensitive resin composition is easier It is thinned and the durability against etching is further improved.
HABI类混合光引发剂HABI type mixed photoinitiator
如上文所述,本发明的HABI类混合光引发剂,具有如通式(I)所示结构,其中含有1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物,且该四种连接位的双咪唑化合物在混合光引发剂中的总质量百分含量为92%以上,优选95%以上,特别优选为100%,As mentioned above, the HABI hybrid photoinitiator of the present invention has the structure shown in the general formula (I), which contains four connections of 1'-2, 2-3', 1-2' and 2'-3 Bis-imidazole compound, and the total mass percentage of the four-linked bis-imidazole compound in the mixed photoinitiator is 92% or more, preferably 95% or more, and particularly preferably 100%,
Figure PCTCN2019120524-appb-000004
Figure PCTCN2019120524-appb-000004
通式(I)中,Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6可以相同也可以不同,各自独立地表示取代或未取代的芳基。 In the general formula (I), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
在上述特征限定范围内,示例性地,本发明的HABI类混合光引发剂可选自或包括:Within the range defined by the above characteristics, exemplarily, the HABI-based hybrid photoinitiator of the present invention may be selected from or include:
化合物A1:Compound A1:
Figure PCTCN2019120524-appb-000005
Figure PCTCN2019120524-appb-000005
化合物A2:Compound A2:
Figure PCTCN2019120524-appb-000006
Figure PCTCN2019120524-appb-000006
Figure PCTCN2019120524-appb-000007
Figure PCTCN2019120524-appb-000007
化合物A3:Compound A3:
Figure PCTCN2019120524-appb-000008
Figure PCTCN2019120524-appb-000008
Figure PCTCN2019120524-appb-000009
Figure PCTCN2019120524-appb-000009
化合物A4:Compound A4:
Figure PCTCN2019120524-appb-000010
Figure PCTCN2019120524-appb-000010
化合物A5Compound A5
Figure PCTCN2019120524-appb-000011
Figure PCTCN2019120524-appb-000011
化合物A6Compound A6
Figure PCTCN2019120524-appb-000012
Figure PCTCN2019120524-appb-000012
化合物A7Compound A7
Figure PCTCN2019120524-appb-000013
Figure PCTCN2019120524-appb-000013
Figure PCTCN2019120524-appb-000014
Figure PCTCN2019120524-appb-000014
化合物A8Compound A8
Figure PCTCN2019120524-appb-000015
Figure PCTCN2019120524-appb-000015
Figure PCTCN2019120524-appb-000016
Figure PCTCN2019120524-appb-000016
化合物A9Compound A9
Figure PCTCN2019120524-appb-000017
Figure PCTCN2019120524-appb-000017
在本发明的六芳基双咪唑类混合光引发剂中,诸如化合物A1、化合物A2等可以单独存在,也可以两种以上混合使用。In the hexaarylbisimidazole-based mixed photoinitiator of the present invention, compounds such as compound A1 and compound A2 may exist alone, or two or more kinds may be used in combination.
在100质量份感光性树脂组合物中,本发明的六芳基双咪唑类混合光引发剂优选为1-10质量份。在此含量范围内,组合物能够表现出良好的体系相容性和优异的固化性能。In 100 parts by mass of the photosensitive resin composition, the hexaarylbisimidazole-based mixed photoinitiator of the present invention is preferably 1 to 10 parts by mass. Within this content range, the composition can exhibit good system compatibility and excellent curing performance.
其它光引发剂和/或增感剂Other photoinitiators and/or sensitizers
本发明的感光性树脂组合物中还可含有其它光引发剂和/或增感剂,以通过共同/协同效应来增加感光树脂体系的相容性、感光度及解析度。The photosensitive resin composition of the present invention may further contain other photoinitiators and/or sensitizers to increase the compatibility, sensitivity, and resolution of the photosensitive resin system through a common/synergistic effect.
所述其它光引发剂和/或增感剂可包括(但不限于):双咪唑类、吡唑啉类、芳香族酮类、蒽醌类、苯偶姻和苯偶姻烷基醚类、肟酯类、三嗪类、三苯胺类、香豆素类、噻吨酮类、吖啶类及其它本领域技术人员已知的光引发剂。这些光引发剂可以单独使用或两种以上组合使用。The other photoinitiators and/or sensitizers may include (but are not limited to): diimidazoles, pyrazolines, aromatic ketones, anthraquinones, benzoin and benzoin alkyl ethers, Oxime esters, triazines, triphenylamines, coumarins, thioxanthones, acridines and other photoinitiators known to those skilled in the art. These photoinitiators can be used alone or in combination of two or more.
示例性地,双咪唑类化合物包括:2,2’-二(邻氯苯基)-4,4’,5,5’-四苯基- 二咪唑、2,2’,5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4’,5’-二苯基-1,1’-二咪唑、2,2’,5-三(2-氟苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-二咪唑、2,2'-二(2,4-二氯苯基)-4,4',5,5'-四苯基-二咪唑、2,2'-二(2-氟苯基)-4-(邻氯苯基)-5-(3,4-二甲氧基苯基)-4’,5'-二苯基-二咪唑、2,2’-二(2-氟苯基)-4,4’,5,5’-四苯基-二咪唑、2,2’-二(2-甲氧基苯基)-4,4’,5,5’-四苯基-二咪唑、2,2'-二(2-氯-5-硝基苯基)-4,4'-二(3,4-二甲氧基苯基)-5,5'-二(邻氯苯基)-二咪唑、2,2'-二(2-氯-5-硝基苯基)-4-(3,4-二甲氧基苯基)-5-(邻氯苯基)-4',5'-二苯基-二咪唑、2,2'-二(2,4-二氯苯基)-4,4’-二(3,4-二甲氧基苯基)-5,5’-二(邻氯苯基)-二咪唑、2-(2,4-二氯苯基)-4-(3,4-二甲氧基苯基)-2',5-二(邻氯苯基)-4’,5’-二苯基-二咪唑、2-(2,4-二氯苯基)-2’-(邻氯苯基)-4,4’,5,5’-四苯基-二咪唑、2,2'-二(2,4-二氯苯基)-4,4’,5,5’-四苯基-二咪唑及其相似物。这些双咪唑类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the bisimidazole compounds include: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl-diimidazole, 2,2',5-tri(o Chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1,1'-diimidazole, 2,2',5-tri(2-fluoro Phenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-diimidazole, 2,2'-bis(2,4-dichlorophenyl)-4 ,4',5,5'-tetraphenyl-diimidazole, 2,2'-bis(2-fluorophenyl)-4-(o-chlorophenyl)-5-(3,4-dimethoxy Phenyl)-4',5'-diphenyl-diimidazole, 2,2'-bis(2-fluorophenyl)-4,4',5,5'-tetraphenyl-diimidazole, 2, 2'-bis(2-methoxyphenyl)-4,4',5,5'-tetraphenyl-diimidazole, 2,2'-bis(2-chloro-5-nitrophenyl)- 4,4'-bis(3,4-dimethoxyphenyl)-5,5'-bis(o-chlorophenyl)-diimidazole, 2,2'-bis(2-chloro-5-nitro Phenyl)-4-(3,4-dimethoxyphenyl)-5-(o-chlorophenyl)-4',5'-diphenyl-diimidazole, 2,2'-bis(2, 4-dichlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-5,5'-bis(o-chlorophenyl)-diimidazole, 2-(2,4- Dichlorophenyl)-4-(3,4-dimethoxyphenyl)-2',5-bis(o-chlorophenyl)-4',5'-diphenyl-diimidazole, 2-( 2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4', 5,5'-tetraphenyl-diimidazole, 2,2'-bis(2,4-dichloro Phenyl)-4,4',5,5'-tetraphenyl-diimidazole and the like. These bisimidazole-based compounds may be used alone or in combination of two or more.
示例性地,吡唑啉类化合物包括:1-苯基-3-(4-叔丁基苯乙烯基)-5-(4-叔丁基苯基)吡唑啉、1-苯基-3-联苯基-5-(4-叔丁基苯基)吡唑啉、乙氧基化(9)三羟甲基吡唑啉酯、乙氧基化(10)双酚A吡唑啉酯及其相似物。这些吡唑啉类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the pyrazoline compounds include: 1-phenyl-3-(4-tert-butylstyryl)-5-(4-tert-butylphenyl)pyrazoline, 1-phenyl-3 -Biphenyl-5-(4-tert-butylphenyl) pyrazoline, ethoxylated (9) trimethylol pyrazoline ester, ethoxylated (10) bisphenol A pyrazoline ester And the like. These pyrazoline compounds may be used alone or in combination of two or more.
示例性地,芳香族酮类化合物包括:苯乙酮、2,2-二甲氧基-2-苯基苯乙酮、2,2-二乙氧基-2-苯基苯乙酮、1,1-二氯苯乙酮、二苯甲酮、4-苯甲酰基二苯硫醚、4-苯甲酰基-4’-甲基二苯硫醚、4-苯甲酰基-4’-乙基二苯硫醚、4-苯甲酰基-4’-丙基二苯硫醚、4,4’-双(二乙基氨基)二苯甲酮、4-对甲苯巯基二苯甲酮、2,4,6-三甲基二苯甲酮、4-甲基二苯甲酮、4,4’-双(二甲氨基)二苯甲酮、4,4’-双(甲基、乙基氨基)二苯甲酮、苯乙酮二甲基缩酮、苯偶酰二甲基缩酮、α,α’-二甲基苯偶酰缩酮、α,α-二乙氧基苯乙酮、2-羟基-2-甲基 -1-苯基丙酮、1-羟基环己基苯甲酮、2-羟基-2-甲基-1-对羟乙基醚基苯基丙酮、2-甲基1-(4-甲巯基苯基)-2-吗啉1-丙酮、2-苄基-2-二甲氨基-1-(4-吗啉苯基)1-丁酮、苯基双(2,4,6-三甲基苯甲酰基)氧膦、2,4,6(三甲基苯甲酰基)二苯基氧化膦、2-羟基-1-{3-[4-(2-羟基-2-甲基-丙酰基)-苯基]-1,1,3-三甲基-茚-5-基}-2-甲基丙酮;和2-羟基-1-{1-[4-(2-羟基-2-甲基-丙酰基)-苯基]-1,3,3-三甲基-茚-5-基}-2-甲基丙酮、1-(4-异丙基苯基)-2-羟基-2-甲基丙-1-酮、4-(2-羟基乙氧基)-苯基-(2-羟基-2-丙基)酮及其相似物。这些芳香族酮类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the aromatic ketone compounds include: acetophenone, 2,2-dimethoxy-2-phenylacetophenone, 2,2-diethoxy-2-phenylacetophenone, 1 ,1-dichloroacetophenone, benzophenone, 4-benzoyldiphenyl sulfide, 4-benzoyl-4'-methyldiphenyl sulfide, 4-benzoyl-4'-ethyl Diphenyl sulfide, 4-benzoyl-4'-propyl diphenyl sulfide, 4,4'-bis(diethylamino) benzophenone, 4-p-toluene mercaptobenzophenone, 2 ,4,6-trimethylbenzophenone, 4-methylbenzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(methyl, ethyl (Amino) benzophenone, acetophenone dimethyl ketal, benzyl dimethyl ketal, α,α'-dimethylbenzoyl ketal, α,α-diethoxyacetophenone , 2-hydroxy-2-methyl-1-phenylacetone, 1-hydroxycyclohexyl benzophenone, 2-hydroxy-2-methyl-1-p-hydroxyethyl ether phenylacetone, 2-methyl 1-(4-Methylmercaptophenyl)-2-morpholine 1-acetone, 2-benzyl-2-dimethylamino-1-(4-morpholinephenyl) 1-butanone, phenylbis(2 ,4,6-trimethylbenzoyl)phosphine oxide, 2,4,6 (trimethylbenzoyl)diphenylphosphine oxide, 2-hydroxy-1-{3-[4-(2-hydroxyl -2-methyl-propionyl)-phenyl]-1,1,3-trimethyl-inden-5-yl}-2-methylacetone; and 2-hydroxy-1-{1-[4- (2-hydroxy-2-methyl-propionyl)-phenyl)-1,3,3-trimethyl-inden-5-yl)-2-methylacetone, 1-(4-isopropylbenzene Yl)-2-hydroxy-2-methylpropan-1-one, 4-(2-hydroxyethoxy)-phenyl-(2-hydroxy-2-propyl)one and the like. These aromatic ketone compounds may be used alone or in combination of two or more.
示例性地,蒽醌类化合物包括:2-苯基蒽醌、2,3-二苯基蒽醌、1-氯蒽醌、2-甲基蒽醌、2,3-二甲基蒽醌、2-乙基蒽-9,10-二乙酯、1,2,3-三甲基蒽-9,10-二辛脂、2-乙基蒽-9,10-二(4-氯丁酸甲酯)、2-(3-((3-乙基氧杂环丁烷-3-基)甲氧基)-3-氧代丙基)蒽-9,10-二乙酯、9,10-二丁氧基蒽、9,10-二乙氧基-2-乙基蒽、9,10-二(3-氯丙氧基)蒽、9,10-二(2-羟基乙巯基)蒽、9,10-二(3-羟基-1-丙巯基)蒽及其相似物。这些蒽醌类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the anthraquinone compounds include: 2-phenylanthraquinone, 2,3-diphenylanthraquinone, 1-chloroanthraquinone, 2-methylanthraquinone, 2,3-dimethylanthraquinone, 2-ethylanthracene-9,10-diethyl, 1,2,3-trimethylanthracene-9,10-dioctyl fat, 2-ethylanthracene-9,10-bis(4-chlorobutyric acid Methyl ester), 2-(3-((3-ethyloxetan-3-yl)methoxy)-3-oxopropyl)anthracene-9,10-diethyl ester, 9,10 -Dibutoxyanthracene, 9,10-diethoxy-2-ethylanthracene, 9,10-bis(3-chloropropoxy)anthracene, 9,10-bis(2-hydroxyethylmercapto)anthracene , 9,10-bis (3-hydroxy-1-propylmercapto) anthracene and its analogs. These anthraquinone compounds may be used alone or in combination of two or more.
示例性地,苯偶姻和苯偶姻烷基醚类化合物包括:苯偶姻甲基醚、苯偶姻乙基醚、苯偶姻苯基醚及其相似物。这些苯偶姻和苯偶姻烷基醚类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, benzoin and benzoin alkyl ether compounds include: benzoin methyl ether, benzoin ethyl ether, benzoin phenyl ether and the like. These benzoin and benzoin alkyl ether compounds may be used alone or in combination of two or more.
示例性地,肟酯类化合物包括:1-(4-苯硫基苯基)-正辛烷-1,2-二酮-2-苯甲酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-乙烷-1-酮-乙酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-丁烷-1-酮-乙酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-丙烷-1-酮-乙酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-1-环己基-甲烷-1-酮-乙酸肟酯、1- (6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-3-环戊基-丙烷-1-酮-乙酸肟酯、1-(4-苯硫基苯基)-(3-环戊基)-丙烷-1,2-二酮-2-苯甲酸肟酯、1-(4-苯硫基苯基)-(3-环己基)-丙烷-1,2-二酮-2-环己基甲酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-(3-环戊基)-丙烷-1,2-二酮-2-乙酸肟酯、1-(6-邻甲基苯甲酰基-9-乙基咔唑-3-基)-(3-环戊基)-丙烷-1,2-二酮-2-苯甲酸肟酯、1-(4-苯甲酰基二苯硫醚)-(3-环戊基丙酮)-1-肟乙酸酯、1-(6-邻甲基苯甲酰基-9-乙基咔唑-3-基)-(3-环戊基丙酮)-1-肟环己基甲酸酯、1-(4-苯甲酰基二苯硫醚)-(3-环戊基丙酮)-1-肟环己基甲酸酯、1-(6-邻甲基苯甲酰基-9-乙基咔唑-3-基)-(3-环戊基)-丙烷-1,2-二酮-2-邻甲基苯甲酸肟酯、1-(4-苯硫基苯基)-(3-环戊基)-丙烷-1,2-二酮-2-环己基甲酸肟酯、1-(4-噻吩甲酰基-二苯硫醚-4’-基)-3-环戊基-丙烷-1-酮-乙酸肟酯、1-(4-苯甲酰基二苯硫醚)-(3-环戊基)-丙烷-1,2-二酮-2-肟乙酸酯、1-(6-硝基-9-乙基咔唑-3-基)-3-环己基-丙烷-1-酮-乙酸肟酯、1-(6-邻甲基苯甲酰基-9-乙基咔唑-3-基)-3-环己基-丙烷-1-酮-乙酸肟酯、1-(6-噻吩甲酰基-9-乙基咔唑-3-基)-(3-环己基丙酮)-1-肟乙酸酯、1-(6-呋喃糠甲酰基-9-乙基咔唑-3-基)-(3-环戊基丙酮)-1-肟乙酸酯、1,4-二苯基丙烷-1,3-二酮-2-乙酸肟酯、1-(6-糠酰基-9-乙基咔唑-3-基)-(3-环己基)-丙烷-1,2-二酮-2-乙酸肟酯、1-(4-苯硫基苯基)-(3-环已基)-丙烷-1,2-二酮-2-乙酸肟酯、1-(6-呋喃糠甲酰基-9-乙基咔唑-3-基)-(3-环己基丙酮)-1-肟乙酸酯、1-(4-苯硫基苯基)-(3-环已基)-丙烷-1,2-二酮-3-苯甲酸肟酯、1-(6-噻吩甲酰基-9-乙基咔唑-3-基)-(3-环己基)-丙烷-1,2-二酮-2-乙酸肟酯、2-((苯甲酰氧基)亚氨基)-1-苯基丙烷-1-酮、1-苯基-1,2-丙二酮-2-(氧代乙酰基)肟、1-(4-苯硫基苯基)-2-(2-甲基苯基)-乙烷-1,2-二 酮-2-乙酸肟酯、1-(9,9-二丁基-7-硝基芴-2-基)-3-环己基-丙烷-1-酮-乙酸肟酯、1-(4-(4-(噻吩-2-甲酰基)苯硫基)苯基)-3-环戊基丙烷-1,2-二酮-2-乙酸肟酯、1-(9,9-二丁基-2-基)-3-环己基丙基丙烷-1,2-二酮-2-乙酸肟酯、1-(6-(2-(苯甲酰氧基亚氨基)-3-环己基丙基-9-乙基咔唑-3-基)辛烷-1,2-二酮-2-苯甲酸肟酯、1-(7-硝基-9,9-二烯丙基芴-2-基)-1-(2-甲基苯基)甲酮-乙酸肟酯、1-(6-(2-甲基苯甲酰基)-9-乙基咔唑-3-基)-3-环戊基-丙烷-1-酮-苯甲酸肟酯、1-(7-(2-甲基苯甲酰基)-9,9-二丁基芴-2-基)-3-环己基丙烷-1,2-二酮-2-乙酸肟酯、1-(6-(呋喃-2-甲酰基)-9-乙基咔唑-3-基)-3-环己基丙烷-1,2-二酮-2-乙氧甲酰肟酯及其相似物。这些肟酯类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the oxime ester compounds include: 1-(4-phenylthiophenyl)-n-octane-1,2-dione-2-benzoic acid oxime ester, 1-(6-(2-methyl Benzoyl)-9-ethylcarbazol-3-yl)-ethane-1-one-oxime acetate, 1-(6-(2-methylbenzoyl)-9-ethylcarbazole- 3-yl)-butane-1-one-oxime acetate, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-propane-1-one-acetic acid Oxime ester, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-1-cyclohexyl-methane-1-one-oxime acetate, 1-(6- (2-methylbenzoyl)-9-ethylcarbazol-3-yl)-3-cyclopentyl-propane-1-one-oxime acetate, 1-(4-phenylthiophenyl)- (3-cyclopentyl)-propane-1,2-dione-2-benzoic acid oxime ester, 1-(4-phenylthiophenyl)-(3-cyclohexyl)-propane-1,2-di Keto-2-cyclohexylcarboxylic acid oxime ester, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-(3-cyclopentyl)-propane-1,2 -Dione-2-acetoxime, 1-(6-o-methylbenzoyl-9-ethylcarbazol-3-yl)-(3-cyclopentyl)-propane-1,2-dione -2-benzoic acid oxime ester, 1-(4-benzoyldiphenyl sulfide)-(3-cyclopentylacetone)-1-oxime acetate, 1-(6-o-methylbenzoyl- 9-ethylcarbazol-3-yl)-(3-cyclopentylacetone)-1-oxime cyclohexyl formate, 1-(4-benzoyldiphenyl sulfide)-(3-cyclopentyl Acetone)-1-oxime cyclohexyl formate, 1-(6-o-methylbenzoyl-9-ethylcarbazol-3-yl)-(3-cyclopentyl)-propane-1,2- Dione-2-o-toluic acid oxime ester, 1-(4-phenylthiophenyl)-(3-cyclopentyl)-propane-1,2-dione-2-cyclohexylcarboxylic acid oxime ester, 1-(4-Thienyl-diphenyl sulfide-4'-yl)-3-cyclopentyl-propane-1-one-oxime acetate, 1-(4-benzoyl diphenyl sulfide)- (3-cyclopentyl)-propane-1,2-dione-2-oxime acetate, 1-(6-nitro-9-ethylcarbazol-3-yl)-3-cyclohexyl-propane -1-one-oxime acetate, 1-(6-o-methylbenzoyl-9-ethylcarbazol-3-yl)-3-cyclohexyl-propane-1-one-oxime acetate, 1- (6-Thienyl-9-ethylcarbazol-3-yl)-(3-cyclohexylacetone)-1-oxime acetate, 1-(6-furanfuranoyl-9-ethylcarbazole -3-yl)-(3-cyclopentylacetone)-1-oxime acetate, 1,4-diphenylpropane-1,3-dione-2-acetoxime, 1-(6-furfuryl Acyl-9-ethylcarbazol-3-yl)-(3-cyclohexyl)-propane-1,2-dione-2-acetic acid oxime ester, 1-(4-phenylthiophenyl)-(3 -Cyclohexyl)-propane-1,2-dione-2-acetoxime, 1-(6- Furanfuranoyl-9-ethylcarbazol-3-yl)-(3-cyclohexylacetone)-1-oxime acetate, 1-(4-phenylthiophenyl)-(3-cyclohexyl )-Propane-1,2-dione-3-benzoic acid oxime ester, 1-(6-thienyl-9-ethylcarbazol-3-yl)-(3-cyclohexyl)-propane-1, 2-dione-2-acetoxime ester, 2-((benzoyloxy)imino)-1-phenylpropane-1-one, 1-phenyl-1,2-propanedione-2- (Oxoacetyl)oxime, 1-(4-phenylthiophenyl)-2-(2-methylphenyl)-ethane-1,2-dione-2-acetic acid oxime ester, 1-( 9,9-dibutyl-7-nitrofluoren-2-yl)-3-cyclohexyl-propane-1-one-oxime acetate, 1-(4-(4-(thiophen-2-formyl) Phenylthio)phenyl)-3-cyclopentylpropane-1,2-dione-2-acetic acid oxime ester, 1-(9,9-dibutyl-2-yl)-3-cyclohexylpropyl Propane-1,2-dione-2-acetoxime, 1-(6-(2-(benzoyloxyimino)-3-cyclohexylpropyl-9-ethylcarbazol-3-yl ) Octane-1,2-dione-2-benzoic acid oxime ester, 1-(7-nitro-9,9-diallylfluoren-2-yl)-1-(2-methylphenyl ) Methanone-oxime acetate, 1-(6-(2-methylbenzoyl)-9-ethylcarbazol-3-yl)-3-cyclopentyl-propane-1-one-benzoic acid oxime Ester, 1-(7-(2-methylbenzoyl)-9,9-dibutylfluoren-2-yl)-3-cyclohexylpropane-1,2-dione-2-acetic acid oxime ester, 1-(6-(furan-2-formyl)-9-ethylcarbazol-3-yl)-3-cyclohexylpropane-1,2-dione-2-ethoxycarbonyl oxime ester and similar Thing. These oxime ester compounds may be used alone or in combination of two or more.
示例性地,三嗪类化合物包括:2-(4-乙基联苯)-4,6-双(三氯甲基)-1,3,5-三嗪、2-(3,4-亚甲氧基苯基)-4,6-双(三氯甲基)-1,3,5-三嗪、3-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}丙酸、1,1,1,3,3,3-六氟异丙基-3-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}丙酸酯、乙基-2-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}乙酸酯、2-乙氧基乙基-2-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}乙酸酯、环己基-2-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}乙酸酯、芐基-2-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}乙酸酯、3-{氯-4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}丙酸、3-{4-[2,4-双(三氯甲基)-s-三嗪-6-基]苯硫基}丙醯胺、2,4-双(三氯甲基)-6-p-甲氧基苯乙烯基-s-三嗪、2,4-双(三氯甲基)-6-(1-p-二甲基胺基苯基)-1,3,-丁二烯基-s-三嗪、2-三氯甲基-4-胺基-6-p-甲氧基苯乙烯基-s-三嗪及其相似物。这些三嗪类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, triazine compounds include: 2-(4-ethylbiphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-(3,4- Methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 3-{4-[2,4-bis(trichloromethyl)-s-triazine -6-yl]phenylthio}propionic acid, 1,1,1,3,3,3-hexafluoroisopropyl-3-{4-[2,4-bis(trichloromethyl)-s- Triazin-6-yl]phenylthio}propionate, ethyl-2-{4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]phenylthio}ethyl Ester, 2-ethoxyethyl-2-{4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]phenylthio}acetate, cyclohexyl-2 -{4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]phenylthio}acetate, benzyl-2-{4-[2,4-bis(tri Chloromethyl)-s-triazin-6-yl]phenylthio}acetate, 3-{chloro-4-[2,4-bis(trichloromethyl)-s-triazin-6-yl ]Phenylthio}propionic acid, 3-{4-[2,4-bis(trichloromethyl)-s-triazin-6-yl]phenylthio}propionamide, 2,4-bis(tris Chloromethyl)-6-p-methoxystyryl-s-triazine, 2,4-bis(trichloromethyl)-6-(1-p-dimethylaminophenyl)-1 ,3,-butadienyl-s-triazine, 2-trichloromethyl-4-amino-6-p-methoxystyryl-s-triazine and the like. These triazine compounds may be used alone or in combination of two or more.
示例性地,三苯胺类化合物包括:N,N-双-[4-(2-苯乙烯基-1-基)-苯 基]-N,N-双(2-乙基-6甲基苯基)-1,1-双苯基-4,4-二胺、N,N-双-[4-(2-苯乙烯基-1-基)-4′-甲基苯基]-N,N-双(2-乙基-6甲基苯基)-1,1-双苯基-4,4-二胺及其相似物。这些三苯胺类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the triphenylamine compounds include: N,N-bis-[4-(2-styryl-1-yl)-phenyl]-N,N-bis(2-ethyl-6methylbenzene Group)-1,1-bisphenyl-4,4-diamine, N,N-bis-[4-(2-styryl-1-yl)-4′-methylphenyl]-N, N-bis(2-ethyl-6methylphenyl)-1,1-bisphenyl-4,4-diamine and the like. These triphenylamine compounds may be used alone or in combination of two or more.
示例性地,香豆素类化合物包括:3,3’-羰基双(7-二乙胺香豆素)、3-苯甲酰基-7-二乙胺香豆素、3,3’-羰基双(7-甲氧基香豆素)、7-(二乙氨基)-4-甲基香豆素、3-(2-苯并噻唑)-7-(二乙基胺基)香豆素、7-(二乙氨基)-4-甲基-2H-1-苯并吡喃-2-酮(7-(二乙氨基)-4-甲基香豆素)、3-苯甲酰基-7-甲氧基香豆素及其相似物。这些香豆素类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the coumarin compounds include: 3,3'-carbonylbis(7-diethylamine coumarin), 3-benzoyl-7-diethylamine coumarin, 3,3'-carbonyl Bis(7-methoxycoumarin), 7-(diethylamino)-4-methylcoumarin, 3-(2-benzothiazole)-7-(diethylamino)coumarin , 7-(diethylamino)-4-methyl-2H-1-benzopyran-2-one (7-(diethylamino)-4-methylcoumarin), 3-benzoyl- 7-Methoxycoumarin and its analogues. These coumarin compounds may be used alone or in combination of two or more.
示例性地,噻吨酮类化合物包括:噻吨酮、2,4-二甲基噻吨酮、2,4-二乙基噻吨酮、2,4-二异丙基噻吨酮、2-氯噻吨酮、1-氯-4-丙氧基噻吨酮、异丙基噻吨酮、二异丙基噻吨酮及相似物。这些噻吨酮类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, the thioxanthone compounds include: thioxanthone, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, 2,4-diisopropylthioxanthone, 2 -Chlorothioxanthone, 1-chloro-4-propoxythioxanthone, isopropylthioxanthone, diisopropylthioxanthone and the like. These thioxanthone compounds may be used alone or in combination of two or more.
示例性地,吖啶类化合物包括:9-苯基吖啶、9-对甲基苯基吖啶、9-间甲基苯基吖啶、9-邻氯苯基吖啶、9-邻氟苯基吖啶、2-乙基-2-(羟甲基)-1,3-丙二醇醚环乙烷醚的[4-(9-吖啶基)苯氧基]乙酸酯(即PAD107,产自常州强力电子新材料股份有限公司)、1,7-二(9-吖啶基)庚烷、9-乙基吖啶、9-(4-溴苯基)吖啶、9-(3-氯苯基)吖啶、1,7-双(9-吖啶)庚烷、1,5-双(9-吖啶戊烷)、1,3-双(9-吖啶)丙烷及其相似物。这些吖啶类化合物可以单独使用,也可以两种以上组合使用。Exemplarily, acridine compounds include: 9-phenyl acridine, 9-p-methylphenyl acridine, 9-m-methylphenyl acridine, 9-o-chlorophenyl acridine, 9-o-fluorine [4-(9-acridinyl)phenoxy]acetate of phenylacridine, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol ether cyclohexane ether (ie PAD107, Produced by Changzhou Qiangli Electronic New Materials Co., Ltd.), 1,7-bis(9-acridinyl)heptane, 9-ethylacridine, 9-(4-bromophenyl)acridine, 9-(3 -Chlorophenyl) acridine, 1,7-bis(9-acridine) heptane, 1,5-bis(9-acridinepentane), 1,3-bis(9-acridine) propane and their Analogs. These acridine compounds may be used alone or in combination of two or more.
优选地,在100质量份感光性树脂组合物中,所述的其它光引发剂和/或增感剂的含量为不超过8质量份。Preferably, in 100 parts by mass of the photosensitive resin composition, the content of the other photoinitiator and/or sensitizer is not more than 8 parts by mass.
助剂Additives
除了上述各组分,任选地,本发明的感光性树脂组合物中还可以根据需要包含适量的其它助剂。示例性地,助剂可以为孔雀绿等染料、三溴苯基砜、无色结晶紫等光显色剂、颜料、填充剂、增塑剂、稳定剂、涂布助剂、剥离促进剂等。In addition to the above-mentioned components, the photosensitive resin composition of the present invention may optionally contain an appropriate amount of other auxiliary agents as needed. Illustratively, the auxiliary agent may be dyes such as malachite green, tribromophenyl sulfone, colorless crystal violet and other light color developers, pigments, fillers, plasticizers, stabilizers, coating aids, peeling accelerators, etc. .
作为上述染料、颜料及光显色剂,示例性地,可以是:三(4-二甲基氨基苯基)甲烷、三(4-二甲基氨基-2甲基苯基)甲烷、荧烷染料、甲苯磺酸一水合物、碱性品红、酞菁绿及酞菁蓝等酞菁系、金胺碱、副品红、结晶紫、甲基橙、尼罗蓝2B、维多利亚蓝、孔雀绿、金刚绿、碱性蓝20、艳绿、伊红、乙基紫、赤藓红钠盐B、甲基绿、苯酚酞、茜素红S、百里香酚酞、甲基紫2B、喹那定红、玫瑰红钠琼脂、米塔尼尔黄、百里香酚磺酞、二甲苯酚蓝、甲基橘、橘IV、二苯基流卡巴腙、2,7-二氯荧光素、泛甲基红、刚果红、本佐红紫4B、α-萘基红、非那西汀、甲基紫、维多利亚纯蓝BOH、罗丹明6G、二苯基胺、二苄基苯胺、三苯基胺、二乙基苯胺、二苯基-对伸苯基二胺、对甲苯胺、苯并三氮唑、甲基苯丙三唑、4,4’-联苯基二胺、邻氯苯胺、白色结晶紫、白色孔雀绿、白色苯胺、白色甲基紫、偶氮系等有机颜料、二氧化钛等无机颜料。在具有良好对比度的考量下,优选使用三(4-二甲基氨基苯基)甲烷(即,隐色结晶紫,LCV)。这些染料、颜料及光显色剂可以单独一种使用,也可两种以上混合使用。As the above-mentioned dyes, pigments, and photochromic agents, exemplarily, tris(4-dimethylaminophenyl)methane, tris(4-dimethylamino-2methylphenyl)methane, fluorane Phthalocyanines such as dyes, toluenesulfonic acid monohydrate, basic magenta, phthalocyanine green and phthalocyanine blue, auramine, by-product magenta, crystal violet, methyl orange, Nile blue 2B, Victoria blue, peacock Green, Diamond Green, Basic Blue 20, Brilliant Green, Eosin, Ethyl Violet, Erythrosine Sodium B, Methyl Green, Phenolphthalein, Alizarin Red S, Thymol Phenolphthalein, Methyl Violet 2B, Quinadine Red, Rose Bengal Agar, Mitaniel Yellow, Thymol Sulfophthalein, Xylenol Blue, Methyl Orange, Orange IV, Diphenyl Flucarbazone, 2,7-Dichlorofluorescein, Pan-Methyl Red , Congo red, Benzo red purple 4B, α-naphthyl red, phenacetin, methyl violet, Victoria pure blue BOH, rhodamine 6G, diphenylamine, dibenzylaniline, triphenylamine, di Ethylaniline, diphenyl-p-phenylene diamine, p-toluidine, benzotriazole, methamphetamine, 4,4'-biphenyldiamine, o-chloroaniline, white crystal violet , White malachite green, white aniline, white methyl violet, azo and other organic pigments, titanium dioxide and other inorganic pigments. In consideration of having a good contrast, it is preferable to use tris(4-dimethylaminophenyl)methane (ie, leuco crystal violet, LCV). These dyes, pigments and photochromic agents may be used alone or in combination of two or more.
作为上述填充剂,示例性地,可以是:二氧化硅、氧化铝、滑石、碳酸钙、硫酸钡等填充剂(不包含上述无机颜料)。填充剂可以单独一种使用,也可两种以上混合使用。As the filler, for example, fillers such as silica, alumina, talc, calcium carbonate, and barium sulfate (excluding the above-mentioned inorganic pigments) may be used. The filler may be used alone or in combination of two or more.
作为上述增塑剂,示例性地,可以是:邻苯二甲酸二丁酯、邻苯二甲 酸二庚酯、邻苯二甲酸二辛酯、邻苯二甲酸二烯丙酯等邻苯二甲酸酯、三甘醇二乙酸酯、四乙二醇二乙酸酯等乙二醇酯、对甲苯磺酰胺、苯磺酰胺、正丁基苯磺酰胺等磺酰胺类、磷酸三苯酯、三甲基磷酸酯、三乙基磷酸酯、三苯基磷酸酯、三甲苯基磷酸酯、三二甲苯基磷酸酯、甲苯基二苯基磷酸酯、三二甲苯基磷酸酯、2-萘基二苯基磷酸酯、甲苯基二2,6-二甲苯基磷酸酯、芳香族缩合磷酸酯、三(氯丙基)磷酸酯、三(三溴新戊基)磷酸酯、含卤缩合磷酸酯、二辛酸三甘醇酯,二(2-乙基己酸)三甘醇酯、二庚酸四甘醇酯、癸二酸二乙酯、辛二酸二丁酯、磷酸三(2-乙基乙酯)、Brij 30〔C 12H 25(OCH 2CH 2) 4OH〕、和Brij 35〔C 12H 25(OCH 2CH 2) 20OH〕等。增塑剂可以单独一种使用,也可两种以上混合使用。 As the above-mentioned plasticizer, for example, it may be: phthalate such as dibutyl phthalate, diheptyl phthalate, dioctyl phthalate, diallyl phthalate, etc. Glycol esters such as acid esters, triethylene glycol diacetate, tetraethylene glycol diacetate, sulfonamides such as p-toluenesulfonamide, benzenesulfonamide, n-butylbenzenesulfonamide, triphenyl phosphate, Trimethyl phosphate, triethyl phosphate, triphenyl phosphate, tricresyl phosphate, tricresyl phosphate, tolyl diphenyl phosphate, tricresyl phosphate, 2-naphthyl Diphenyl phosphate, tolyl bis 2,6-xylyl phosphate, aromatic condensed phosphate, tri(chloropropyl) phosphate, tri(tribromo neopentyl) phosphate, halogen-containing condensed phosphate , Triethylene glycol dicaprylate, triethylene glycol bis(2-ethylhexanoate), tetraethylene glycol diheptanoate, diethyl sebacate, dibutyl suberate, tris(2-ethyl phosphate Ethyl ester), Brij 30 [C 12 H 25 (OCH 2 CH 2 ) 4 OH], Brij 35 [C 12 H 25 (OCH 2 CH 2 ) 20 OH], etc. The plasticizer may be used alone or in combination of two or more.
作为上述稳定剂,示例性地,可以是:氢醌、1,4,4-三甲基-重氮二环(3.2.2)-壬-2-烯-2,3-二氧化物、1-苯基-3-吡唑烷酮、对甲氧基苯酚、烷基和芳基取代的氢醌和醌、叔丁基邻苯二酚、1,2,3-苯三酚、树脂酸铜、萘胺、β-萘酚、氯化亚铜、2,6-二叔丁基对甲酚、吩噻嗪、吡啶、硝基苯、二硝基苯、对甲苯醌和氯醌等。稳定剂可以单独一种使用,也可两种以上混合使用。As the above stabilizer, exemplarily, it may be: hydroquinone, 1,4,4-trimethyl-diazobicyclo(3.2.2)-non-2-ene-2,3-dioxide, 1 -Phenyl-3-pyrazolidone, p-methoxyphenol, alkyl and aryl substituted hydroquinones and quinones, tert-butylcatechol, 1,2,3-pyrogallol, copper resinate, naphthalene Amine, β-naphthol, cuprous chloride, 2,6-di-tert-butyl-p-cresol, phenothiazine, pyridine, nitrobenzene, dinitrobenzene, p-toluoquinone and chloroquinone. The stabilizer may be used alone or in combination of two or more.
作为上述涂布助剂,从安全性、通用性方面考虑,可以是:丙酮、甲醇、甲基醇、乙基醇、异丙基醇、甲基乙基酮、丙二醇单甲基醚乙酸酯、乳酸乙酯、环己酮、γ-丁内酯、二氯甲烷等。涂布助剂可以单独一种使用,也可两种以上混合使用。As the coating aid, from the viewpoint of safety and versatility, it may be: acetone, methanol, methyl alcohol, ethyl alcohol, isopropyl alcohol, methyl ethyl ketone, propylene glycol monomethyl ether acetate , Ethyl lactate, cyclohexanone, γ-butyrolactone, dichloromethane, etc. The coating aid may be used alone or in combination of two or more.
作为上述剥离促进剂,示例性地,可例举出:苯磺酸、甲苯磺酸、二甲苯磺酸、苯酚磺酸、甲基、丙基、庚基、辛基、癸基、十二烷基等烷基苯磺酸等。剥离促进剂可以单独一种使用,也可两种以上混合使用。Examples of the above-mentioned peeling accelerator include benzenesulfonic acid, toluenesulfonic acid, xylenesulfonic acid, phenolsulfonic acid, methyl, propyl, heptyl, octyl, decyl, and dodecane Alkylbenzene sulfonic acid, etc. The peeling accelerator may be used alone or in combination of two or more.
优选地,在100质量份感光性树脂组合物中,助剂含量为不超过10质量份。Preferably, in 100 parts by mass of the photosensitive resin composition, the content of the auxiliary agent is not more than 10 parts by mass.
<应用><application>
本发明的感光性树脂组合物可以制备成干膜,即感光性树脂层叠体,并应用于印刷电路板、保护图案、导体图案、引框线、半导体封装的制造中,经过不同的工序在不同的基材上形成所需要的图案。The photosensitive resin composition of the present invention can be prepared as a dry film, that is, a photosensitive resin laminate, and is used in the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, and semiconductor packages through different processes in different The desired pattern is formed on the substrate.
本发明的感光性树脂组合物也可以通过湿膜涂布机涂布至各对应制造步骤中对应的基材上,即作为湿膜应用于印刷电路板、保护图案、导体图案、引框线、半导体封装的制造中,经过不同的工序在不同的基材上形成所需要的图案。The photosensitive resin composition of the present invention can also be applied to the corresponding substrate in each corresponding manufacturing step by a wet film coating machine, that is, used as a wet film for printed circuit boards, protective patterns, conductor patterns, frame wires, In the manufacture of semiconductor packages, different patterns are formed on different substrates through different processes.
干膜应用Dry film applications
本发明的干膜即感光性树脂层叠体,其包含:感光性树脂组合物形成的感光性树脂层以及支撑该感光性树脂层的支撑体。The photosensitive resin laminate which is a dry film of the present invention includes a photosensitive resin layer formed of a photosensitive resin composition and a support that supports the photosensitive resin layer.
通常,干膜的制作包括:将感光性树脂组合物涂布在支撑体上,干燥以形成感光性树脂层;任选地,根据需要贴合覆盖膜(保护层)。较佳地,干燥条件是60-100℃下干燥0.5-15min。感光性树脂层的厚度优选为5-95μm,再优选为10-50μm,更优选为15-30μm。若感光性树脂层的厚度小于5μm,则绝缘性不佳,而若感光性树脂层的厚度超过95μm,则解析度可能会较差。Generally, the production of a dry film includes: coating a photosensitive resin composition on a support and drying to form a photosensitive resin layer; optionally, attaching a cover film (protective layer) as needed. Preferably, the drying conditions are at 60-100°C for 0.5-15 min. The thickness of the photosensitive resin layer is preferably 5-95 μm, more preferably 10-50 μm, and more preferably 15-30 μm. If the thickness of the photosensitive resin layer is less than 5 μm, the insulation is not good, and if the thickness of the photosensitive resin layer exceeds 95 μm, the resolution may be poor.
作为支撑体,具体实例可以是各种类型的塑胶膜,如聚对苯二甲酸乙二醇酯、聚乙烯萘二酸酯、聚丙烯、聚乙烯、纤维素乙酸酯、聚甲基丙烯酸烷酯、甲基丙烯酸酯共聚物、聚氯乙烯、聚乙烯醇、聚碳酸酯、聚苯乙烯、玻璃纸、氯乙烯共聚物、聚酰胺、聚亚酰胺、乙烯氯-乙酸乙烯酯共聚物、聚四氟乙烯、聚三氟乙烯及其相似物。此外,亦可使用由两种或以上 材料所组成的复合材料。优选地,使用的是具有极佳光穿透性的聚对苯二甲酸乙二醇酯。支撑体的厚度优选为5-150μm,更优选为10-50μm。As a support, specific examples may be various types of plastic films, such as polyethylene terephthalate, polyethylene naphthalate, polypropylene, polyethylene, cellulose acetate, polyalkylmethacrylate Ester, methacrylate copolymer, polyvinyl chloride, polyvinyl alcohol, polycarbonate, polystyrene, cellophane, vinyl chloride copolymer, polyamide, polyimide, ethylene chloride-vinyl acetate copolymer, polytetramethylene Vinyl fluoride, polytrifluoroethylene and the like. In addition, composite materials composed of two or more materials can also be used. Preferably, polyethylene terephthalate having excellent light penetration is used. The thickness of the support is preferably 5-150 μm, and more preferably 10-50 μm.
对感光性树脂组合物的涂布并无特殊限制,例如可使用喷涂法、滚筒式涂布法、旋转式涂布法、狭缝式涂布法、压缩涂布法、帘涂法、染料涂布法、线条涂布法、刮刀涂布法、辊涂法、刮涂法、喷涂法、浸涂法等常规方法。The coating of the photosensitive resin composition is not particularly limited, and for example, a spray coating method, a drum coating method, a spin coating method, a slit coating method, a compression coating method, a curtain coating method, and a dye coating can be used Conventional methods such as cloth method, line coating method, blade coating method, roll coating method, blade coating method, spray coating method, dip coating method, etc.
进一步地,本发明提供上述干膜在制造印刷电路板中的应用,包括:Further, the present invention provides the application of the above dry film in the manufacture of printed circuit boards, including:
(1)层叠工序:将感光性树脂层叠体层叠于覆铜层叠板或柔性基板上;(1) Lamination step: Laminating a photosensitive resin laminate on a copper-clad laminate or flexible substrate;
(2)曝光工序:对感光性树脂层叠体中的感光性树脂层进行曝光,以图像状照射活性光线使曝光部分进行光固化;(2) Exposure step: Expose the photosensitive resin layer in the photosensitive resin laminate, and irradiate active light in the form of an image to photocur the exposed portion;
(3)显影工序:将感光性树脂层的未曝光部分用显影液去除,以形成保护图案;(3) Development process: remove the unexposed part of the photosensitive resin layer with a developing solution to form a protective pattern;
(4)导体图案形成工序:对覆铜层叠板或柔性基板表面的未被保护图案覆盖的部分进行刻蚀或镀覆;(4) Conductor pattern forming process: etching or plating the part of the surface of the copper-clad laminate or flexible substrate that is not covered by the protection pattern;
(5)剥离工序:将保护图案从该覆铜层叠板或柔性基板剥离。(5) Peeling step: peeling the protective pattern from the copper-clad laminate or flexible substrate.
进一步地,本发明提供上述干膜在制造保护图案中的应用,包括如上所述的层叠工序、曝光工序和显影工序,不同在于:层叠工序中感光性树脂层叠体可层叠于各种不同材质的基板上。Further, the present invention provides the application of the above dry film in manufacturing a protective pattern, including the above-mentioned lamination step, exposure step and development step, the difference is that in the lamination step, the photosensitive resin laminate can be laminated on various materials On the substrate.
进一步地,本发明提供上述干膜在制造导体图案中的应用,包括如上所述的层叠工序、曝光工序、显影工序和导体图案形成工序,不同在于:层叠工序中感光性树脂层叠体层叠于金属板或金属覆膜绝缘板上。Further, the present invention provides the application of the above dry film in manufacturing a conductor pattern, including the above-mentioned lamination step, exposure step, development step, and conductor pattern formation step, except that in the lamination step, the photosensitive resin laminate is laminated on the metal Board or metal-coated insulating board.
进一步地,本发明提供上述干膜在制造引框线中的应用,包括如上所述的层叠工序、曝光工序、显影工序、和导体图案形成工序,不同在于: 层叠工序中感光性树脂层叠体层叠于金属板上,导体图案形成工序中对未被保护图案覆盖的部分进行刻蚀。Further, the present invention provides the application of the above dry film in manufacturing a frame wire, including the above-mentioned lamination step, exposure step, development step, and conductor pattern forming step, except that the photosensitive resin laminate is laminated in the lamination step On the metal plate, the part not covered by the protection pattern is etched in the conductor pattern forming process.
进一步地,本发明提供上述干膜在制造半导体封装中的应用,包括如上所述的层叠工序、曝光工序、显影工序、和导体图案形成工序,不同在于:层叠工序中感光性树脂层叠体层叠于具有大规模集成电路的晶片上,导体图案形成工序中对未被保护图案覆盖的部分进行镀覆。Further, the present invention provides the application of the above dry film in the manufacture of semiconductor packages, including the above-mentioned lamination step, exposure step, development step, and conductor pattern forming step, the difference is that in the lamination step, the photosensitive resin laminate is laminated on On a wafer with a large-scale integrated circuit, the part not covered by the protection pattern is plated in the conductor pattern forming process.
湿膜应用Wet film applications
本发明的感光性树脂组合物可以湿膜方式直接涂布在基板上使用,以用于印刷电路板、保护图案、导体图案、引框线、半导体封装等的制造。The photosensitive resin composition of the present invention can be directly applied on a substrate by a wet film method, and is used for the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, semiconductor packages, and the like.
非限制性地,可利用辊涂、刮涂、喷涂、浸涂等常规方法将感光性树脂组合物涂布于基板上,干燥后形成感光性树脂层。Without limitation, the photosensitive resin composition can be applied on the substrate by conventional methods such as roll coating, blade coating, spray coating, and dip coating, and dried to form the photosensitive resin layer.
在基板上形成感光性树脂层后,后续工序如曝光工序、显影工序、导体图案形成工序和剥离工序,均可参照干膜应用的方式进行。After the photosensitive resin layer is formed on the substrate, subsequent processes such as an exposure process, a development process, a conductor pattern forming process, and a peeling process can all be performed with reference to the application method of the dry film.
工序步骤Process steps
曝光工序中,曝光可以列举出掩模曝光法(布线图的负或正掩模图形将活性光线呈图像状地照射的方法)、投影曝光法,也可以采用通过激光直接成像曝光法、数字光学处理曝光法等直接描画曝光法将活性光线呈图像状地照射的方法。作为活性光线的光源,可使用公知的光源,如碳弧灯、汞蒸气弧灯、超高压示灯、高压示灯、氙灯、氩气激光等气体激光、YAG激光等固体激光、半导体激光和氮化镓系蓝紫色激光等有效放射出紫外线的光源。此外,还可以使用照相用泛光灯、日光灯等有效放射出可见光的光源。In the exposure process, the exposure may include a mask exposure method (a method in which a negative or positive mask pattern of a wiring pattern irradiates active light in the form of an image), a projection exposure method, or a direct imaging exposure method using laser, digital optics The method of direct drawing exposure, such as the processing exposure method, irradiates the active light in the form of an image. As the light source of active light, a well-known light source such as a carbon arc lamp, a mercury vapor arc lamp, an ultra-high pressure indicator lamp, a high-pressure indicator lamp, a gas laser such as a xenon lamp, an argon laser, a solid laser such as a YAG laser, a semiconductor laser, and gallium nitride can be used It is a blue-violet laser and other light sources that effectively emit ultraviolet light. In addition, a light source that efficiently emits visible light such as a floodlight for photography or a fluorescent lamp can also be used.
本发明的感光性树脂组合物对活性光线的光源种类没有特别限制,曝 光量优选为10-1000mJ/cm 2The photosensitive resin composition of the present invention is not particularly limited to the type of light source of active light, and the exposure amount is preferably 10-1000 mJ/cm 2 .
显影工序中,将感光性树脂层的未曝光部分用显影液去除。在感光性树脂层上存在支撑体的情况下,可利用自动剥离器等先除去支撑体,然后再使用碱性水溶液、水系显影液、有机溶剂等显影液除去未曝光部分。碱性水溶液的例子可以是0.1-5质量%的碳酸钠溶液、0.1-5质量%的碳酸钾溶液、0.1-5质量%的氢氧化钠溶液等,pH值优选为9-11。碱性水溶液中还可以加入表面活性剂、消泡剂、有机溶剂等。显影的方式可以是浸渍、喷雾、刷洗等常规方式。In the development step, the unexposed portion of the photosensitive resin layer is removed with a developer. When the support is present on the photosensitive resin layer, the support can be removed by an automatic peeler, etc., and then the unexposed portion can be removed using a developer such as an alkaline aqueous solution, an aqueous developer, or an organic solvent. Examples of the alkaline aqueous solution may be 0.1-5 mass% sodium carbonate solution, 0.1-5 mass% potassium carbonate solution, 0.1-5 mass% sodium hydroxide solution, etc. The pH value is preferably 9-11. Surfactants, defoamers, organic solvents, etc. can also be added to the alkaline aqueous solution. The development method may be conventional methods such as dipping, spraying, and brushing.
刻蚀处理中,以形成于基板上的抗蚀图案(即保护图案)作为掩模,将未被覆盖的电路形成用基板的导体层刻蚀除去,从而形成导体图案。刻蚀处理的方法可以根据待去除的导体层而选择。例如,作为蚀刻液可以列举出氧化铜溶液、氧化铁溶液、碱蚀刻溶液、过氧化氢系蚀刻液等。In the etching process, using the resist pattern (ie, the protection pattern) formed on the substrate as a mask, the conductor layer of the uncovered circuit-forming substrate is etched away to form a conductor pattern. The etching method can be selected according to the conductor layer to be removed. For example, examples of the etching solution include copper oxide solution, iron oxide solution, alkali etching solution, hydrogen peroxide-based etching solution, and the like.
镀敷处理中,以形成于基板上的抗蚀图案为掩模,在未被覆盖的电路形成用基板的绝缘板上镀覆铜和焊锡等。镀敷处理后,除去抗蚀图案从而形成导体图案。作为镀敷处理的方法,既可以是电镀处理,也可以是无电解镀覆处理,优选无电解镀覆处理。作为无电解镀覆处理,可以列举出:硫酸铜镀敷和焦磷酸铜镀敷等铜镀敷、高均匀焊锡(high-throw solder)镀敷等焊锡镀敷、瓦特浴(硫酸镍-氯化镍)镀敷和氨基磺酸镍镀敷等镍镀敷、硬质金镀敷和软质金镀敷等金镀敷。In the plating process, using the resist pattern formed on the substrate as a mask, copper, solder, or the like is plated on the insulating plate of the uncovered circuit-forming substrate. After the plating process, the resist pattern is removed to form a conductor pattern. As a method of the plating treatment, either electroplating treatment or electroless plating treatment may be used, and electroless plating treatment is preferable. Examples of the electroless plating treatment include copper plating such as copper sulfate plating and copper pyrophosphate plating, high-throw solder plating and other solder plating, and watt bath (nickel sulfate-chloride) Nickel) plating and nickel sulfamate plating and other nickel plating, hard gold plating and soft gold plating and other gold plating.
抗蚀图案的除去可以通过比显影工序中使用的碱性水溶液碱性更强的水溶液来进行剥离。作为强碱性水溶液的实例,可使用例如1-10质量%的氢氧化钠水溶液。The resist pattern can be removed by an aqueous solution that is more alkaline than the alkaline aqueous solution used in the development step. As an example of a strong alkaline aqueous solution, for example, a 1-10% by mass sodium hydroxide aqueous solution can be used.
附图说明BRIEF DESCRIPTION
图1是化合物a1的高效液相谱图。Figure 1 is a high performance liquid chromatogram of compound a1.
图2是T1经单晶衍射得到的结构谱图Figure 2 is the structure spectrum of T1 obtained by single crystal diffraction
图3是化合物a1、a2、a3、a8、a9、a10感光度测试结果对比Figure 3 is a comparison of the sensitivity test results of compounds a1, a2, a3, a8, a9, a10
具体实施方式detailed description
以下将结合具体实施例对本发明作进一步详细说明,但不应将其理解为对本发明保护范围的限制。The present invention will be further described in detail in conjunction with specific embodiments below, but it should not be construed as limiting the protection scope of the present invention.
1.六芳基双咪唑类混合光引发剂1. Hexaarylbisimidazole mixed photoinitiator
1.1六芳基双咪唑类混合光引发剂a1的制备1.1 Preparation of hexaarylbisimidazole mixed photoinitiator a1
氮气保护下,向1L的四口烧瓶中投入31.8g 2-(邻氯苯基)-4,5-二苯基-咪唑(M1)、51.3g 2,5-二(邻氯苯基)-4-(4,5-二甲氧基苯基)-咪唑(M2)、4.2g30%液碱、4.0g四丁基溴化铵和300g甲苯,加热搅拌,并在60-65℃时滴加85g次氯酸钠(11%的水溶液),滴加结束后保温反应,取样通过HPLC进行中控,至M1和M2均小于1%,反应完全,结束保温。Under the protection of nitrogen, put 31.8g 2-(o-chlorophenyl)-4,5-diphenyl-imidazole (M1), 51.3g 2,5-di(o-chlorophenyl)- into a 1L four-necked flask 4-(4,5-dimethoxyphenyl)-imidazole (M2), 4.2g 30% liquid alkali, 4.0g tetrabutylammonium bromide and 300g toluene, heated and stirred, and added dropwise at 60-65℃ 85g of sodium hypochlorite (11% aqueous solution), after the dropwise addition, the reaction was kept warm, and the samples were collected and controlled by HPLC, until both M1 and M2 were less than 1%, the reaction was complete, and the heat preservation was ended.
保温反应结束后,用100g纯水洗涤四次,然后用20g甲苯萃取一次水层,将有机层进行减压蒸馏。向蒸馏得到的物料中加入70g甲醇,加热搅拌至溶清,再将溶清液滴加至由30g甲醇和50g纯水配置而成的重结晶溶液中,滴加结束后进行过滤、淋洗、烘干,得到79.1g产物a1。After the holding reaction was completed, it was washed four times with 100 g of pure water, and then the aqueous layer was extracted once with 20 g of toluene, and the organic layer was distilled under reduced pressure. Add 70g of methanol to the material obtained by distillation, heat and stir until it is dissolved, and then add the droplets of solution to the recrystallization solution made up of 30g of methanol and 50g of pure water. After drying, 79.1 g of product a1 was obtained.
使用高效液相色谱对产物进行分析。The product was analyzed using high performance liquid chromatography.
图1是产物a1的高效液相色谱图。分析结果显示,1’-2、2-3’、1-2’和2’-3四种连接位的产品峰总含量为92.5%。Figure 1 is a high performance liquid chromatogram of product a1. The analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.5%.
产物a1是由两个不同的单咪唑(即M1、M2)经两两自身偶合和相互偶合得到的混合物,包括T1、T2和T3。为精确验证产物的结构组成,分别对成分a1-1、a1-2和a1-3进行验证分析。The product a1 is a mixture obtained from two different monoimidazoles (ie, M1, M2) by pair-wise coupling and mutual coupling, including T1, T2, and T3. In order to accurately verify the structural composition of the product, the components a1-1, a1-2 and a1-3 were verified and analyzed.
通过单咪唑自身偶合、柱层析、色谱分离等手段,分别得到纯的T1、T2和T3,分别进行结构确认。By means of monoimidazole self-coupling, column chromatography, chromatographic separation and other means, pure T1, T2 and T3 were obtained, respectively, and the structure was confirmed.
T1在液相中只有一个峰,但通过单晶衍射得到两个峰形,见附图2。结合结构特征可以确定,两个单咪唑偶合其主要产物是其中一个咪唑上的含有氢的N与另一个咪唑上2位的C连接而成的混合物,由此表明T1的结构为本发明中所述的1-2’和2’-3两种连接位。T1 has only one peak in the liquid phase, but two peak shapes are obtained by single crystal diffraction, see Figure 2. According to the structural characteristics, it can be determined that the main product of the coupling of two monoimidazoles is a mixture of N containing hydrogen on one imidazole and C on the 2-position of the other imidazole, thus indicating that the structure of T1 is The 1-2' and 2'-3 connection positions mentioned above.
合成T1的咪唑是M1,属于对称型咪唑,所以偶合得到的1-2’和2’-3极性相似,液相难以进行分离。并且由于M1的结构对称性,由其自身偶合得到的产物结构中1-2’与1’-2结构相同,2’-3与3-2’的结构也相同,所以T1主结构为1-2’和3-2’两种连接位的产物,结构式如下所示,分别为T1-1:2,2’-二(邻氯苯基)-4,4’,5,5’-四苯基-1,2’-二咪唑和T1-2:2,2’-二(邻氯苯基)-4,4’,5,5’-四苯基-2’,3-二咪唑;The imidazole used to synthesize T1 is M1, which belongs to symmetric imidazole, so the 1-2' and 2'-3 obtained by coupling are of similar polarity, and the liquid phase is difficult to separate. And because of the structural symmetry of M1, the structure of the product obtained by its own coupling is 1-2' and 1'-2, and 2'-3 and 3-2' are the same, so the main structure of T1 is 1- The products of the two connecting positions of 2'and 3-2' have the structural formulas as shown below, respectively T1-1: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl -1,2'-diimidazole and T1-2: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole;
Figure PCTCN2019120524-appb-000018
Figure PCTCN2019120524-appb-000018
同样,对分离得到的纯T2进行分析,主结构为四个连接位产品,进行LCMS确认结构。质谱分析借助仪器附带软件得到849与850分子碎片峰,产 品的分子量为848,与T+1和T+2吻合,证明这四个产物结构相仿,分子量相同。合成T2的单咪唑M2属于不对称的单咪唑,M2存在两种构型,M2-1和M2-2,如下所示:Similarly, the separated pure T2 was analyzed, the main structure was four connected products, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained 849 and 850 molecular fragment peaks with the aid of software attached to the instrument. The molecular weight of the product was 848, which was consistent with T+1 and T+2, proving that these four products have similar structures and the same molecular weight. The monoimidazole M2 synthesized by T2 belongs to asymmetric monoimidazole. There are two configurations of M2, M2-1 and M2-2, as shown below:
Figure PCTCN2019120524-appb-000019
Figure PCTCN2019120524-appb-000019
T2由不对称的单咪唑偶合合成,理论存在八种1-2和2-3连接位连接的主结构,但对于自身偶合的单咪唑,结构中的1-2’与1’-2结构相同,2’-3与3-2’的结构也相同,所以对于T2来说,其实际存在四种1-2和2-3连接位连接的主结构,其组成分别为:T2 is synthesized by asymmetric monoimidazole coupling. In theory, there are eight main structures connected by 1-2 and 2-3 connecting sites, but for the self-coupled monoimidazole, the structure of 1-2' is the same as 1'-2. , The structure of 2'-3 and 3-2' is also the same, so for T2, there are actually four main structures connected by 1-2 and 2-3 connection sites, and their compositions are:
T2-1:2,2’,5,5'-四(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-2’,3-二咪唑,T2-2:2,2’,4,5'-四(邻氯苯基)-4’,5-双(3,4-二甲氧基苯基)-1,2’-二咪唑,T2-3:2,2’,5,5'-四(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-1,2’-二咪唑,T2-4:2,2’,4,5'-四(邻氯苯基)-4’,5-双(3,4-二甲氧基苯基)-2’,3-二咪唑,结构如下所示:T2-1: 2,2',5,5'-tetra(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-2',3-diimidazole, T2 -2: 2,2',4,5'-tetra(o-chlorophenyl)-4',5-bis(3,4-dimethoxyphenyl)-1,2'-diimidazole, T2- 3: 2,2',5,5'-tetra(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-1,2'-diimidazole, T2-4 : 2,2',4,5'-tetra(o-chlorophenyl)-4',5-bis(3,4-dimethoxyphenyl)-2',3-diimidazole, the structure is shown below :
Figure PCTCN2019120524-appb-000020
Figure PCTCN2019120524-appb-000020
T3是由M1与M2两两偶合而成,分离得到的纯T3在液相中主结构为四种连接位的产品,对四种连接位的产品进行LCMS确认结构。质谱分析借助仪器附带软件得到755与756分子碎片峰,产品的分子量为754,与T+1和T+2吻合,证明这四个产物结构相仿,分子量相同。T3由对称的咪唑M1与不对称的咪唑M2两两连接而成,存在四种1-2和2-3连接位连接的主结构,其组成分别为:T3 is formed by coupling M1 and M2 two by two. The main structure of the pure T3 separated in the liquid phase is the product with four kinds of connection positions. The structure of the products with four kinds of connection positions is confirmed by LCMS. Mass spectrometry analysis obtained molecular fragment peaks of 755 and 756 with the software attached to the instrument. The molecular weight of the product was 754, which was consistent with T+1 and T+2, proving that these four products have similar structures and the same molecular weight. T3 is formed by connecting symmetrical imidazole M1 and asymmetrical imidazole M2 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, which are composed of:
T3-1:2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1,2’-二咪唑,T3-2:2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-2’,3-二咪 唑,T3-3:2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-2,3’-二咪唑,T3-4:2,2',5-三(邻氯苯基)-4-(3,4-二甲氧基苯基)-4',5'-二苯基-1’,2-二咪唑,结构式如下:T3-1: 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-1,2'-di Imidazole, T3-2: 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2',3 -Diimidazole, T3-3: 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl-2, 3'-diimidazole, T3-4: 2,2',5-tris(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-4',5'-diphenyl- 1',2-Diimidazole, the structural formula is as follows:
Figure PCTCN2019120524-appb-000021
Figure PCTCN2019120524-appb-000021
综合上述实验分析确定,产物a1是由T1(T1-1、T1-2)、T2(T2-1、T2-2、T2-3、T2-4)和T3(T3-1、T3-2、T3-3、T3-4)组合而成,其中由1’-2、2-3’、1-2’和2’-3四种连接位构成的双咪唑化合物在a1中的含量为92.5%。Based on the above experimental analysis, it is determined that the product a1 is composed of T1 (T1-1, T1-2), T2 (T2-1, T2-2, T2-3, T2-4) and T3 (T3-1, T3-2, T3-3, T3-4) combined, in which the content of the biimidazole compound composed of four connecting positions 1'-2, 2-3', 1-2' and 2'-3 in a1 is 92.5% .
1.2 a2-a10的制备1.2 Preparation of a2-a10
分别制备得到a2-a10,各产品情况如下表1所示。A2-a10 were prepared separately, and the conditions of each product are shown in Table 1 below.
表1Table 1
Figure PCTCN2019120524-appb-000022
Figure PCTCN2019120524-appb-000022
从上表溶解度数据可以看出,单一结构的纯HABI(a6和a7)溶解性很差,即使和其他HABI混合(a4和a5)溶解性也无法得到提高,本发明所述的HABI类混合光引发剂必须是相同取代基的结构同时存在四种连接位才能达到本发明所示的最优的溶解性。It can be seen from the solubility data in the above table that the solubility of pure HABI (a6 and a7) with a single structure is very poor, and even if it is mixed with other HABI (a4 and a5), the solubility cannot be improved. The initiator must have the structure of the same substituent and there are four kinds of linking sites simultaneously to achieve the optimal solubility shown in the present invention.
1.3感光度测试1.3 Sensitivity test
由于使用纯的T2-3或T3-4时溶解性很差,难以进行感光度测试,因此仅测试了a1、a2、a3、a8、a9、a10的感光度数据。Due to the poor solubility when using pure T2-3 or T3-4, it is difficult to perform sensitivity test, so only the sensitivity data of a1, a2, a3, a8, a9, a10 were tested.
参照表2中所示配方,制得比较例1-6的感光性树脂组合物以进行感光度测试,表中各物质用量单位均为g。Referring to the formulation shown in Table 2, the photosensitive resin compositions of Comparative Examples 1-6 were prepared for sensitivity test, and the unit of dosage of each substance in the table was g.
表2Table 2
Figure PCTCN2019120524-appb-000023
Figure PCTCN2019120524-appb-000023
上述表1中,TMPTA采购于天津市北联精细化学品开发有限公司,NPG采购于深圳市鹏顺兴科技有限公司,PGMEA采购于济南汇丰达化工有限公司。In Table 1 above, TMPTA was purchased from Tianjin Beilian Fine Chemical Development Co., Ltd., NPG was purchased from Shenzhen Pengshunxing Technology Co., Ltd., and PGMEA was purchased from Jinan Huifengda Chemical Co., Ltd.
按上述配方进行样品配制,混合均匀后取1.0mg样品平铺于坩埚底部,后放入差示扫描量热仪(型号:DSC8000,厂家:PerkinElmer)的炉体中进行测试。Prepare the sample according to the above formula. After mixing, take 1.0 mg of the sample and lay it flat on the bottom of the crucible, and then put it into the furnace body of the differential scanning calorimeter (model: DSC8000, manufacturer: PerkinElmer) for testing.
峰值代表最大放热量,mw/mg,放热量越大,感光度越高。斜率代表固化速率,斜率越小,则感光度越高。The peak value represents the maximum heat dissipation, mw/mg, the greater the heat dissipation, the higher the sensitivity. The slope represents the curing rate, the smaller the slope, the higher the sensitivity.
结果如附图3所示,感光度测试结果为:a10(76.1%)<a9(83.0%)≈a8(88.5%)<a1(92.5%)≈a2(95.6%)≈a3(98.3)。这进一步证实,1’-2、2-3’、1-2’和2’-3四种连接位构成的双咪唑化合物在混合光引发剂中的总质量对感光度具有一定的影响,当含量高于92%时感光度得到了提高。The results are shown in Figure 3. The sensitivity test results are: a10 (76.1%) <a9 (83.0%) ≈ a8 (88.5%) <a1 (92.5%) ≈ a2 (95.6%) ≈ a3 (98.3). This further confirms that the total mass of the biimidazole compound composed of four connection sites of 1'-2, 2-3', 1-2' and 2'-3 in the mixed photoinitiator has a certain effect on the sensitivity, when When the content is higher than 92%, the sensitivity is improved.
1.4 a11的制备1.4 Preparation of a11
氮气保护下,向1L的四口烧瓶中投入50g 2-(4-氯苯基)-5-(6-氯苯基)-4-(3,4-二甲氧基苯基)-咪唑(M3)、51g2,5-二(邻氯苯基)-4-(3,4-二甲氧基苯基)-咪唑(M2)、5.6g 30%液碱、4.0g四丁基溴化铵和300g甲苯,加热搅拌,并在60-65℃时滴加90g次氯酸钠(11%的水溶液),滴加结束后保温反应,取样通过HPLC进行中控,至M2和M3均小于1%,反应完全,结束保温。Under nitrogen protection, put 50g 2-(4-chlorophenyl)-5-(6-chlorophenyl)-4-(3,4-dimethoxyphenyl)-imidazole into a 1L four-necked flask ( M3), 51g 2,5-bis(o-chlorophenyl)-4-(3,4-dimethoxyphenyl)-imidazole (M2), 5.6g 30% liquid alkali, 4.0g tetrabutylammonium bromide And 300g of toluene, heated and stirred, and 90g of sodium hypochlorite (11% aqueous solution) was added dropwise at 60-65°C. After the end of the addition, the reaction was kept warm, and the sample was controlled by HPLC until both M2 and M3 were less than 1%, the reaction was complete To end the insulation.
保温反应结束后,用100g纯水洗涤四次,然后用20g甲苯萃取一次水层,将有机层进行减压蒸馏。向蒸馏得到的物料中加入70g甲醇,加热搅拌至溶清,再将溶清液滴加至由30g甲醇和50g纯水配置而成的重结晶溶液中,滴加结束后进行淋洗、抽干、烘料,得到98g产物a11。After the holding reaction was completed, it was washed four times with 100 g of pure water, and then the aqueous layer was extracted once with 20 g of toluene, and the organic layer was distilled under reduced pressure. Add 70g of methanol to the material obtained by distillation, heat and stir until the solution is clear, then add the solution clear droplets to the recrystallization solution composed of 30g methanol and 50g pure water, rinse and drain after the end of the addition , Baking material, to obtain 98g of product a11.
分析结果显示,1’-2、2-3’、1-2’和2’-3四种连接位的产品峰总含量为92.5%。The analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.5%.
产物a11是由两个不同的单咪唑(即M2、M3)经两两自身偶合和相互偶合得到的混合物,包括T2、T4和T5。为精确验证产物的结构组成,分别对成分T2、T4和T5进行验证分析。The product a11 is a mixture obtained from two different monoimidazoles (ie, M2 and M3) by pairwise coupling and mutual coupling, including T2, T4 and T5. In order to accurately verify the structure of the product, the components T2, T4 and T5 were analyzed and verified.
通过单咪唑自身偶合、柱层析、色谱分离等手段,分别得到T2、T4和 T5,分别进行结构确认。By means of monoimidazole self coupling, column chromatography, chromatographic separation and other means, T2, T4 and T5 were obtained respectively, and the structure was confirmed separately.
T2与化合物a1中结构一致。T2 has the same structure as compound a1.
T4由不对称的单咪唑M3自身偶合而成,存在四种1-2和2-3连接位连接的主结构,其组成分别为:T4 is formed by the coupling of asymmetric monoimidazole M3 itself, there are four main structures connected by 1-2 and 2-3 connection sites, and their composition is:
T4-1:2,2’-双(4-氯苯基)-5,5’-双(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-2,3’-二咪唑,T4-2:2,2’-双(4-氯苯基)-4,5’-双(邻氯苯基)-4’,5-双(3,4-二甲氧基苯基)-1,2’-二咪唑,T4-3:2,2’-双(4-氯苯基)-5,5’-双(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-1,2’-二咪唑,T4-4:2,2’-双(4-氯苯基)-4’,5–双(邻氯苯基)-4,5’-双(3,4-二甲氧基苯基)-2,3’-二咪唑,结构式如下所示:T4-1: 2,2'-bis(4-chlorophenyl)-5,5'-bis(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)- 2,3'-Diimidazole, T4-2: 2,2'-bis(4-chlorophenyl)-4,5'-bis(o-chlorophenyl)-4',5-bis(3,4- Dimethoxyphenyl)-1,2'-diimidazole, T4-3: 2,2'-bis(4-chlorophenyl)-5,5'-bis(o-chlorophenyl)-4,4 '-Bis(3,4-dimethoxyphenyl)-1,2'-diimidazole, T4-4: 2,2'-bis(4-chlorophenyl)-4',5-bis(o Chlorophenyl)-4,5'-bis(3,4-dimethoxyphenyl)-2,3'-diimidazole, the structural formula is as follows:
Figure PCTCN2019120524-appb-000024
Figure PCTCN2019120524-appb-000024
Figure PCTCN2019120524-appb-000025
Figure PCTCN2019120524-appb-000025
进行LCMS确认结构,四个结构谱图一致。质谱分析借助仪器附带软件得到849与850分子碎片峰,产品的分子量为848,与T+1和T+2吻合,证明这四个产物峰结构相仿,分子量相同。The structure was confirmed by LCMS, and the four structural spectra were consistent. Mass spectrometry analysis obtained the peaks of 849 and 850 molecular fragments with the software attached to the instrument. The molecular weight of the product is 848, which is in agreement with T+1 and T+2. It proves that these four product peaks have similar structures and the same molecular weight.
T5由不对称的M2和不对称的M3两两偶合而成,存在四种1-2和2-3连接位连接的主结构,其组成分别为:T5 is formed by the coupling of asymmetric M2 and asymmetric M3, and there are four main structures connected by 1-2 and 2-3 connection sites. Their composition is:
T5-1:2-(4-氯苯基)-2’,5,5’-三(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-2,3’-二咪唑,T5-2:2’-(4-氯苯基)-2,5,5’-三(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-1,2’-二咪唑,T5-3:2-(4-氯苯基)-2’,5,5’-三(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-2’,3-二咪唑,T5-4:2’-(4-氯苯基)-2,5,5’-三(邻氯苯基)-4,4’-双(3,4-二甲氧基苯基)-1’,2-二咪唑,结构式如下所示:T5-1: 2-(4-chlorophenyl)-2', 5,5'-tri(o-chlorophenyl)-4,4'-bis(3,4-dimethoxyphenyl)-2 ,3'-diimidazole, T5-2: 2'-(4-chlorophenyl)-2,5,5'-tri(o-chlorophenyl)-4,4'-bis(3,4-dimethyl Oxyphenyl)-1,2'-diimidazole, T5-3: 2-(4-chlorophenyl)-2',5,5'-tris(o-chlorophenyl)-4,4'-bis (3,4-dimethoxyphenyl)-2',3-diimidazole, T5-4: 2'-(4-chlorophenyl)-2,5,5'-tri(o-chlorophenyl) -4,4'-bis(3,4-dimethoxyphenyl)-1',2-diimidazole, the structural formula is as follows:
Figure PCTCN2019120524-appb-000026
Figure PCTCN2019120524-appb-000026
Figure PCTCN2019120524-appb-000027
Figure PCTCN2019120524-appb-000027
进行LCMS确认结构,四个结构谱图一致。质谱分析借助仪器附带软件得到849与850分子碎片峰,产品的分子量为848,与T+1和T+2吻合,证明这四个产物峰结构相仿,分子量相同。The structure was confirmed by LCMS, and the four structural spectra were consistent. Mass spectrometry analysis obtained the peaks of 849 and 850 molecular fragments with the software attached to the instrument. The molecular weight of the product is 848, which is in agreement with T+1 and T+2. It proves that these four product peaks have similar structures and the same molecular weight.
综合上述实验分析确定,产物a11是由T2(T2-1、T2-2、T2-3、T2-4)、T4(T4-1、T4-2、T4-3、T4-4)和T5(T5-1、T5-2、T5-3、T5-4)组合而成,其中由1’-2、2-3’、1-2’和2’-3四种连接位构成的双咪唑化合物在a11中的含量为92.5%。Based on the above experimental analysis, it is determined that the product a11 is composed of T2 (T2-1, T2-2, T2-3, T2-4), T4 (T4-1, T4-2, T4-3, T4-4) and T5 ( T5-1, T5-2, T5-3, T5-4), which consists of biimidazole compounds composed of four connecting positions 1'-2, 2-3', 1-2' and 2'-3 The content in a11 is 92.5%.
分别制备得到a12-a20,各产品情况如下表3所示。A12-a20 were prepared separately, and the conditions of each product are shown in Table 3 below.
表3table 3
Figure PCTCN2019120524-appb-000028
Figure PCTCN2019120524-appb-000028
Figure PCTCN2019120524-appb-000029
Figure PCTCN2019120524-appb-000029
上表溶解度数据进一步表明,单一结构的纯HABI(a16和a17)溶解性很差,即使和其他HABI混合(a14和a15)溶解性也无法得到提高,本发明所述的HABI类混合光引发剂必须是相同取代基的结构同时存在四种连接位才能达到本发明所示的最优的溶解性。The solubility data in the table above further shows that the solubility of pure HABI (a16 and a17) with a single structure is very poor, and even if it is mixed with other HABI (a14 and a15), the solubility cannot be improved. It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
1.5 a21的制备1.5 Preparation of a21
氮气保护下,向1L的四口烧瓶中投入35g 2-(邻氯苯基)-4,5-二苯基-咪唑(M1)、39g2-(2,4-二氯苯基)-4,5-二苯基-咪唑(M4)、5.6g 30%液碱、4.0g四丁基溴化铵和250g甲苯,加热搅拌,并在60-65℃时滴加87g次氯酸钠,滴加结束后保温反应,取样通过HPLC进行中控,至M1和M4均小于1%,反应完全,结束保温。Under nitrogen protection, put 35g 2-(o-chlorophenyl)-4,5-diphenyl-imidazole (M1), 39g2-(2,4-dichlorophenyl)-4 into a 1L four-necked flask, 5-Diphenyl-imidazole (M4), 5.6g 30% liquid alkali, 4.0g tetrabutylammonium bromide and 250g toluene, heated and stirred, and 87g sodium hypochlorite was added dropwise at 60-65°C, and kept warm after the dropwise addition The reaction was sampled and controlled by HPLC until both M1 and M4 were less than 1%. The reaction was complete and the heat preservation was completed.
保温反应结束后,用100g纯水洗涤四次,然后用20g甲苯萃取一次水层, 将有机层进行减压蒸馏。向蒸馏得到的物料中加入60g甲醇,加热搅拌至溶清,再将溶清液滴加至由30g甲醇和50g纯水配置而成的重结晶溶液中,滴加结束后进行淋洗、抽干、烘料,得到66g产物a21。After the heat retention reaction was completed, it was washed four times with 100 g of pure water, and then the aqueous layer was extracted once with 20 g of toluene, and the organic layer was distilled under reduced pressure. Add 60g of methanol to the material obtained by distillation, heat and stir until it is dissolved, and then add the droplets of solution to the recrystallization solution made up of 30g of methanol and 50g of pure water. After the dropwise addition, rinse and drain. , Baking material, to obtain 66g of product a21.
分析结果显示,1’-2、2-3’、1-2’和2’-3四种连接位的产品峰总含量为92.1%。The analysis result showed that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 was 92.1%.
产物a21是由两个不同的对称型单咪唑(即M1、M4)经两两自身偶合和相互偶合得到的混合物,包括T1、T6和T7。为精确验证产物的结构组成,分别对成分T1、T6和T7进行验证分析。The product a21 is a mixture obtained from two different symmetrical monoimidazoles (ie, M1, M4) by pairwise self-coupling and mutual coupling, including T1, T6, and T7. In order to accurately verify the structure of the product, the components T1, T6 and T7 were verified and analyzed.
通过单咪唑自身偶合、柱层析、色谱分离等手段,分别得到T1、T6和T7,分别进行结构确认。By means of monoimidazole self coupling, column chromatography, chromatographic separation and other means, T1, T6 and T7 were obtained respectively, and the structure was confirmed separately.
T1与化合物a1中结构一致。T1 has the same structure as compound a1.
T6有两种结构,但在液相中只有一个峰,其结构组成与T1类似,T6是由对称型咪唑进行自身偶合得到的,所以偶合得到的1-2’和2’-3极性相似,液相难以进行分离,结构式如下所示,分别为T6-1:2,2’-双(2,4-二氯苯基)-4,4’,5,5’-四苯基-1,2’-二咪唑和T6-2:2,2’-双(2,4-二氯苯基)-4,4’,5,5’-四苯基-2’,3-二咪唑;T6 has two structures, but there is only one peak in the liquid phase, and its structural composition is similar to that of T1. T6 is obtained by self-coupling of symmetric imidazole, so the polarities of 1-2' and 2'-3 obtained by coupling are similar , The liquid phase is difficult to separate, the structural formula is as follows, respectively T6-1: 2,2'-bis(2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-1 , 2'-diimidazole and T6-2: 2,2'-bis(2,4-dichlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole;
Figure PCTCN2019120524-appb-000030
Figure PCTCN2019120524-appb-000030
对分离得到的T6进行分析,经LCMS确认结构。质谱分析借助仪器附带软件得到729与730分子碎片峰,产品的分子量为728,与T+1和T+2吻合,证明这两个产物峰结构相仿,分子量相同。The separated T6 was analyzed, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained 729 and 730 molecular fragment peaks with the software attached to the instrument. The molecular weight of the product was 728, which was in agreement with T+1 and T+2, proving that these two products have similar peak structures and the same molecular weight.
T7由对称的M1和对称的M4两两偶合而成,存在四种1-2和2-3连接位连接的主结构,其组成分别为:T7 is formed by coupling symmetrical M1 and symmetrical M4 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, whose composition are:
T7-1:2-(2,4-二氯苯基)-2’-(邻氯苯基)-4,4’,5,5’-四苯基-2,3’-二咪唑,T7-2:2-(2,4-二氯苯基)-2’-(邻氯苯基)-4,4’,5,5’-四苯基-1’,2-二咪唑,T7-3:2-(2,4-二氯苯基)-2’-(邻氯苯基)-4,4’,5,5’-四苯基-1,2’-二咪唑,T7-4:2-(2,4-二氯苯基)-2’-(邻氯苯基)-4,4’,5,5’-四苯基-2’,3-二咪唑,结构式如下所示:T7-1: 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2,3'-diimidazole, T7 -2: 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-1',2-diimidazole, T7- 3: 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-diimidazole, T7-4 : 2-(2,4-dichlorophenyl)-2'-(o-chlorophenyl)-4,4',5,5'-tetraphenyl-2',3-diimidazole, the structural formula is shown below :
Figure PCTCN2019120524-appb-000031
Figure PCTCN2019120524-appb-000031
对分离得到的T7进行分析,经LCMS确认结构。质谱分析借助仪器附带 软件得到695与696分子碎片峰,产品的分子量为694,与T+1和T+2吻合,证明这四个产物峰结构相仿,分子量相同。The separated T7 was analyzed, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained 695 and 696 molecular fragment peaks with the aid of software attached to the instrument. The molecular weight of the product is 694, which is in agreement with T+1 and T+2, proving that the four products have similar peak structures and the same molecular weight.
综合上述实验分析确定,产物a21是由T1(T1-1、T1-2)、T6(T6-1、T6-2)和T7(T7-1、T7-2、T7-3、T7-4)组合而成,其中由1’-2、2-3’、1-2’和2’-3四种连接位构成的双咪唑化合物在a21中的含量为92.1%。Based on the above experimental analysis, it is determined that the product a21 is composed of T1 (T1-1, T1-2), T6 (T6-1, T6-2) and T7 (T7-1, T7-2, T7-3, T7-4) It is a combination, in which the content of the biimidazole compound composed of four connecting positions of 1'-2, 2-3', 1-2' and 2'-3 in a21 is 92.1%.
分别制备得到a22-a30,各产品情况如下表4所示。A22-a30 were prepared separately, and the conditions of each product are shown in Table 4 below.
表4Table 4
Figure PCTCN2019120524-appb-000032
Figure PCTCN2019120524-appb-000032
Figure PCTCN2019120524-appb-000033
Figure PCTCN2019120524-appb-000033
上表溶解度数据进一步表明,单一结构的纯HABI(a26和a27)溶解性很差,即使和其他HABI混合(a24和a25)溶解性也无法得到提高,本发明所述的HABI类混合光引发剂必须是相同取代基的结构同时存在四种连接位才能达到本发明所示的最优的溶解性。The solubility data in the table above further shows that the solubility of pure HABI (a26 and a27) with a single structure is very poor, and even if it is mixed with other HABI (a24 and a25), the solubility cannot be improved. The HABI-type mixed photoinitiators described in the present invention It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
1.5 a31的制备1.5 Preparation of a31
氮气保护下,向1L的四口烧瓶中投入35g 2-(邻氯苯基)-4,5-二苯基-咪唑(M1)、44g2-(邻氯苯基)-4,5-二(2-萘基)-咪唑(M5)、5.6g 30%液碱、4.0g四丁基溴化铵和300g甲苯,加热搅拌,并在60-65℃时滴加97g次氯酸钠,滴加结束后保温反应,取样通过HPLC进行中控,至M1和M5均小于1%,反应完全,结束保温。Under nitrogen protection, put 35g 2-(o-chlorophenyl)-4,5-diphenyl-imidazole (M1), 44g2-(o-chlorophenyl)-4,5-di( 2-naphthyl)-imidazole (M5), 5.6g of 30% liquid alkali, 4.0g of tetrabutylammonium bromide and 300g of toluene, heating and stirring, and adding 97g of sodium hypochlorite dropwise at 60-65°C, keeping warm after the dropwise addition The reaction was sampled and controlled by HPLC until both M1 and M5 were less than 1%. The reaction was complete and the heat preservation was completed.
保温反应结束后,用100g纯水洗涤四次,然后用20g甲苯萃取一次水层,将有机层进行减压蒸馏。向蒸馏得到的物料中加入60g甲醇,加热搅拌至溶清,再将溶清液滴加至由30g甲醇和50g纯水配置而成的重结晶溶液中,滴加结束后进行淋洗、抽干、烘料,得到76g产物a31。After the holding reaction was completed, it was washed four times with 100 g of pure water, and then the aqueous layer was extracted once with 20 g of toluene, and the organic layer was distilled under reduced pressure. Add 60g of methanol to the material obtained by distillation, heat and stir until it is dissolved, and then add the droplets of solution to the recrystallization solution made up of 30g of methanol and 50g of pure water. After the dropwise addition, rinse and drain. , Baking material, to obtain 76g of product a31.
分析结果显示,1’-2、2-3’、1-2’和2’-3四种连接位的产品峰总含量为92.7%。The analysis result shows that the total content of the product peaks of the four connection sites of 1'-2, 2-3', 1-2' and 2'-3 is 92.7%.
产物a31是由两个不同的对称型单咪唑(即M1、M5)经两两自身偶合和相互偶合得到的混合物,包括T1、T8和T9。为精确验证产物的结构组成,分别对成分T1、T8和T9进行验证分析。The product a31 is a mixture obtained from two different symmetrical monoimidazoles (ie, M1, M5) through pairwise self-coupling and mutual coupling, including T1, T8, and T9. In order to accurately verify the structure of the product, the components T1, T8 and T9 were verified and analyzed.
通过单咪唑自身偶合、柱层析、色谱分离等手段,分别得到T1、T8和T9,分别进行结构确认。By means of monoimidazole self coupling, column chromatography, chromatographic separation and other means, T1, T8 and T9 were obtained respectively, and the structure was confirmed separately.
T1与化合物a1中结构一致。T1 has the same structure as compound a1.
T8有两种结构,但在液相中只有一个峰,其结构组成与T1类似,T8是由对称型咪唑(M5)进行自身偶合得到的,所以偶合得到的1-2’和2’-3极性相似,液相难以进行分离,结构式如下所示,分别为T8-1:2,2’-二(邻氯苯基)-4,4’,5,5’-四(2-萘基)-1,2’-二咪唑和T8-2:2,2’-二(邻氯苯基)-4,4’,5,5’-四(2-萘基)-2’,3-二咪唑;T8 has two structures, but there is only one peak in the liquid phase, and its structural composition is similar to that of T1. T8 is obtained by self-coupling of symmetric imidazole (M5), so the 1-2' and 2'-3 obtained by coupling The polarities are similar, and the liquid phase is difficult to separate. The structural formulas are as follows: T8-1: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetra(2-naphthyl )-1,2'-diimidazole and T8-2: 2,2'-bis(o-chlorophenyl)-4,4',5,5'-tetrakis(2-naphthyl)-2',3- Diimidazole
Figure PCTCN2019120524-appb-000034
Figure PCTCN2019120524-appb-000034
对分离得到的T8进行分析,经LCMS确认结构。质谱分析借助仪器附带软件得到860与861分子碎片峰,产品的分子量为859,与T+1和T+2吻合,证明这两个产物峰结构相仿,分子量相同。The separated T8 was analyzed, and the structure was confirmed by LCMS. Mass spectrometry analysis obtained the molecular fragment peaks of 860 and 861 with the software attached to the instrument. The molecular weight of the product was 859, which was in agreement with T+1 and T+2, proving that the two products had similar peak structures and the same molecular weight.
T9由对称的M1和对称的M5两两偶合而成,存在四种1-2和2-3连接位连接的主结构,其组成分别为:T9 is formed by coupling symmetrical M1 and symmetrical M5 two by two. There are four main structures connected by 1-2 and 2-3 connection sites, and their composition is:
T9-1:2,2’-二(邻氯苯基)-4,5-二(2-萘基)-4’5’-二苯基-1,2’-二咪唑,T9-2:2,2’-二(邻氯苯基)-4,5-二(2-萘基)-4’5’-二苯基-2’,3-二咪唑,T9-3:2,2’-二(邻氯苯基)-4,5-二(2-萘基)-4’5’-二苯基-1’,2-二咪唑,T9-4:2,2’-二(邻氯苯基)-4,5-二(2-萘基)-4’5’-二苯基-2,3’-二咪唑,结构式如下所示:T9-1: 2,2'-bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-1,2'-diimidazole, T9-2: 2,2'-bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-2',3-diimidazole, T9-3: 2,2' -Bis(o-chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-1',2-diimidazole, T9-4: 2,2'-bis(o Chlorophenyl)-4,5-bis(2-naphthyl)-4'5'-diphenyl-2,3'-diimidazole, the structural formula is as follows:
Figure PCTCN2019120524-appb-000035
Figure PCTCN2019120524-appb-000035
对分离得到的T9进行分析,经LCMS确认结构。质谱分析借助仪器附带软件得到760与761分子碎片峰,产品的分子量为759,与T+1和T+2吻合,证明这四个产物峰结构相仿,分子量相同。The separated T9 was analyzed, and the structure was confirmed by LCMS. The mass spectrometry analysis obtained the molecular fragment peaks of 760 and 761 with the software attached to the instrument. The molecular weight of the product was 759, which was consistent with T+1 and T+2, which proved that the four products had similar peak structures and the same molecular weight.
综合上述实验分析确定,产物a31是由T1(T1-1、T1-2)、T8(T8-1、T8-2)和T9(T9-1、T9-2、T9-3、T9-4)组合而成,其中由1’-2、2-3’、1-2’和2’-3四种连接位构成的双咪唑化合物在a21中的含量为92.7%。Based on the above experimental analysis, it is determined that the product a31 is composed of T1 (T1-1, T1-2), T8 (T8-1, T8-2) and T9 (T9-1, T9-2, T9-3, T9-4) It is a combination, in which the content of the biimidazole compound composed of four connecting positions of 1'-2, 2-3', 1-2' and 2'-3 in a21 is 92.7%.
分别制备得到a32-a40,各产品情况如下表5所示。A32-a40 were prepared separately, and the conditions of each product are shown in Table 5 below.
表5table 5
Figure PCTCN2019120524-appb-000036
Figure PCTCN2019120524-appb-000036
Figure PCTCN2019120524-appb-000037
Figure PCTCN2019120524-appb-000037
上表溶解度数据进一步表明,单一结构的纯HABI(a36和a37)溶解性很差,即使和其他HABI混合(a34和a35)溶解性也无法得到提高,本发明所述的HABI类混合光引发剂必须是相同取代基的结构同时存在四种连接位才能达到本发明所示的最优的溶解性。The solubility data in the above table further shows that the solubility of pure HABI (a36 and a37) with a single structure is very poor, and even if it is mixed with other HABI (a34 and a35), the solubility cannot be improved. The HABI-type mixed photoinitiators described in the present invention It is necessary for the structure of the same substituent to have four kinds of connection sites at the same time in order to achieve the optimal solubility shown in the present invention.
2.感光性树脂组合物的制备2. Preparation of photosensitive resin composition
参照表5-7中所示配方,将各组分混合均匀制得感光性树脂组合物。如无特别说明,表中所示份数均为质量份。Referring to the formulations shown in Tables 5-7, the components are mixed uniformly to prepare a photosensitive resin composition. Unless otherwise specified, the parts shown in the table are parts by mass.
表6Table 6
Figure PCTCN2019120524-appb-000038
Figure PCTCN2019120524-appb-000038
表7Table 7
Figure PCTCN2019120524-appb-000039
Figure PCTCN2019120524-appb-000039
Figure PCTCN2019120524-appb-000040
Figure PCTCN2019120524-appb-000040
表8Table 8
Figure PCTCN2019120524-appb-000041
Figure PCTCN2019120524-appb-000041
Figure PCTCN2019120524-appb-000042
Figure PCTCN2019120524-appb-000042
表9Table 9
Figure PCTCN2019120524-appb-000043
Figure PCTCN2019120524-appb-000043
表6-9中各组分代号表示的含义如表10中所示。The meaning of each component code in Table 6-9 is shown in Table 10.
表10Table 10
Figure PCTCN2019120524-appb-000044
Figure PCTCN2019120524-appb-000044
Figure PCTCN2019120524-appb-000045
Figure PCTCN2019120524-appb-000045
表10中,碱可溶性聚合物C1的制备:在氮气氛围下,向配有搅拌器、回流冷却器、温度计和滴液漏斗的烧瓶中加入由甲基溶纤剂和甲苯以质量比3:2配制而成的混合溶剂500g,搅拌加热至80℃。将甲基丙烯酸100g、甲基丙烯酸乙酯200g、丙烯酸乙酯100g、苯乙烯100g和偶氮双异丁腈0.8g混合制得溶液,随后慢慢滴加至烧瓶中,滴加时间为4小时,滴加结束后继续反应2小时。接着,向烧瓶内滴加溶解有1.2g偶氮双异丁腈的混合溶剂(组成同上)100g,滴加时间为10分钟,滴加结束后,在80℃下进一步反应3小时,再升温至90℃继续反应2小时。反应结束后,过滤得到碱可溶性聚合物C1,重均分子量约为80000。In Table 10, the preparation of alkali soluble polymer C1: Under a nitrogen atmosphere, a flask equipped with a stirrer, reflux cooler, thermometer and dropping funnel was charged with methyl cellosolve and toluene at a mass ratio of 3:2 500g of the prepared mixed solvent is stirred and heated to 80°C. A solution was prepared by mixing 100g of methacrylic acid, 200g of ethyl methacrylate, 100g of ethyl acrylate, 100g of styrene, and 0.8g of azobisisobutyronitrile, which was then slowly added dropwise to the flask for 4 hours After the dropwise addition, the reaction was continued for 2 hours. Next, 100 g of a mixed solvent (the composition is the same as above) in which 1.2 g of azobisisobutyronitrile was dissolved was dropped into the flask, and the dropping time was 10 minutes. After the dropwise addition, the reaction was further performed at 80° C. for 3 hours, and the temperature was raised to The reaction was continued at 90°C for 2 hours. After the reaction, the alkali soluble polymer C1 was obtained by filtration, and the weight average molecular weight was about 80,000.
3.性能评价3. Performance evaluation
3.1评价方式3.1 Evaluation method
以干膜应用方式为例,检测上述实施例和比较例所示的感光性树脂组合物的各项应用性能。Taking the dry film application method as an example, each application performance of the photosensitive resin compositions shown in the above examples and comparative examples was tested.
<干膜的制作><Production of dry film>
将感光性树脂组合物充分搅拌,使用棒涂器将其均匀涂布在作为支撑体的25μm厚的聚对苯二甲酸乙二醇酯薄膜的表面上,在干燥机中95℃干燥5分钟,形成厚度为40μm的感光性树脂层,然后在感光性树脂层的没有层压聚对苯二甲酸乙二醇酯薄膜的表面贴合作为保护层的15μm厚的聚乙烯薄膜,获得干膜。The photosensitive resin composition was sufficiently stirred, and it was evenly coated on the surface of a 25 μm thick polyethylene terephthalate film as a support using a bar coater, and dried in a dryer at 95° C. for 5 minutes. A photosensitive resin layer with a thickness of 40 μm was formed, and then a 15 μm-thick polyethylene film as a protective layer was laminated on the surface of the photosensitive resin layer where no polyethylene terephthalate film was laminated to obtain a dry film.
<基板表面整平><Plane surface leveling>
作为基板,使用层压有35μm厚的轧制铜箔的1.2mm厚的覆铜层压板,对表面进行湿式抛光辊研磨(3M公司制造的Scotch-Brite(注册商标)HD#600,通过两次)。As a substrate, a 1.2-mm-thick copper-clad laminate laminated with a 35-μm-thick rolled copper foil was used, and the surface was subjected to wet polishing roll grinding (Scotch-Brite (registered trademark) HD#600 manufactured by 3M Corporation, and passed twice ).
<层压><lamination>
将聚乙烯薄膜保护层从干膜上剥离,然后使用热辊层压机(旭化成(株)制造的AL-70),以105℃的辊温度将其层压于预热至60℃的覆铜层压板上。气体压力为0.35MPa,层压速度为1.5m/min。The polyethylene film protective layer was peeled off from the dry film, and then using a hot roll laminator (AL-70 manufactured by Asahi Kasei Co., Ltd.), it was laminated on a copper clad preheated to 60°C at a roll temperature of 105°C. Laminate. The gas pressure is 0.35 MPa, and the lamination speed is 1.5 m/min.
<曝光><exposure>
将掩膜放置在作为支撑体的聚对苯二甲酸乙二醇酯薄膜上,通过超高压汞灯(ORCMANUFACTURINGCO.,LTD.制造的HMW-201KB)进行曝光。The mask was placed on a polyethylene terephthalate film as a support, and exposed by an ultra-high pressure mercury lamp (HMW-201KB manufactured by ORCMANUFACTURINGCO., LTD.).
<显影><Development>
剥离聚对苯二甲酸乙二醇酯薄膜,使用碱显影机(FujiKikoCo.,Ltd.制 造的干膜用显影机),将30℃的1质量%的Na 2CO 3水溶液喷雾在感光性树脂层上,用2倍于最小显影时间的时间溶解除去感光性树脂层的未曝光部分。以未曝光部分的感光性树脂层完全溶解所需的最短时间为最小显影时间。 The polyethylene terephthalate film was peeled off, and a 1% by mass Na 2 CO 3 aqueous solution at 30° C. was sprayed on the photosensitive resin layer using an alkali developing machine (developer for dry film manufactured by FujiKiko Co., Ltd.) Above, the unexposed portion of the photosensitive resin layer is dissolved and removed in a time twice as long as the minimum development time. The minimum development time is the shortest time required to completely dissolve the photosensitive resin layer of the unexposed portion.
3.2评价内容3.2 Evaluation content
(1)相容性(1) Compatibility
将感光性树脂组合物充分搅拌,使用棒涂布器将组合物均匀涂布于作为支撑体的25μm厚的聚对苯二甲酸乙二醇酯薄膜的表面上。在干燥机中95℃干燥5min,形成感光性树脂层。随后目测感光性树脂层表面,按以下方式分级:The photosensitive resin composition was sufficiently stirred, and the composition was uniformly coated on the surface of a 25 μm-thick polyethylene terephthalate film as a support using a bar coater. Dry in a dryer at 95°C for 5 min to form a photosensitive resin layer. Then the surface of the photosensitive resin layer was visually inspected and graded as follows:
◇:表面均匀;◇: Even surface;
◆:表面析出未溶物。◆: Undissolved matter is deposited on the surface.
(2)感光度(2) Sensitivity
使用具有从透明到黑色的21级明亮度变化的Stouffer制造的21级阶段式曝光表对感光性树脂层曝光15min,以评价其感光度。曝光后,以最小显影时间的2倍时间进行显影,根据抗蚀膜完全残留的阶段式曝光表级数为8的曝光量,进行如下分级:The photosensitive resin layer was exposed for 15 minutes using a 21-stage stepped exposure meter manufactured by Stouffer with a 21-stage brightness change from transparent to black to evaluate its sensitivity. After the exposure, development is carried out at twice the minimum development time, and according to the exposure amount of the stepped exposure table with the resist film completely remaining being 8, the following classification is performed:
○:曝光量为20mJ/cm 2以下; ○: The exposure is 20mJ/cm 2 or less;
◎:曝光量为20mJ/cm 2-50mJ/cm 2,不包括端值; ◎: The exposure is 20mJ/cm 2 -50mJ/cm 2 , excluding the end value;
●:曝光量为50mJ/cm 2以上。 ●: The exposure is 50mJ/cm 2 or more.
(3)分辨率(3) Resolution
利用具有Line/Space=10:10-150:150(单位:μm)的布线图案的光掩模进行曝光显影后,测量干膜的分辨率。分辨率是在曝光后显影形成的抗蚀图案中,未曝光部分被清除干净后的图案的最小值。After exposure and development using a photomask having a wiring pattern of Line/Space=10:10-150:150 (unit: μm), the resolution of the dry film was measured. The resolution is the minimum value of the pattern after the unexposed portion is cleaned out of the resist pattern formed by development after exposure.
○:分辨率值在30μm以下;○: Resolution value is below 30μm;
◎:分辨率值在30μm-50μm,不包括端值;◎: The resolution value is 30μm-50μm, excluding the end value;
●:分辨率值在50μm以上。●: The resolution value is above 50μm.
(4)亲水性(4) Hydrophilicity
通过感光性树脂层溶解后的沉淀量来评价亲水性。The hydrophilicity was evaluated by the amount of precipitation after the photosensitive resin layer was dissolved.
将感光性树脂组合物充分搅拌,使用棒涂布器均匀地涂布于作为支撑体的25μm厚的聚对苯二甲酸乙二醇酯薄膜的表面上。在干燥机中95℃干燥4min,形成感光性树脂层,层厚约为30.5μm,层重约为3.2g。The photosensitive resin composition was sufficiently stirred, and applied uniformly on the surface of a 25 μm-thick polyethylene terephthalate film as a support using a bar coater. Dry in a dryer at 95°C for 4 minutes to form a photosensitive resin layer with a layer thickness of approximately 30.5 μm and a layer weight of approximately 3.2 g.
将20g碳酸钠溶于2L水中,加1.5 ml的P1uronic RPG3110(BASF,Mt.Olive,NJ,此试剂是聚氧乙烯和聚氧丙烯共聚物增塑剂),制得显影液。将上述附有感光性树脂层的薄膜放入100g显影液中,试样静置直至树脂层溶解,沉淀量按下列等级确定:Dissolve 20g of sodium carbonate in 2L of water, add 1.5ml of P1uronic RPG3110 (BASF, Mt. Olive, NJ, this reagent is polyoxyethylene and polyoxypropylene copolymer plasticizer) to prepare a developer. Put the above-mentioned film with photosensitive resin layer into 100g developer solution, let the sample stand until the resin layer is dissolved, and the amount of precipitation is determined according to the following grade:
0=沉淀量低于0.005g;0=precipitation amount is less than 0.005g;
1=少量的细分散浅黄物,沉淀量在0.005-0.01g之间;1 = A small amount of finely dispersed light yellow matter with a precipitation amount between 0.005-0.01g;
5=中等量浅黄物(通常较细),沉淀量在0.05-0.08g之间;5=Medium amount of light yellow substance (usually fine), the amount of precipitation is between 0.05-0.08g;
10=有大量固体层浅黄物(通常呈薄片状),沉淀量在0.1g以上。10=There are a large number of light yellow substances in the solid layer (usually in the form of flakes), and the amount of precipitation is above 0.1 g.
(5)显影性(5) developability
显影之后通过扫描电子显微镜(SEM)观察光刻胶图案,以评价显影性。After development, the photoresist pattern was observed by a scanning electron microscope (SEM) to evaluate developability.
显影性根据以下标准评价:The developability is evaluated according to the following criteria:
□:在未曝光部分未观察到残留物;□: No residue was observed in the unexposed part;
△:在未曝光部分观察到少量残留物,但残留量可以接受;△: A small amount of residue was observed in the unexposed part, but the amount of residue was acceptable;
×:在未曝光部分观察到明显残留物。×: A clear residue was observed in the unexposed part.
3.3评价结果3.3 Evaluation results
评价结果如表11中所示。The evaluation results are shown in Table 11.
Figure PCTCN2019120524-appb-000046
Figure PCTCN2019120524-appb-000046
Figure PCTCN2019120524-appb-000047
Figure PCTCN2019120524-appb-000047
Figure PCTCN2019120524-appb-000048
Figure PCTCN2019120524-appb-000048
本发明的HABI类混合光引发剂,应用于感光性树脂组合物时具有优异的相容性,组合物的感光度高、分辨率和显影性好,且具有优异的亲水性,使得显影液可重复利用,不会出现显影垃圾堵塞滤网的情况。相较于比较例1-28的感光性树脂组合物,本发明的综合应用性能优势显著。The HABI mixed photoinitiator of the present invention has excellent compatibility when applied to a photosensitive resin composition. The composition has high sensitivity, good resolution and developability, and has excellent hydrophilicity, making the developer It can be reused, and there will be no clogging of the filter by developing garbage. Compared with the photosensitive resin composition of Comparative Examples 1-28, the comprehensive application performance advantage of the present invention is remarkable.
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其它的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited by the above embodiments. Any other changes, modifications, substitutions, combinations, changes, modifications, substitutions, combinations, etc. that do not depart from the spirit and principles of the present invention The simplifications should all be equivalent replacement methods, which are all included in the protection scope of the present invention.

Claims (20)

  1. 一种六芳基双咪唑类混合光引发剂,具有如通式(I)所示结构,其中含有1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物,且由这四种连接位组成的双咪唑化合物在六芳基双咪唑混合光引发剂中的总质量百分含量为92%以上,A hexaarylbisimidazole mixed photoinitiator with a structure as shown in the general formula (I), which contains four connection positions of 1'-2, 2-3', 1-2' and 2'-3 A double imidazole compound, and the total mass percentage of the double imidazole compound composed of these four connection positions in the hexaarylbisimidazole mixed photoinitiator is more than 92%,
    Figure PCTCN2019120524-appb-100001
    Figure PCTCN2019120524-appb-100001
    通式(I)中,Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6可以相同也可以不同,各自独立地表示取代或未取代的芳基。 In the general formula (I), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 , and Ar 6 may be the same or different, and each independently represents a substituted or unsubstituted aryl group.
  2. 根据权利要求1所述的六芳基双咪唑类混合光引发剂,其特征在于,满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物具有下列结构:The hexaarylbisimidazole-based mixed photoinitiator according to claim 1, characterized in that it satisfies 1'-2, 2-3', 1-2' and 2'- of the structure represented by the general formula (I) 3 Four kinds of biimidazole compounds at the linking position have the following structure:
    Figure PCTCN2019120524-appb-100002
    Figure PCTCN2019120524-appb-100002
    Figure PCTCN2019120524-appb-100003
    Figure PCTCN2019120524-appb-100003
  3. 根据权利要求1或2所述的六芳基双咪唑类混合光引发剂,其特征在于:芳基上的取代基为卤素、硝基、氰基、胺基、羟基、C 1-C 20的烷基或链烯基、C 1-C 8的烷氧基,其中各独立变量中的亚甲基可以任选地被氧、硫、亚胺基所取代。 The hexaarylbisimidazole mixed photoinitiator according to claim 1 or 2, wherein the substituents on the aryl group are halogen, nitro, cyano, amine, hydroxyl, C 1 -C 20 Alkyl or alkenyl, C 1 -C 8 alkoxy, wherein the methylene in each independent variable may be optionally substituted with oxygen, sulfur, imino.
  4. 根据权利要求1-3中任一项所述的六芳基双咪唑类混合光引发剂,其特征在于:芳基上的取代基为氟、氯、溴、硝基、氰基、胺基、羟基、C 1-C 10的烷基或链烯基、C 1-C 5的烷氧基,其中各独立变量中的亚甲基可以任选地被氧、硫、亚胺基所取代。 The hexaarylbisimidazole mixed photoinitiator according to any one of claims 1-3, wherein the substituents on the aryl group are fluorine, chlorine, bromine, nitro, cyano, amine, Hydroxyl group, C 1 -C 10 alkyl group or alkenyl group, C 1 -C 5 alkoxy group, wherein the methylene group in each independent variable may be optionally substituted by oxygen, sulfur, imine group.
  5. 根据权利要求1-4中任一项所述的六芳基双咪唑类混合光引发剂,其特征在于:Ar 1、Ar 2、Ar 3、Ar 4、Ar 5、Ar 6中至少一个是含有卤素取代基的芳基。 The hexaarylbisimidazole mixed photoinitiator according to any one of claims 1 to 4 , wherein at least one of Ar 1 , Ar 2 , Ar 3 , Ar 4 , Ar 5 and Ar 6 contains The aryl group of the halogen substituent.
  6. 根据权利要求5所述的六芳基双咪唑类混合光引发剂,其特征在于:所述的卤素取代基为氯。The hexaarylbisimidazole mixed photoinitiator according to claim 5, wherein the halogen substituent is chlorine.
  7. 根据权利要求1-6中任一项所述的六芳基双咪唑类混合光引发剂,其特征在于:满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物在混合光引发剂中的总质量百分含量为95%以上。The hexaarylbisimidazole mixed photoinitiator according to any one of claims 1-6, characterized in that it satisfies 1'-2, 2-3', 1- that satisfy the structure represented by the general formula (I) The total mass percentage content of the 4′ and 2′-3 biimidazole compounds in the mixed photoinitiator is more than 95%.
  8. 根据权利要求1-7中任一项所述的六芳基双咪唑类混合光引发剂,其特征在于:由满足通式(I)所示结构的1’-2、2-3’、1-2’和2’-3四种连接位的双咪唑化合物组成。The hexaarylbisimidazole-based mixed photoinitiator according to any one of claims 1 to 7, characterized in that: 1'-2, 2-3', 1 satisfying the structure represented by the general formula (I) -2'and 2'-3 four imidazole compounds connected position.
  9. 感光性树脂组合物,含有权利要求1-9中任一项所述的六芳基双咪唑类混合光引发剂。A photosensitive resin composition containing the hexaarylbisimidazole mixed photoinitiator according to any one of claims 1-9.
  10. 根据权利要求9所述的感光性树脂组合物,还包含:碱可溶性聚合 物,具有烯属不饱和双键的化合物,其它光引发剂和/或增感剂,以及任选的助剂。The photosensitive resin composition according to claim 9, further comprising: an alkali-soluble polymer, a compound having an ethylenically unsaturated double bond, other photoinitiators and/or sensitizers, and optional auxiliary agents.
  11. 根据权利要求10所述的感光性树脂组合物,其特征在于:所述的碱可溶性聚合物选自(甲基)丙烯酸系聚合物、苯乙烯系聚合物、环氧系聚合物、脂肪族聚氨酯(甲基)丙烯酸酯聚合物、芳香族聚氨酯(甲基)丙烯酸酯聚合物、酰胺系树脂、酰胺环氧系树脂、醇酸系树脂、以及酚醛系树脂。The photosensitive resin composition according to claim 10, wherein the alkali-soluble polymer is selected from (meth)acrylic polymer, styrene polymer, epoxy polymer, and aliphatic polyurethane (Meth)acrylate polymer, aromatic urethane (meth)acrylate polymer, amide resin, amide epoxy resin, alkyd resin, and phenol resin.
  12. 根据权利要求10或11所述的感光性树脂组合物,其特征在于:所述碱可溶性聚合物是含羧基的碱可溶性聚合物。The photosensitive resin composition according to claim 10 or 11, wherein the alkali-soluble polymer is an alkali-soluble polymer containing a carboxyl group.
  13. 根据权利要求12所述的感光性树脂组合物,其特征在于:所述含羧基的碱可溶性聚合物是由(甲基)丙烯酸酯、乙烯性不饱和羧酸和其它可共聚单体共聚而成的(甲基)丙烯酸酯系聚合物。The photosensitive resin composition according to claim 12, wherein the carboxyl group-containing alkali-soluble polymer is formed by copolymerizing (meth)acrylate, ethylenically unsaturated carboxylic acid, and other copolymerizable monomers (Meth)acrylate polymer.
  14. 根据权利要求10所述的感光性树脂组合物,其特征在于:所述具有烯属不饱和双键的化合物是在分子内具有至少一个乙烯性不饱和键的光聚合性化合物。The photosensitive resin composition according to claim 10, wherein the compound having an ethylenically unsaturated double bond is a photopolymerizable compound having at least one ethylenically unsaturated bond in the molecule.
  15. 根据权利要求10或14所述的感光性树脂组合物,其特征在于:所述具有烯属不饱和双键的化合物选自双酚A类(甲基)丙烯酸酯化合物和分子内具有氨酯键的(甲基)丙烯酸酯化合物。The photosensitive resin composition according to claim 10 or 14, wherein the compound having an ethylenically unsaturated double bond is selected from bisphenol A (meth)acrylate compounds and has a urethane bond in the molecule (Meth)acrylate compound.
  16. 根据权利要求10所述的感光性树脂组合物,其特征在于:所述其它光引发剂和/或增感剂选自双咪唑类、吡唑啉类、芳香族酮类、蒽醌类、苯偶姻和苯偶姻烷基醚类、肟酯类、三嗪类、三苯胺类、香豆素类、噻吨酮类、吖啶类光引发剂中的至少一种。The photosensitive resin composition according to claim 10, wherein the other photoinitiator and/or sensitizer is selected from the group consisting of diimidazoles, pyrazolines, aromatic ketones, anthraquinones, and benzene At least one of benzoin and benzoin alkyl ethers, oxime esters, triazines, triphenylamines, coumarins, thioxanthones, and acridine photoinitiators.
  17. 根据权利要求10所述的感光性树脂组合物,其特征在于:所述助剂选自染料、光显色剂、颜料、填充剂、增塑剂、稳定剂、涂布助剂、剥 离促进剂中的至少一种。The photosensitive resin composition according to claim 10, wherein the auxiliary agent is selected from the group consisting of dyes, photochromic agents, pigments, fillers, plasticizers, stabilizers, coating aids, and peeling accelerators At least one of them.
  18. 感光性树脂层叠体,包含:权利要求9-17中任一项所述的感光性树脂组合物形成的感光性树脂层,以及支撑该感光性树脂层的支撑体。A photosensitive resin laminate comprising: the photosensitive resin layer formed of the photosensitive resin composition according to any one of claims 9-17; and a support for supporting the photosensitive resin layer.
  19. 权利要求18所述的感光性树脂层叠体在制造印刷电路板、保护图案、导体图案、引框线、半导体封装中的应用。Use of the photosensitive resin laminate according to claim 18 in the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, and semiconductor packages.
  20. 权利要求9-17中任一项所述的感光性树脂组合物在制造印刷电路板、保护图案、导体图案、引框线、半导体封装中的应用。Use of the photosensitive resin composition according to any one of claims 9 to 17 in the manufacture of printed circuit boards, protective patterns, conductor patterns, lead wires, and semiconductor packages.
PCT/CN2019/120524 2018-11-30 2019-11-25 Hexaarylbiimidazole hybrid photoinitiator and application WO2020108421A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021531320A JP7264535B2 (en) 2018-11-30 2019-11-25 Mixed photoinitiators of hexaarylbisimidazoles and their uses
KR1020217020531A KR102542920B1 (en) 2018-11-30 2019-11-25 Hexaarylbisimidazole-based mixed photoinitiator and applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811451262.4 2018-11-30
CN201811451262.4A CN111258180B (en) 2018-11-30 2018-11-30 Hexaarylbisimidazoles mixed photoinitiator and application thereof

Publications (1)

Publication Number Publication Date
WO2020108421A1 true WO2020108421A1 (en) 2020-06-04

Family

ID=70853735

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/120524 WO2020108421A1 (en) 2018-11-30 2019-11-25 Hexaarylbiimidazole hybrid photoinitiator and application

Country Status (4)

Country Link
JP (1) JP7264535B2 (en)
KR (1) KR102542920B1 (en)
CN (1) CN111258180B (en)
WO (1) WO2020108421A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111747897A (en) * 2019-03-29 2020-10-09 常州格林感光新材料有限公司 Hexaarylbisimidazole photoinitiator and application thereof
CN111752100A (en) * 2019-03-29 2020-10-09 常州强力电子新材料股份有限公司 Photosensitive resin composition containing bisimidazole photoinitiator, application thereof, color filter and image display device
CN112062721B (en) * 2019-05-23 2023-06-30 常州正洁智造科技有限公司 HABI photoinitiator capable of improving system stability and application thereof
CN113929624A (en) * 2020-07-13 2022-01-14 常州强力电子新材料股份有限公司 Pyrazoline compound, photosensitive resin composition and patterning method
CN112433445B (en) * 2020-11-06 2023-12-26 福斯特(安吉)新材料有限公司 Photosensitive resin composition for UV LED light source marking and dry film resist
CN115128899A (en) * 2021-03-26 2022-09-30 常州正洁智造科技有限公司 Photosensitive resin composition with improved system hue stability

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA824633A (en) * 1969-10-07 E.I. Du Pont De Nemours And Company Photopolymerizable products and processes
US3549367A (en) * 1968-05-24 1970-12-22 Du Pont Photopolymerizable compositions containing triarylimidazolyl dimers and p-aminophenyl ketones
US3784557A (en) * 1962-03-21 1974-01-08 Du Pont Phototropic 2,4,5-triphenylimidazolyl radicals and dimers thereof
US4311783A (en) * 1979-08-14 1982-01-19 E. I. Du Pont De Nemours And Company Dimers derived from unsymmetrical 2,4,5,-triphenylimidazole compounds as photoinitiators
CN1043797A (en) * 1988-12-23 1990-07-11 纳幕尔杜邦公司 The visible sensitizers that is used for photopolymerizable composition
JP2001222106A (en) * 2000-02-08 2001-08-17 Hitachi Chem Co Ltd Photosensitive resin composition, photosensitive element using same, method for producing resist pattern and method for producing printed wiring board
CN101379434A (en) * 2006-02-08 2009-03-04 日合·莫顿株式会社 Photosensitive resin composition and photoresist film using the same
CN101432139A (en) * 2006-04-25 2009-05-13 伊斯曼柯达公司 Bakeable radiation-sensitive elements with a high resistance to chemicals
CN110114376A (en) * 2017-03-31 2019-08-09 株式会社Adeka Solidification compound, the manufacturing method of solidfied material, its solidfied material and the bonding agent using it

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622286A (en) * 1985-09-16 1986-11-11 E. I. Du Pont De Nemours And Company Photoimaging composition containing admixture of leuco dye and 2,4,5-triphenylimidazolyl dimer
US5153100A (en) * 1990-08-27 1992-10-06 E. I. Du Pont De Nemours And Company Borate coinitiators for photopolymerizable compositions
JPH1036354A (en) * 1996-07-19 1998-02-10 Nippon Kayaku Co Ltd Production of hexaarylbisimidazoles
US6180319B1 (en) * 1998-03-11 2001-01-30 E. I. Du Pont De Nemours And Company Process for the continuous liquid processing of photosensitive compositions having reduced levels of residues
WO2001095033A1 (en) 2000-06-06 2001-12-13 Hodogaya Chemical Co., Ltd. Photosensitive resin composition and photosensitive material using the same
JP4393051B2 (en) * 2002-10-15 2010-01-06 昭和電工株式会社 Hexaarylbiimidazole compound and photopolymerization initiator composition containing the same
JP4230209B2 (en) 2002-12-12 2009-02-25 保土谷化学工業株式会社 Photosensitive resin composition
CN1727999A (en) 2005-04-11 2006-02-01 常州华钛化学有限公司 New type hexa aryl and di-imidazole photoinitiator, and photosensitive combination of polyimide
DE602006012366D1 (en) * 2005-12-20 2010-04-01 Basf Se Oximester-photoinitiatoren
CN101558356B (en) * 2006-12-19 2013-09-25 日立化成株式会社 Photosensitive resin composition, photosensitive element, method for resist pattern formation, and method for manufacturing printed wiring board
CN101302257A (en) * 2008-06-03 2008-11-12 江南大学 Ultraviolet photosensitive composite initiation system and use thereof
KR101121038B1 (en) * 2008-07-01 2012-03-15 주식회사 엘지화학 Photoresist resin composition containing a number of photo-initiators, transparent thin film layer and liquid crystal display using the same
JP2010122381A (en) 2008-11-18 2010-06-03 Hitachi Chem Co Ltd Black photosensitive resin composition, method for producing black matrix, method for producing color filter, and color filter
CN101418051A (en) * 2008-12-01 2009-04-29 常州强力电子新材料有限公司 Photoinitiator contaning asymmetic hexaaryl bis imidazole and preparation method thereof
JP2011237736A (en) 2010-05-13 2011-11-24 Hitachi Chem Co Ltd Photosensitive resin composition, photosensitive film and permanent resist
JP2015087429A (en) 2013-10-28 2015-05-07 日立化成株式会社 Photosensitive resin composition, photosensitive element, and method for forming resist pattern
JP6755109B2 (en) 2016-03-29 2020-09-16 旭化成株式会社 Photosensitive resin composition, photosensitive resin laminate, resist pattern forming method and conductor pattern manufacturing method

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA824633A (en) * 1969-10-07 E.I. Du Pont De Nemours And Company Photopolymerizable products and processes
US3784557A (en) * 1962-03-21 1974-01-08 Du Pont Phototropic 2,4,5-triphenylimidazolyl radicals and dimers thereof
US3549367A (en) * 1968-05-24 1970-12-22 Du Pont Photopolymerizable compositions containing triarylimidazolyl dimers and p-aminophenyl ketones
US4311783A (en) * 1979-08-14 1982-01-19 E. I. Du Pont De Nemours And Company Dimers derived from unsymmetrical 2,4,5,-triphenylimidazole compounds as photoinitiators
CN1043797A (en) * 1988-12-23 1990-07-11 纳幕尔杜邦公司 The visible sensitizers that is used for photopolymerizable composition
JP2001222106A (en) * 2000-02-08 2001-08-17 Hitachi Chem Co Ltd Photosensitive resin composition, photosensitive element using same, method for producing resist pattern and method for producing printed wiring board
CN101379434A (en) * 2006-02-08 2009-03-04 日合·莫顿株式会社 Photosensitive resin composition and photoresist film using the same
CN101432139A (en) * 2006-04-25 2009-05-13 伊斯曼柯达公司 Bakeable radiation-sensitive elements with a high resistance to chemicals
CN110114376A (en) * 2017-03-31 2019-08-09 株式会社Adeka Solidification compound, the manufacturing method of solidfied material, its solidfied material and the bonding agent using it

Also Published As

Publication number Publication date
JP7264535B2 (en) 2023-04-25
KR102542920B1 (en) 2023-06-14
JP2022523892A (en) 2022-04-27
CN111258180A (en) 2020-06-09
KR20210110815A (en) 2021-09-09
CN111258180B (en) 2024-03-08

Similar Documents

Publication Publication Date Title
WO2020108421A1 (en) Hexaarylbiimidazole hybrid photoinitiator and application
WO2020108420A1 (en) Hexaarylbisimidazole hybrid photoinitiator
JP6673196B2 (en) Photosensitive resin composition, photosensitive element, method for forming resist pattern, and method for manufacturing printed wiring board
WO2020200020A1 (en) Hexaarylbiimidazole photoinitiator and application thereof
WO2020233700A1 (en) Habi photoinitiator capable of improving system stability and application thereof
TWI766645B (en) Ethoxy/propoxy modified pyrazoline organics, their applications, photocurable compositions and photoresists
JP7332807B2 (en) EO/PO-modified 9-phenylacridine photosensitizer and use thereof
TWI810605B (en) A kind of pyrazoline compound, photosensitive resin composition and patterning method
WO2022199625A1 (en) Photosensitive resin composition having improved system hue stability
CN114326309A (en) Photosensitive resin composition and application thereof
CN116410135A (en) Naphthalene vinyl pyridine compound, photosensitive resin composition, application thereof and patterning method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19888584

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021531320

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2101003075

Country of ref document: TH

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19888584

Country of ref document: EP

Kind code of ref document: A1